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PUBLICATION DISSERTATION OPTION

The Introduction and Background sections of this dissertation provide information
about the research topic, and a review of the literature. The body of this dissertation has
been compiled in the format for publication in peer-reviewed journals. Seven papers have
been included in the following order. The first paper, “Freeze Casting of Porous
Hydroxyapatite Scaffolds - I. Processing and General Microstructure,” was published in
Journal of Biomedical Materials Research Part B Applied Biomaterials in July 2008 in
Volume 86 Issue 1 pages 25-58. The second paper, “Freeze Casting of Porous
Hydroxyapatite Scaffolds - II. Sintering, Microstructure, and Mechanical Behavior,” was
published in Journal of Biomedical Materials Research Part B Applied Biomaterials in
August 2008 in Volume 86 Issue 2 pages 59-88. The third paper, “Freeze-cast
Hydroxyapatite Scaffolds for Bone Tissue Engineering Applications,” was published in
Biomedical Materials in June 2008 in Volume 3 Issue 2 pages 89-109. This paper was
selected by the editors as one of the highlights of the papers published in Biomedical
Materials in 2008. The fourth paper, “Proliferation and Function of MC3T3-E1 Cells on
Freeze-cast Hydroxyapatite Scaffolds with Oriented Pore Architectures,” was published
in Journal of Materials Science: Materials in Medicine in May 2009 Volume 20 Issue 5
pages 110-128. The fifth paper, “In vitro Cellular Response to Hydroxyapatite Scaffolds
with Oriented Pore Architectures,” was accepted by Materials Science and Engineering
C in April 2009 pages 129-154. The sixth paper, “Preparation and In vitro Evaluation of
Bioactive Glass (13-93) Scaffolds with Oriented Microstructures for Repair and
Regeneration of Load-Bearing Bones,” was accepted by Journal of Biomedical Materials
Research Part A in July 2009 page 155-187. The seventh paper, “In vivo evaluation of
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13-93 bioactive glass scaffolds with trabecular and oriented microstructures in a
subcutaneous rat implantation model,” was prepared for submission to Acta
Biomaterialia page 188-213.
Three papers related to the present research, but not included in the main body of
this dissertation, are given in the appendix. The first manuscript, “Possible Toughening
Mechanisms in Unidirectional Hydroxyapatite Scaffolds Prepared by Freeze Casting,”
was prepared to provide supplemental information to the body text. The second paper,
“Preparation and Bioactive Characteristics of a Porous 13-93 Glass, and Fabrication into
the Articulating Surface of a Proximal Tibia,” was published in Journal of Biomedical
Materials Research Part A in July 2007 Volume 82 Issue 1 pages 231-256. The third
paper, “Mechanical and In vitro Performance of 13-93 Bioactive Glass Scaffolds
Prepared by a Polymer Foam Replication Technique,” was published in Acta
Biomaterialia in November 2008 Volume 4 Issue 6 pages 257-293.
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ABSTRACT

The main objectives of this dissertation were to explore the production of
bioactive ceramic and glass scaffolds with oriented pore architectures by unidirectional
freezing of suspensions, and to characterize the mechanical and biological performance
of the scaffolds. Freezing of aqueous suspensions of hydroxyapatite (HA) or bioactive
13-93 glass particles resulted in the formation of scaffolds with a lamellar-type
microstructure (pore width = 5–30 µm). The addition of polar organic solvents (such as
60 wt% dioxane) to the aqueous suspensions markedly changed the morphology and size
of the oriented pores, giving scaffolds with a columnar-type microstructure and larger
pore width (90–110 µm). The scaffolds showed a unique ‘elastic–plastic’ mechanical
response in compression along the orientation direction, with large strain for failure
(>20%) and strain rate sensitivity. For a similar porosity, the bioactive glass scaffolds had
a higher strength than the HA scaffolds, presumably because of better sintering
characteristics. Columnar bioactive glass scaffolds (porosity = 55–60%) had a
compressive strength of 25 ± 3 MPa. The columnar scaffolds with the larger pore width
showed better ability than the lamellar scaffolds to support the proliferation and function
of murine osteoblastic cells (MLO-A5 or MC3T3-E1). Subcutaneous implantation in the
dorsum of rats showed abundant tissue ingrowth into the pores of the columnar scaffolds
and integration of the scaffolds with surrounding tissue. The results indicate that
bioactive 13-93 glass scaffolds with the columnar microstructure could be used for the
repair of segmental defects in load-bearing bones.

vi
ACKNOWLEDGMENTS

I am grateful to my advisor, Dr. Mohamed N. Rahaman, for his advice,
encouragement and guidance through the course of my study. His time, effort and
commitment have been invaluable to me. I would also like to thank my co-advisor, Dr.
Fatih Dogan, for introducing me to the “freeze-processing” field, and for his guidance
and helpful discussion during this study.
I sincerely appreciate Dr. Roger F. Brown for his assistance with in vitro and in
vivo experiments, and for helpful discussions. I would like to thank the rest of my
committee, Drs. B. Sonny Bal and Delbert E. Day for their constructive suggestions for
my study and for reviewing this dissertation. Sincere thanks also go to Dr. Wenhai Huang
at Tongji University for introducing me to the idea of studying in the USA, and giving
me good encouragement.
All of my friends and colleagues deserve many thanks as well. Working and
learning with you have brought a lot of fun to my life. Thank you Yadong Li in Suzhou
University, Dr. Shi-Chang Zhang, Dr. Tieshu Huang, Dr. Sumin Zhu, Sheng Chao, Xuhui
Lv, Hailuo Fu, Xin Liu, Steven Jung, and Vernon Modglin.
Thank you to all my friends who have helped me enjoy staying four years in a
small town as Rolla.
Last but not the least thanks to those who made this possible: my parents,
Changlai Fu and Zhengling Cai, and my wife, Liying Zhang. It is their love, belief and
bearing that kept me moving forward with my research.

vii
TABLE OF CONTENTS

Page
PUBLICATION DISSERTATION OPTION.................................................................... iii
ABSTRACT........................................................................................................................ v
ACKNOWLEDGMENTS ................................................................................................. vi
LIST OF ILLUSTRATIONS........................................................................................... xiv
LIST OF TABLES......................................................................................................... xxiv
SECTION
1. PURPOSE OF THIS DISSERTATION..................................................................... 1
2. BACKGROUND........................................................................................................ 2
2.1. SCAFFOLDS FOR BONE TISSUE ENGINEERING....................................... 2
2.2. FREEZE CASTING OF POROUS GLASS AND CERAMIC SCAFFOLDS 12
2.2.1. Formation of the Structure ..................................................................... 13
2.2.2. Microstructure Development.................................................................. 15
2.2.3. Mechanical Properties ............................................................................ 18
2.2.4. Physical Limits ....................................................................................... 19
2.3. REFERENCES ................................................................................................. 21
PAPER
1. FREEZE CASTING OF POROUS HYDROXYAPATITE – I. PROCESSING
AND MICROSTRUCTURE.................................................................................... 25
1.1. ABSTRACT...................................................................................................... 25
1.2. INTRODUCION............................................................................................... 26
1.3. MATERIALS AND METHODS...................................................................... 30

viii
1.3.1. Processing of HA Suspensions............................................................... 30
1.3.2. Freeze Casting of Suspensions ............................................................... 31
1.3.3. Microstructural Characterization of Porous HA Constructs .................. 32
1.4. RESULTS ......................................................................................................... 33
1.4.1. Rheological Behavior of HA Suspensions Used for Freeze Casting. .... 33
1.4.2. Microstructure of Freeze-Cast HA Constructs ....................................... 34
1.4.2.1 Constructs Prepared from Aqueous Suspensions .......................34
1.4.2.2 Constructs Prepared from Suspensions with Water-Glycerol
and Water-Dioxane Mixtures......................................................36
1.5. DISCUSSION ................................................................................................... 37
1.6. CONCLUSIONS............................................................................................... 42
1.7. REFERENCES ................................................................................................. 43
2. FREEZE CASTING OF POROUS HYDROXYAPATITE SCAFFOLDS – II.
SINTERING, MICROSTRUCTURE AND MECHANICAL BEHAVIOR ........... 59
2.1. ABSTRACT...................................................................................................... 59
2.2. INTRODUCTION ............................................................................................ 60
2.3. MATERIALS AND METHODS...................................................................... 63
2.4. RESULTS ......................................................................................................... 65
2.5. DISCUSSION ................................................................................................... 70
2.6. CONCLUSIONS............................................................................................... 74
2.7. REFERENCES ................................................................................................. 75
3. FREEZE-CAST HYDROXYAPATITE SCAFFOLDS FOR BONE TISSUE
ENGINEERING APPLICATIONS ......................................................................... 89
3.1. ABSTRACT...................................................................................................... 89
3.2. INTRODUCTION ............................................................................................ 90

ix
3.3. MATERIALS AND METHODS...................................................................... 92
3.3.1. Freeze Casting of Suspensions ............................................................... 92
3.4. RESULTS AND DISCUSSION ....................................................................... 94
3.4.1. Microstructure of Constructs Prepared from Aqueous Suspensions...... 94
3.4.2. Effects of Sintering Conditions .............................................................. 95
3.4.3. Effect of Solvent Composition on Microstructure ................................. 96
3.4.4. Mechanical Response of HA Constructs................................................ 97
3.5. CONCLUSION................................................................................................. 99
3.6. REFERENCES ............................................................................................... 100
4. PROLIFERATION AND FUNCTION OF MC3T3-E1 CELLS ON
FREEZE-CAST HYDROXYAPATITE SCAFFOLDS WITH ORIENTED
PORE ARCHITECTURES .................................................................................... 110
4.1. ABSTRACT.................................................................................................... 110
4.2. INTRODUCTION .......................................................................................... 111
4.3. MATERIALS AND METHODS.................................................................... 113
4.3.1. Preparation of HA Scaffolds ................................................................ 113
4.3.2. Cell Culture .......................................................................................... 114
4.3.3. MTT Staining of Viable Cells .............................................................. 114
4.3.4. Cell Morphology .................................................................................. 115
4.3.5. Quantitative Protein Assay................................................................... 115
4.3.6. Alkaline Phosphatase Activity ............................................................. 115
4.3.7. Statistical Analysis ............................................................................... 116
4.4. RESULTS AND DISCUSSION ..................................................................... 116
4.5. CONCLUSIONS............................................................................................. 120

x
4.6. REFERENCES ............................................................................................... 121
5. IN VITRO CELL RESPONSE TO HYDROXYAPATITE SCAFFOLDS WITH
ORIENTED PORE ARCHITECTURES ............................................................... 129
5.1. ABSTRACT.................................................................................................... 129
5.2. INTRODUCTION .......................................................................................... 130
5.3. MATERIALS AND METHODS.................................................................... 132
5.3.1. Preparation of HA Scaffolds ................................................................ 132
5.3.2. Cell Culture .......................................................................................... 132
5.3.3. Cell Morphology .................................................................................. 133
5.3.4. MTT Detection of Viable Cells............................................................ 133
5.3.5. Quantitative Protein Assay................................................................... 134
5.3.6. Alkaline Phosphatase (ALP) Activity .................................................. 134
5.3.7. Alizarin Red S staining for Mineralization and Quantitation............... 135
5.3.8. Statistical Analysis ............................................................................... 135
5.4. RESULTS ....................................................................................................... 135
5.4.1. Microstructure of HA Scaffolds ........................................................... 135
5.4.2. SEM Examination of Cultures ............................................................. 136
5.4.3. MTT Assay........................................................................................... 136
5.4.4. Quantitation of Protein ......................................................................... 138
5.4.5. Alkaline Phosphatase Activity ............................................................. 139
5.4.6. Mineralization ...................................................................................... 139
5.5. DISCUSSION ................................................................................................. 140
5.6. CONCLUSION............................................................................................... 141
5.7. REFERENCES ............................................................................................... 142

xi
6. PREPARATION AND IN VITRO EVALUATION OF BIOACTIVE GLASS
(13-93) SCAFFOLDS WITH ORIENTED MICROSTRUCTURES FOR
REPAIR AND REGENERATION OF LOAD-BEARING BONES..................... 155
6.1. ABSTRACT.................................................................................................... 155
6.2. INTRODUCTION .......................................................................................... 156
6.3. MATERIALS AND METHODS.................................................................... 159
6.3.1. Preparation of Porous 13-93 Glass Scaffolds....................................... 159
6.3.2. Characterization of Porous 13-93 Glass Constructs............................. 160
6.3.3. Cell Culture .......................................................................................... 161
6.3.4. Cell Morphology .................................................................................. 162
6.3.5. Cell Viability and Growth .................................................................... 162
6.3.6. Quantitative Protein Assay................................................................... 163
6.3.7. Alkaline Phosphatase (ALP) Activity .................................................. 163
6.3.8. Alizarin Red S Staining for Mineralization and Quantitation.............. 163
6.3.9. Statistical Analysis ............................................................................... 164
6.4. RESULTS ....................................................................................................... 164
6.4.1. Microstructure of the Freeze-cast 13-93 Glass Scaffold ...................... 164
6.4.2. Mechanical Behavior of the Freeze-cast 13-93 Glass Scaffold............ 165
6.4.3. SEM Examination of Cultures ............................................................. 166
6.4.4. Cell Proliferation and Cell Infiltration ................................................. 167
6.4.5. Cell Function ........................................................................................ 168
6.5. DISCUSSION ................................................................................................. 169
6.6. CONCLUSIONS............................................................................................. 171
6.7. REFERENCES ............................................................................................... 172

xii
7. IN VIVO EVALUATION OF 13-93 BIOACTIVE GLASS SCAFFOLDS
WITH TRABECULAR AND ORIENTED MICROSTRUCTURES IN A
SUBCUTANEOUS RAT IMPLANTATION MODEL......................................... 188
7.1. ABSTRACT.................................................................................................... 188
7.2. INTRODUCTION .......................................................................................... 189
7.3. MATERIALS AND METHODS.................................................................... 191
7.3.1. Preparation of Trabecular and Columnar Scaffolds ............................. 191
7.3.2. Seeding of Scaffolds with Mesenchymal Stem Cells........................... 192
7.3.3. Animal Implantation............................................................................. 193
7.3.4. Histology .............................................................................................. 193
7.3.5. SEM Observation ................................................................................. 194
7.3.6. Statistical Analysis ............................................................................... 194
7.4. RESULTS ....................................................................................................... 194
7.4.1. Microstructure of As-prepared Scaffolds ............................................. 194
7.4.2. Morphological and Compositional Changes of Scaffolds In vivo........ 195
7.4.3. Histological Evaluation of Tissue Infiltration of Implants................... 196
7.5. DISCUSSION ................................................................................................. 198
7.6. CONCLUSION............................................................................................... 201
7.7. REFERENCE.................................................................................................. 202
SECTION
3. CONCLUSIONS .................................................................................................... 214
4. FUTURE WORK ................................................................................................... 217
APPENDICES
A. POSSIBLE TOUGHENING MECHANISMS IN UNIDIRECTIONAL
HYDROXYAPATITE SCAFFOLDS PREPARED BY FREEZE CASTING.......... 219

xiii

B. PREPARATION AND BIOACTIVE CHARACTERIZATION OF A POROUS
13-93 GLASS, AND FABRICATION INTO THE ARTICULATING SURFACE
OF A PROXIMAL TIBIA ......................................................................................... 231
C. MECHANICAL AND IN VITRO PERFORMANCE OF 13-93 BIOACTIVE
GLASS SCAFFOLDS PREPARED BY A POLYMER FOAM REPLICATION
TECHNIQUE ............................................................................................................. 257
VITA .............................................................................................................................. 294

xiv
LIST OF ILLUSTRATIONS

Page
BACKGROUND
Figure 2.1. Key components in tissue engineering ............................................................ 4
Figure 2.2. Illustration of cortical and trabecular bone...................................................... 5
Figure 2.3. Typical structures of porous scaffolds: (a) hydroxyapatite scaffold
fabricated by solvent-casting and particulate-leaching 54, (b) bioactive
13-93 glass scaffold fabricated by polymer foam replication56, (c) solid
freeform fabrication12 and (d) bioactive 70S30C glass fabricated by a
foaming method61. The scaffolds show an isotropic structure. ....................... 9
Figure 2.4. Processing steps in freeze casting: slurry preparation, solidification,
sublimation and sintering71. ........................................................................... 12
Figure 2.5. Schematic graph of the particle motion at the solidification front ................ 14
Figure 2.6. Typical porous scaffolds obtained by unidirectional freezing of
suspensions: (a) hydroxyapatite using water as a solvent69,
(b). hydroxyapatite using water/glycerol (20 wt% glycerol) as a solvent69,
(c) hydroxyapatite using waster/dioxane (60 wt% dioxane) as a solvent69,
(d) calcium phosphate using camphene as a solvent77................................... 16
Figure 2.7. Compressive strength vs. porosity of freeze-cast hydroxyapatite
constructs. Comparison with compact bone and literature values of
porous HA for tissue engineering67. ............................................................. 19
PAPER 1
Figure 1.

Viscosity of aqueous HA suspension (20 vol%) as a function of shear
rate for different dispersants. ......................................................................... 48

Figure 2.

Viscosity of aqueous HA suspension (20 vol%) as a function of
dispersant concentration for a shear rate of 100 s–1....................................... 49

Figure 3.

Relative viscosity at a shear rate of 100 s-1 versus volume fraction of HA
particles stabilized by Dynol 604. ................................................................. 50

Figure 4.

Optical image of a sintered HA sample, showing the shape uniformity.
(Scale is in inches.) ........................................................................................ 51

xv
Figure 5.

SEM images of the HA sample cross section perpendicular (a, b) and
parallel (c, d) to the freezing direction. The sample was sintered for 3 h
at 1350°C. ...................................................................................................... 52

Figure 6.

Mercury porosimetry data for the sintered HA sample, showing the pore
volume and the pore size distribution as functions of the pore diameter. ..... 53

Figure 7.

SEM images of the sintered HA sample fabricated from suspensions with
different particle concentrations: (a), (b), 10 vol%; (c), (d), 5 vol%. (The
cross section is perpendicular to the freezing direction.) .............................. 54

Figure 8.

SEM images of the cross section perpendicular (a), (c), and parallel (b),
(d), to the freezing direction, for sintered HA samples fabricated by
freezing the suspension on substrates at (a), (b) –50°C; (c), (d) –196°C. ..... 55

Figure 9.

Effects of glycerol concentration on the microstructure of the sintered
HA sample (a), (b) 5 wt%; (c), (d) 20 wt%. (The cross section is
erpendicular to the freezing direction.).......................................................... 56

Figure 10. Mercury porosimetry data for the sintered HA sample prepared from
suspensions with 20 wt% glycerol, showing the pore volume and the
pore size distribution as functions of the pore diameter. ............................... 57
Figure 11. Effects of dioxane concentration on the microstructure of the sintered
HA sample (a), (b) 30 wt%; (c), (d) 60 wt%. (The cross section is
perpendicular to the freezing direction.)........................................................ 58
PAPER 2
Figure 1.

X-ray diffraction (XRD) patterns of the as-received HA powder, the
powder heated for 1 h at 900°C, and the freeze-cast construct sintered for
3 h at 1375°C. ................................................................................................ 79

Figure 2.

Influence of sintering temperature on the porosity and compressive
strength (in the direction of freezing) for HA constructs prepared from
aqueous suspensions with 20 vol% particles. All pairs of the porosity
were significantly different except the pair between HA constructs
sintered at 1350 and 1375 ºC (p = 0.99); all pairs of compressive
strength were significantly different except the pairs between 1250
and 1275 ºC, 1300 and 1325, 1350 and 1375 ºC (p = 0.97, 0.22, 1.0
respectively)................................................................................................... 80

xvi
Figure 3.

Effect of glycerol addition to the aqueous suspension (20 vol% particles)
on the porosity and compressive strength of constructs sintered for 3 h at
1350°C. All pairs of the porosity of the HA constructs with different
glycerol addition were significantly different; all pairs of the compressive
strength of HA construct were significantly different except the pairs
between HA constructs prepared from 0 and 5, 5 and 10, 15 and
20 wt% glycerol (p = 0.69, 0.28, 0.50 respectively)...................................... 81

Figure 4.

Stress-strain behavior in compression testing parallel and perpendicular
to the freezing direction, for HA constructs prepared from aqueous
suspensions (20 vol% particles) and sintered for 3 h at 1350°C. Three
different regions are outlined for the curve corresponding to the parallel
testing direction: I, elastic region; II, stress plateau region; III, failure
region. ............................................................................................................ 82

Figure 5.

Effect of loading rate on the compressive mechanical response of HA
constructs prepared from aqueous suspension with 20 vol% particles.......... 83

Figure 6.

Stress-strain behavior in three-point bending for HA constructs
prepared from aqueous suspensions (20 vol% particles) and sintered for
3 h at 1350°C. ................................................................................................ 84

Figure 7.

Stress-strain behavior of HA constructs prepared from suspensions with
20 wt% glycerol and sintered fro 3 h at 1350°C. The load was applied in
compression, parallel and perpendicular to the freezing direction. ............... 85

Figure 8.

Effect of loading rate on the mechanical response of the HA constructs
prepared from aqueous suspensions (10 vol% particles) containing
60 wt% dioxane. ............................................................................................ 86

Figure 9.

Fractured surfaces, after compression testing, of HA constructs prepared
from suspensions without glycerol: (a) top surface, perpendicular to the
freezing direction; (b) surface parallel to the freezing direction. .................. 87

Figure 10. Fractured surfaces, after compression testing, of HA constructs prepared
from suspensions with 20 wt% glycerol: (a) top surface, perpendicular
to the freezing direction; (b) surface parallel to the freezing direction. ........ 88
PAPER 3
Figure 1.

X-ray diffraction (XRD) patterns of as-received HA powder, the
freeze-cast constructs sintered for 3 h at 1350ºC. The pattern for a
reference HA (JCPDS 72-1243) is also shown............................................ 104

Figure 2.

SEM images of the HA sample cross section (a) perpendicular, and (b)
parallel to the freezing direction; (c) higher magnification image of the

xvii
cross section in (b), showing the pore structure; (d) surface of the
sample. The sample was sintered for 3 h at 1350°C.................................... 105
Figure 3.
Figure 4.

Influence of sintering temperature on porosity and compressive strength
of HA samples. ............................................................................................ 106
Effects of solvent composition on the microstructure of HA constructs
prepared from 10 vol% suspension: (a) water; (b) water + 20 wt%
glycerol; (c) water + 60 wt% dioxane.......................................................... 107

Figure 5.

Stress-strain response in compression testing parallel and perpendicular
to the freezing direction, for HA constructs prepared from aqueous
suspensions (20 vol% particles) and sintered for 3 h at 1350°C. Three
different regions are outlined for the curve corresponding to the
parallel testing direction: I, elastic region; II, stress plateau region;
III, failure region.......................................................................................... 108

Figure 6.

Effect of strain (or strain) rate on the mechanical response of the HA
constructs prepared from aqueous suspension (20 vol% particles). ........... 109

PAPER 4
Figure 1.

SEM images of MC3T3-E1 cell morphology on freeze-cast constructs
with a, c, e lamellar-type and b, d, f cellular-type microstructures after
culturing for a, b 2 days; c, d 4 days; e, f 6 days ......................................... 124

Figure 2.

Quantitative measurement of total protein content of cell-seeded
scaffolds or control incubated for 2, 4, and 6 days. Mean ± sd; n = 4.
*Significant increase in total amount of protein on the porous HA
constructs with increasing culture duration (p<0.05). ................................. 125

Figure 3.

Cell-seeded HA constructs treated with MTT: (left) surface of constructs
with a lamellar-type and c cellular-type microstructure after culture
intervals of 2, 4, and 6 days (left to right, respectively); (right) freezefracture section of scaffold cultured for 6 days, showing considerably
greater infiltration of MTT-labeled cells into the interior of the cellular
microstructure d than in the lamellar microstructure b................................ 126

Figure 4.

Quantitative analysis of the purple formazan on the HA constructs with
lamellar- and cellular-type microstructures. Mean ± sd; n = 4.
*Significant increase in formazan extracted from the porous HA
constructs with increasing culture duration (p<0.05). ................................. 127

Figure 5.

Alkaline phosphatase activity in MC3T3-E1 cells cultured on two types
(lamellar- and cellular-type) of freeze-cast HA scaffolds and control
wells. Enzyme activity is expressed as nmol of p-NP formed per min.
Mean ± sd; n = 4. *Significant increase in enzyme activity on the

xviii
porous HA constructs with increasing culture duration (p<0.05)................ 128
PAPER 5
Figure 1.

SEM images of HA constructs prepared by unidirectional freezing of
suspensions (10 vol% particles) with three different microstructures:
(a) columnar; (b) lamellar........................................................................... 144

Figure 2.

SEM images of MLO-A5 cell morphology on freeze-cast HA constructs
with (a-c) columnar-type, (d-f) lamellar-type, after culturing for (a, d) 2
days; (b, e) 4 days; (c, f) 6 days.................................................................. 145

Figure 3.

Cell-seeded HA constructs treated with MTT: surface of constructs
with (a) columnar-type, (c) lamellar-type microstructure after culture
intervals of 2, 4, and 6 days (left to right, respectively); (b, d)
freeze-fracture face of scaffolds cultured for 6 days, showing clusters
of MTT-labeled cells within the interior. .................................................... 146

Figure 4.

Quantitative measurement of the amount of the formazan present in the
cell-seeded constructs after MTT labeling. Except where indicated, all
pairs are significantly different (p<0.05). .................................................... 147

Figure 5.

Proliferation of MLO-A5 cells into the unidirectional pores of the
columnar-type scaffolds as a function of culture time. The ingrowth of
cells was determined by measuring the depth of the purple color visible
on the fracture face. The inset image indicates the ingrowth of cells
throughout the porous construct after 12 days of culture. ........................... 148

Figure 6.

HA constructs with a columnar-type microstructure after they were
dipped slightly (< 1 mm) in a cell suspension, and then treated with
MTT: (a, b) surface and (c, d) cross section of construct, showing the
MTT-labeled cell clusters on and within the scaffolds................................ 149

Figure 7.

Quantitative measurement of total protein content per scaffold or well in
MLO-A5 cell cultures incubated for 2, 4, 6 and 8 days on HA constructs
with different pore morphology, and in control wells. Mean ± sd; n = 4.
Except where indicated, all pairs are significantly different (p<0.05). ....... 150

Figure 8.

Alkaline phosphatase activity in MLO-A5 cells cultured on HA
scaffolds with different pore morphology and control well for 2, 4, 6
and 8 days. Mean ± sd; n = 4. Except where indicated, all pairs are
significantly different (p<0.05).................................................................... 151

Figure 9.

Optical images of bone nodules recovered from HA constructs with the
columnar-type microstructure cultured for (a) 3, (b) 6, (c) 9 and (d)
12 days, and stained with alizarin red S. ..................................................... 152

xix
Figure 10. Optical image of bone nodules recovered by trypsinization from HA
constructs with a columnar-type microstructure stained with alizarin
red S. The construct was cultured for12 days.............................................. 153
Figure 11. Quantitative analysis of the mineralization by measuring the absorbance
of the extracted alizarin red dye. Except where indicated, all pairs are
significantly different (p<0.05).................................................................... 154
PAPER 6
Figure 1.

SEM images of the cross sections of 13-93 bioactive glass scaffolds
prepared with different microstructures from suspensions containing
15 vol% particles: (a, b) columnar microstructure (solvent: water +
60 wt% dioxane); (c, d) lamellar microstructure (aqueous solvent). The
cross sections are perpendicular to the freezing direction. .......................... 176

Figure 2.

Compressive strength (in the direction of pore orientation) and porosity
of 13-93 bioactive glass scaffolds with (a) columnar microstructure and
(b) lamellar microstructure, prepared from suspensions containing
different concentrations of particles. ........................................................... 177

Figure 3.

Compressive stress vs. deformation for 13-93 bioactive glass scaffolds
tested at the deformation rates shown: (a) columnar scaffolds; (b)
lamellar scaffolds......................................................................................... 178

Figure 4.

SEM images showing the cell growth on (left) columnar scaffolds, and
(right) lamellar scaffolds after (a, b) 2 days, (c, d) 4 days, and (e, f) 6
days of culture.............................................................................................. 179

Figure 5.

Cell-seeded glass scaffolds treated with MTT: surface of (a) columnar
scaffolds, and (c) lamellar scaffolds after culture intervals of 2, 4, and 6
days (left to right, respectively); (b, d) freeze-fracture cross section of the
corresponding scaffolds cultured for 6 days, showing MTT-labeled cells
within the interior. ....................................................................................... 180

Figure 6.

Quantitative analysis of the purple formazan extracted from cell-seeded
columnar and lamellar scaffolds. Mean ± sd; n = 4. *Significant increase
in formazan extracted from the porous glass constructs with increasing
culture duration (p<0.05). ............................................................................ 181

Figure 7.

Bioactive glass scaffold with the columnar microstructure after one end
was dipped slightly (< 1 mm) in a suspension of MLO-A5 cells, and
treated with MTT: (a) surface and (b) cross section, showing the MTTlabeled cells on and within the scaffolds. .................................................... 182

xx
Figure 8.

Proliferation of MLO-A5 cells into the pores in the interior of the
columnar scaffolds, determined by measuring the depth of the purple
color across a fracture cross section. The inset image shows complete
cell proliferation into scaffold after 15 days of culture. .............................. 183

Figure 9.

Total protein content in MLO-A5 cells cultured on columnar and
lamellar scaffolds and in control wells. Mean ± sd; n = 4. *Significant
increase in total amount of protein on the porous 13-93 glass constructs
with increasing culture incubation (p < 0.05).............................................. 184

Figure 10. Alkaline phosphatase activity in MLO-A5 cells cultured on columnar
and lamellar scaffolds and in control wells for 2, 4 and 6 days.
Mean ± sd; n = 4. *Significant increase in alkaline phosphatase activity
on the porous 13-93 glass constructs with increasing culture incubation
(p < 0.05). .................................................................................................... 185
Figure 11. Bone nodule formation by MLO-A5 cells cultured on columnar scaffold
for 9 days. ................................................................................................... 186
Figure 12. Quantitative analysis of mineralization in columnar and lamellar
scaffolds and in control wells, by measuring the absorbance (optical
density) of the extracted alizarin red staining dye using an Optima plate
reader at 520 nm. *Significant increase in the extracted red staining dye
on the porous 13-93 glass constructs with increasing culture incubation
(p < 0.05). .................................................................................................... 187
PAPER 7
Figure 1.

SEM images of 13-93 bioactive glass scaffolds with (a) trabecular
microstructure, similar to the microstructure of dry human trabecular
bone, and (b) columnar microstructure of oriented pores (cross section
perpendicular to the pore orientation direction). ......................................... 207

Figure 2.

Gross appearance of bioactive glass scaffolds 4 weeks after
subcutaneous implantation in the dorsum of rats. ....................................... 208

Figure 3.

SEM backscattered electron images of trabecular implants (a) without
MSCs and (b) seeded with MSCs; and columnar implants (c) without
MSCs and (d) seeded with MSCs, after subcutaneous implantation for 4
weeks. G denotes glass; T denotes tissue; P denotes PMMA..................... 209

Figure 4.

SEM backscattered electron image of bioactive glass in trabecular
scaffold (without MSCs) after subcutaneous implantation for 4 weeks
(a), and corresponding X-ray maps for Ca(K) (b), P(K) (c), and Si(K)
(d). C denotes unconverted glass core; S denotes SiO2-rich layer;
H denotes hydroxyapatite layer. .................................................................. 210

xxi
Figure 5.

Transmitted light images of toluidine blue stained sections for
trabecular implants (a) without MSCs, (b) seeded with MSCs, and for
columnar implants (c) without MSCs, and (d) seeded with MSCs, after
implantation for 4 weeks. ............................................................................ 211

Figure 6.

Transmitted light images of Goldner’s trichrome stained sections for
trabecular implants (a) without MSCs, (b) seeded with MSCs, and for
columnar implants (c) without MSCs, and (d) seeded with MSCs, after
implantation for 4 weeks. ............................................................................ 212

Figure 7.

Transmitted light images of thin sections stained with SandersonTM
Bone Stain for trabecular implants (a) without MSCs, and (b) seeded
with MSCs, and columnar implants (c) without MSCs, and (d) seeded
with MSCs, after subcutaneous implantation for 4 weeks. G denotes
bioactive glass; S denotes soft tissue; O denotes osteoid production......... 213

APPENDIX A
Figure 1.

SEM images of the cross sections of HA scaffolds with a lamellar
microstructure prepared by unidirectional freezing of suspensions:
(a, b) perpendicular, and (c, d) parallel to the freezing direction. ............... 228

Figure 2.

Stress-deformation curve in compression testing parallel to the freezing
direction for HA constructs prepared from aqueous suspension (20
vol% particles). Three different regions are outline for the curve: I,
elastic region; II, stress plateau region; III, failure region........................... 229

Figure 3.

Microstructures (a1–d1) of lamellar-type HA scaffolds after testing in
compression (in the direction of freezing) to increasing strains
(deformation) shown. (Regions I, II, and III refer to the different
regions of the strss vs. deformation curve in Fig, 2). The diagrams on
the right illustrate the dominant toughening mechanisms: (a2)
microcracking, (b2) crack deflection, (c2) tortuous crack path, and
(d2) sliding................................................................................................... 230

APPENDIX B
Figure 1.
Figure 2.

Figure 3.

Differential thermal analysis of 13-93 glass, showing the glass transition
and crystallization regions. .......................................................................... 248
SEM of (a) the surface of a porous glass construct prepared by
sintering, (b) the neck region between two particles, showing bonding
between the particles, and (c) a cross-section of the construct showing
the bonded particles and pores..................................................................... 249
Mercury porosimetry of the fabricated constructs, showing the pore
volume and the pore size distribution as functions of the pore radius......... 250

xxii
Figure 4.

Thin-film XRD of the 13-93 glass, and the glass after immersion in a
simulated body fluid at 37°C for various times. .......................................... 251

Figure 5.

FTIR of the 13-93 glass and the glass after immersion in a simulated
body fluid at 37°C for various times............................................................ 252

Figure 6.

SEM micrographs of the cross-sections of the 13-93 glass (a) prior to
immersion, and (b)after immersion for 14 d in a simulated body fluid
at 37°C, showing the hydroxyapatite layer.................................................. 253

Figure 7.

Thickness of the hydroxyapatite layer formed on the 13-93 glass as a
function of the immersion time in a simulated body fluid at 37°C.
(Linear regression, thickness vs. time: Y=0.363X, r=0.9954, p<0.0001). .. 254

Figure 8.

SEM of (a) the surface of 13-93 glass, and the surface after immersing
the glass in a simulated body fluid for 1 day (b), and 7 days (c). A
high magnification micrograph of the surface (7 days immersion) is
shown in (d). ................................................................................................ 255

Figure 9.

Optical micrograph of a porous construct with the shape of the
articulating surface of a human proximal tibia prepared by slip casting
and sintering 13-93 glass particles............................................................... 256

APPENDIX C
Figure 1.

Zeta-potential of 13-93 glass particles versus pH, for suspensions
without dispersant, and for suspensions containing 1 wt.% Darvan 811,
Darvan C, or EasySperse. ............................................................................ 283

Figure 2.

Viscosity of aqueous suspensions containing 35 vol% 13-93 glass
particles versus dispersant concentration (shear rate = 100 s–1). ................. 284

Figure 3.

Relative viscosity versus volume fraction of glass particles in aqueous
suspensions stabilized with 0.5 wt% EasySperse (shear rate = 100 s-1)...... 285

Figure 4.

Microstructures of: (a) polyurethane foam used in the experiments; (b)
dry human trabecular bone; and (c, d) 13–93 glass scaffolds fabricated
by a polymer foam replication technique. ................................................... 286

Figure 5.

Mercury porosimetry data for the pore volume and pore size distribution
versus pore radius, for the fabricated 13-93 glass scaffolds........................ 287

Figure 6.

Stress-strain response of porous 13-93 glass constructs in compression. ... 288

xxiii
Figure 7.

SEM images of the surface of 13-93 glass construct after immersion
for 7 days in SBF: (a) lower magnification image; (b, c) higher
magnification image showing fine needle-like hydroxyapatite crystals...... 289

Figure 8.

X-ray diffraction patterns of: (a) reference hydroxyapatite
(JCPDS 72-1243); (b) porous 13–93 glass scaffold in the as-sintered
condition; (c) sintered 13–93 glass scaffold after immersion in a
simulated body fluid for 7 days; and (d) human trabecular bone. ............... 290

Figure 9.

SEM images of 13-93 glass constructs seeded with MC3T3-E1 cells
and cultured for (a) 2 days; (b,c) 4 days; (d,e) 6 days. ............................... 291

Figure 10. Quantitative measurement of total protein content per scaffold or well in
MC3T3-E1 cell cultures incubated for 2, 4, and 6 d on porous 13-93
constructs prepared by the polymer foam replication method, and in
control wells. Mean ± sd; n = 4. *Significantly increase in total amount
of protein on the porous 13-93 glass constructs with increasing culture
duration (p<0.05). ........................................................................................ 292
Figure 11. Cell-seeded 13–93 glass scaffolds treated with MTT: (a) surface of
scaffolds after culture intervals of 2, 4 and 6 days (left to right,
respectively); and (b) freeze-fracture section of scaffold cultured for 6
days, showing clusters of MTT-labeled cells within the interior. ............... 293

xxiv
LIST OF TABLES

Page
PAPER 1
Table I:

Summary of lamellar thickness, porosity, and pore width for
constructs prepared from aqueous suspensions with 5, 10, and 20 wt%
particles.......................................................................................................... 46

Table II:

Comparison of porosity and pore widths for constructs prepared from
aqueous suspensions, suspensions with glycerol, and suspensions with
dioxane........................................................................................................... 47

PAPER 2
Table I.

Summary of pore characteristics and compressive strength of porous
scaffolds fabricated by a variety of methods. ................................................ 78

PAPER 3
Table 1:

Comparison of porosity, pore width, microstructure and compressive
mechanical properties of HA constructs prepared from aqueous
suspensions, suspensions with glycerol, and suspensions with dioxane. .... 103

PAPER 4
Table 1.

Microstructural characteristics of HA scaffolds prepared by a
unidirectional freezing of suspensions (10 vol% particles)......................... 123

PAPER 5
Table 1.

Microstructural characteristics of HA scaffolds prepared by
unidirectional freezing of suspensions (10 vol% particles) and used in
this work. ..................................................................................................... 143

PAPER 6
Table 1.

Microstructural characteristics of 13-93 bioactive glass scaffolds
prepared by unidirectional freezing of suspensions (15 vol% particles)
which were used in cell culture experiments............................................... 175

xxv
PAPER 7
Table 1.

Characteristics of the 13-93 bioactive glass scaffolds with trabecular
and columnar microstructure ....................................................................... 205

Table 2.

Tissue ingrowth scores# for total amount of tissue, glycosaminoglycan
(GAG), and collagen infiltrated into the trabecular and columnar
implants seeded with mesenchymal stem cells (MSCs) or unseeded
(without MSCs). .......................................................................................... 206

APPENDIX B
Table 1.

Ion concentration (mM) in SBF and in human blood plasma [31].............. 247

1. PURPOSE OF THIS DISSERTATION

The main purpose of this Ph.D. research was to develop porous three-dimensional
bioactive glass and ceramic scaffolds using a freeze casting method for potential
applications in bone repair and regeneration.
Both HA and 13-93 glass belong to the family of materials know as bioactive
ceramics, which are desirable scaffold materials for use in bone tissue engineering
because of their ability to enhance bone formation and bond to surrounding tissue. HA is
the main inorganic component in human bone. It is biocompatible, osteoconductive and
produce no systemic toxicity or immunological reactions. The glass designated 13-93
(composition in wt%: 53 SiO2, 6 Na2O, 12 K2O; 5 MgO, 20 CaO and 4 P2O5) is a
silicate-based bioactive glass with a modified 45S5 composition. In addition to its
bioactivity and biocompatibility, the glass has more facile viscous flow behavior and less
tendency to crystallize than 45S5. HA and 13-93 glass have been formed into threedimensional scaffolds for potential use in bone tissue engineering applications.
This first phase of these studies was meant to fabricate porous HA and 13-93
glass scaffolds with a unidirectional structure by a freeze casting technique. The
relationship between the process parameters, microstructure and mechanical properties of
hydroxyapatite (HA) and bioactive 13-93 glass scaffolds was investigated. Once the
scaffolds were successfully fabricated, the goal was to evaluate their in vitro cellular
response using murine MC3T3-E1 or MLO-A5 cells, an osteoblastic cell line, and their in
vivo performance using a subcutaneous rat implantation model.

2
2. BACKGROUND

2.1. SCAFFOLDS FOR BONE TISSUE ENGINEERING
Each year, millions of patients in the United States suffer tissue loss or end-stage
organ failure, with a total national healthcare cost of over $400 billion [1]. Traditional
treatments of organ or tissue loss include transplanting organs from one individual to
another, performing surgical reconstruction, and using mechanical devices [2-4]. Despite
the fact that they have saved and improved the lives of patients, these traditional therapies
suffer from limitations, such as shortage of donors, long-term problems with the surgical
reconstruction, and limited functions of the mechanical devices [1, 5].
Tissue engineering, an interdisciplinary field based on the principles of
engineering and the life sciences toward the creation of new biological substitutes to
restore, maintain, or improve tissue function, has emerged as a promising approach for
the regeneration of lost or damaged tissues [1, 6]. The creation of tissues and organs for
medical use is already a fact, although to a limited extent, in hospitals across the US [7].
These groundbreaking applications involve engineered skin [8], cartilage [9,10], bone
[11, 12], ligament [13, 14], nervous system [15, 16] and periodontal tissues [17, 18]. The
market for tissue-engineered products reached nearly $4 billion in 1999, and it was
projected to expand at ~20% per year [19].
A major area of emphasis for future tissue engineering research is the
development of new, more advanced biomaterials to replace the loss of hard and soft
tissues due to age-related attrition or degeneration, disease, or trauma. The traditional
techniques for treating bone defects include autografting and allografting cancellous
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bone, applying vascularized grafts of the fibula and iliac crest, and using other bone
transplantation. However, the use of autografts is constrained by limited donor sites, and
associated infection, pain, and hematoma in the donor sites [20-22]. The use of allografts
results in possible disease transmission and infections, and possible reduction or complete
loss of the bone inductive factors [23]. Bone tissue engineering, which involves use of a
scaffolding material to either induce formation of bone from the surrounding tissue, or to
act as a carrier or template for implanted bone cells or other agents, may potentially
provide alternative solutions for bone repair and regeneration.
The key components of this approach (Figure 1) are a suitable supply of cells,
environmental factors such as growth and differentiation supplements, and three
dimensional biomaterial scaffolds that can guide the growth of new tissue in vitro and in
vivo [24-28]. The scaffold serves as an initial biomechanical substrate on which seeded
cells can organize and develop into the desired organ or tissue prior to implantation. The
scaffold is either degraded or metabolized during the formation, deposition, and
organization of the newly generated matrix, which eventually leaves a vital organ or
tissue. Scaffold materials for tissue engineering applications must be biocompatible and
are designed to meet both nutritional and biological needs for the specific cell population
involved in tissue formation [29].
In addition to being biocompatible, an ideal scaffold for bone tissue engineering
should fulfill a number of criteria [12, 19, 24, 29, 31, 32]: (1) three-dimensional and
highly porous structure with an interconnected pore network for cell growth, and flow
transport of nutrients and metabolic waste; (2) bioactive, or biodegradable at a rate to
match cell/tissue growth in vitro and/or in vivo; (3) suitable surface chemistry for cell

4
attachment, proliferation and function; (4) mechanical competence to provide mechanical
stability in load bearing sites; (5) near-net-shape fabrication and scalability for costeffective industrial manufacturing.

Scaffolds
(collagen, bone mineral, synthetics)

Tissue
Cells
(osteoblasts)

Signals
(growth factors)

Figure 2.1. Key components in tissue engineering

As the scaffolds for bone tissue engineering are in contact with bone, it is
important to understand the structure and properties of bones in the body. Bone is a living
material composed of cells and a blood supply encased in a strong, interwoven composite
structure. Three major components are: collagen, which is flexible and tough;
hydroxyapatite bone mineral, which is the reinforcing phase of the composite; and the
bone matrix or ground substance, which is a three dimensional system that has maximum
strength and toughness along the lines of applied stress [33].
As shown in Figure 2, bone is generally classified into two types: cortical bone,
also referred to as compact bone, and trabecular bone, also referred to as cancellous or
spongy bone. Cortical bone, found primarily in the shaft of long bones and as the outer
shell around cancellous bone, is much denser, with a porosity of 5–10% [27]. Trabecular
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bone, found at the end of long bones, in vertebrae, and in flat bones such as the pelvis, is
much more porous, with porosity in the range 50–90% [28].

Figure 2.2. Illustration of cortical and trabecular bone

The mechanical properties of bone vary between subjects, from one bone to
another, and within different regions of the same bone. The mechanical properties are
also highly anisotropic, as a result of the oriented microstructure. The Young’s modulus
and the tensile and compressive strength in the longitudinal direction are approximately 2
and 1.5 times higher than those in the radial or tangential direction, respectively. Also,
the mechanical behavior of bone shows a high strain rate sensitivity. The Young’s
modulus, ultimate compressive strength, and yield strength increase with increasing rate
of loading. However, based on the testing of large specimens, the compressive strength
and elastic modulus of cortical bone has been reported in the range 100–150 MPa and
10–20 GPa in the direction parallel to the orientation (long axis) axis [34-36 ]. The
strength and modulus in the direction perpendicular to the long axis are typically 1.5 to 2
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times lower. A wide range has been reported for the Young’s modulus (0.1–5 GPa) and
compressive strength (2–12 MPa) of cancellous bone [35, 36].
So far, several scaffold materials have been investigated for bone tissue
engineering applications. Natural or synthetic polymers such as poly(lactic acid), PLA,
poly(glycolic acid), PGA, copolymers of PLA and PGA, known as poly(lactic co-glycolic
acid), PLGA, and collagen are biodegradable, so the scaffold can be gradually replaced
by new bone matrix synthesized by tissue-forming cells [37-40]. The chemical properties
of the saturated poly-α-hydroxy esters, such as PLA, PGA and PLGA, allow hydrolytic
degradation through de-esterification. The body has highly regulated mechanisms to
completely remove the degraded monomer components of each polymer through a
natural pathway. PLA and PGA have been approved by the US Food and Drug
Administration (FDA) to use in products and devices such as degradable sutures [41].
However, the bulk erosion process of these polymers may result in the failure of the
scaffolds prematurely. Rapid release of the acidic degradation products may also cause a
strong inflammatory response [42, 43].
The application of biodegradable polymers in the repair of load-bearing bones is
limited because of their low mechanical strength [37]. Although the strength of dense
polymers matches cancellous bone properties and approach cortical bone properties, the
strength of the porous scaffolds are at least one order of magnitude lower than that of
cancellous bone, and orders of magnitude lower than that of the cortical bone [31]. To
improve the load-bearing properties of biodegradable polymer scaffolds, attempts have
been made to reinforce the polymers with particles or short fibers. The use of reinforcing
materials such as hydroxyapatite, Ca10(PO4)6(OH)2, HA, and bioactive glass provides
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scaffolds that are biodegradable as well as bioactive [44-46]. However, the increase in the
strength is small, due mainly to the lack of interfacial bonding strength between the
ceramic phase and the polymer matrix [31].
Certain compositions of glasses, glass-ceramics, and ceramics, referred to as
‘bioactive ceramics’, have been widely investigated for healing bone defects, due to their
ability to enhance bone formation and to bond to surrounding tissue [47]. Certain glass
compositions with excellent biocompatibility as well as the ability to bond to bone were
first discovered by Hench et al. in 1971 [48]. The basic components of most bioactive
glasses are SiO2, Na2O, CaO and P2O5. The bioactive glass designated 45S5 (composition
in wt%: 45 SiO2, 24.5 Na2O, 24.5 CaO, 6 P2O5) and other silicate bioactive glasses based
on the 45S5 composition [49], such as the glass designated 13-93 (composition in wt%:
53 SiO2, 6 Na2O, 12 K2O, 5 MgO, 20 CaO, 4 P2O5) [50], have been widely studied for
biomedical applications [51].
A common characteristic of bioactive glasses and ceramics is a time-dependent
modification of the surface that occurs upon implantation. The formation of a
biologically active hydroxyl-carbonate apatite (HCA) layer on the surface provides the
bonding interface with the tissues. The equivalence in chemical properties and structure
of the HCA phase with that of the mineral phase in bone is believed to be responsible for
the interfacial bonding [49]. Although some details still remain unclear, it is widely
accepted that a layer of biologically active HCA must form for the bonding with bone to
occur, and that HCA is the only common feature of all the known bioactive implant
materials [47].
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As the main mineral constituent of bone, HA has been widely investigated as a
scaffold material for bone tissue engineering. Scaffolds of HA, both synthetic and
natural, are biocompatible as well as osteoconductive. They produce no systemic toxicity
or immunological reactions, and show biological affinity to bony tissues [49]. A
disadvantage of HA is its brittleness, which limits the scaffolds to applications subjected
to mainly compressive loading. One approach to this mechanical limitation is the use of
HA as the bioactive phase in composites, mainly polymer matrix composites [49, 52]. By
stiffening a compliant biocompatible synthetic polymer such as polyethylene (PE) with
HA particles (40 vol %), composites with mechanical properties comparable to those of
cortical bone, coupled with bone-bonding ability due to the HA phase, have been
developed [52]. Besides bioactive glass, HA and related calcium phosphates, such as αand β-tricalcium phosphate (α-TCP and β-TCP), also show excellent ability to bond to
bone. However, the low mechanical strength and relative long degradation time, typically
on the order of months or even years, of the crystalline calcium phosphates limit their
application in engineering new bone tissue [31].
Several methods have been used to produce porous scaffolds for bone repair and
regeneration, including solvent-casting and particulate-leaching [53, 54], polymer foam
replication [55, 56], solid free-form fabrication [12, 57, 58], and the use of foaming
agents [59-61]. These methods commonly provide an isotropic microstructure, as shown
in Figure 3. The strength of these scaffolds varies with the composition of the scaffold
and the fabrication method. Typically, the compressive strength of bioactive ceramic
scaffolds prepared by these methods is comparable to that of trabecular bone (2–12 MPa).
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A brief review of these fabrication techniques is presented in the following paragraphs to
give a general idea of the methodology.

(a)

(b)

(c)

(d)

500µm

200µm

Figure 2.3. Typical structures of porous scaffolds: (a) hydroxyapatite scaffold fabricated
by solvent-casting and particulate-leaching 54, (b) bioactive 13-93 glass scaffold
fabricated by polymer foam replication56, (c) solid freeform fabrication12 and (d)
bioactive 70S30C glass fabricated by a foaming method61. The scaffolds show an
isotropic structure.

The solvent-casting and particulate-leaching method was first developed by
Mikos et al. in 1993 to show that biodegradable polymers could be processed into various
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cell foams by using sodium chloride particles as a porogen [53]. The method involves the
combination of a suitable porogen with a solution of polymer in an appropriate mold to
manufacture solid polymer-porogen constructs. The porogen is then leached out to form
porous polymer sponges for the bone tissue engineering applications. Porogens such as
sodium chloride [53] and starch [54] are not soluble in the organic solvents typically used
to dissolve biodegradable polymers. The main advantage of the technique is the ease of
the scaffold fabrication without the need for complex machinery. The primary
disadvantages of the solvent casting method are: (1) poor pore interconnectivity at low
porogen loading; (2) limited number of polymers and solvents that are compatible with
the process; (3) the possible retention of toxic solvent within the scaffold; (4) the
degradation of polymer due to the long duration of the leaching process in water. There
has been limited work done on producing ceramic or polymer/ceramic composite
scaffolds using the solvent leaching process.
The polymer foam replication method was first used to produce macroporous
ceramics by Schwartzwalder and Somer [62]. They used polymeric sponges as templates
to prepare cellular ceramic structures of different pore sizes, porosity and chemical
compositions. In this method, a synthetic (e.g. polyurethane, PU) or natural (e.g. coral;
wood) foam is initially soaked in a ceramic suspension to obtain a uniform coating on the
foam struts. After drying of the coating, the polymer template and organic binders are
burned out through careful heat treatment between 300-600 ºC. The densification of the
ceramic struts is done by sintering at temperatures between 1000 to 15000 ºC, depending
on the ceramic material. The main advantage of this method is the production of highly
porous ceramics with open and interconnected porosity in the range 40-95%. One
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disadvantage of the method is the presence of a triangular void in the center of the struts
resulting from the removal of the polymer skeleton on heating, which significantly
reduces the mechanical strength of the porous ceramics. However, the use of the glass
with a proper thermal behavior has been show to effectively fill the void by the viscous
flow sintering of glass particles [56].
Solid freeform fabrication (SFF), also referred to as rapid prototyping, is a term to
describe a group of techniques that can be used to manufacture objects in a layer-by-layer
fashion from a computer-aided design (CAD) file, without the use of traditional tools
such as dies or molds. The SFF techniques differs significantly in the way they build
parts, but they all employ three steps in their process: data input, data file preparation,
and object building. Several SFF techniques have been used for scaffold fabrication,
including: three-dimensional printing (3DP), fused deposition modeling (FDM), ink-jet
printing and indirect casting (IC), stereolithography (SL), and selective laser sintering
(SLS) [63]. Scaffolds with controlled internal architecture and interconnectivity are made
with SFF from a variety of biomaterials. Polycaprolactone and HA scaffolds with fully
interconnected porous networks have been fabricated by the SFF technique [57, 58]. A
limitation of the method lies in the needs to improve the resolution at the micro scale.
In general, the methods mentioned above produce porous scaffolds with an
isotropic microstructure. Considering the complexity of the structure of bones, the
mechanical behavior varies from site to site. The mechanical properties of bone are
highly anisotropic due to its oriented microstructure. It would be beneficial to develop
scaffolds with oriented microstructure to fulfill the needs of different defect sites.
Unidirectional freezing of suspensions has been used to produce porous polymer
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constructs with oriented microstructure [64-66], and the method has been applied recently
to the production of porous bioceramics [67-70].

2.2. FREEZE CASTING OF POROUS GLASS AND CERAMIC SCAFFOLDS
For the production of porous ceramic scaffolds, the freeze casting route involves
rapid freezing of a colloidally-stable suspension of ceramic particles in a nonporous
mold, and sublimation of the frozen solvent under cold temperatures in a vacuum, as
shown in Figure 4 [71].

Figure 2.4. Processing steps in freeze casting: slurry preparation, solidification,
sublimation and sintering71.

After drying, the porous green samples are sintered to improve their mechanical
strength. The porosity in the constructs is a replica of the frozen solvent. During the
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freezing process, crystals of the solidified solvent are formed, and they grow into the
ceramic suspension, while the ceramic particles are rejected by the moving solidification
front, concentrated and entrapped between the solvent crystals. The microstructure and,
hence, the properties of the final sintered body are determined essentially by the
suspension parameters (such as particle size, particle concentration, and colloid stability
of the suspension), the freezing conditions (rate and direction of freezing), and the
sintering conditions (temperature and time).
2.2.1. Formation of the Structure. To obtain porous ceramic structures using
the unidirectional freezing technique, two requirements must be met [71]:
(1) The ceramic particles in the suspension must be assembled within the ice
template by rejection from the growing ice crystals. Figure 5 shows a schematic diagram
of the interaction of the particle with the advancing solid–liquid interface of the growing
ice crystal front. The interaction determines the engulfment or rejection of the particles
by the solidification front. Thermodynamically, a particle is rejected when the interfacial
energy between the particle and the solid phase, σsp, is larger than the sum of the energies
for the solid–liquid, σsl, and liquid–particle, σlp, interfaces:

∆σ 0 = σ sp − (σ sl + σ lp ) > 0

(1)

Based on the thermodynamic condition in Eq. (1), the balance of the repulsive
force and attractive drag force of a spherical particle moving close to a solidification front
gives the critical solidification front velocity for particle engulfment [72, 73]:
vc =

∆σ 0 d a 0 n
( )
3ηr d

(2)
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where r is the particle radius, a0 is the average intermolecular distance, d is the
distance between the particle and the solidification front, η is the solution viscosity, and n
is an exponent that varies from 1 to 4 depending on the specific model. The critical
velocity can be estimated by making assumptions that the disjoining force is negligible,
(in which case n = 1), and using the reported values27 for ∆σ0 ≈ 10-2 J m-2 and a0 ≈ 10-8 m.
Then the critical velocity can be obtained once the particle size and the viscosity of the
solution are determined. For the freezing of HA suspensions, the critical velocity is
determined to be vc = 0.01–0.1 m s–1 for a particle size of ~1 µm, and the viscosity of the
suspensions, of 10–2–10–3 Pa s.

Particle

R

Suspension
Ice

d

V

Figure 2.5. Schematic graph of the particle motion at the solidification front

(2) The ice crystals must grow into a non-planar morphology. If the ice front is
planar and the ceramic particles are rejected, all the particles are pushed to one side of the
sample after the solidification resulting into a dense packed cast body. The ceramic
particles must be rejected from the ice front and redistributed between the gaps of the
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solidification front to form porous structures. The eventual architecture of the ceramic
constructs is determined essentially by the morphology of the solidification front.
2.2.2. Microstructure Development. The morphology of the growing crystals of

the frozen solvent determines the pore morphology (a replica of the solidified crystals) of
the sintered materials. Figure 6 shows that the pore morphology varies from lamellar, to
rectangular, to columnar types. Depending on the processing parameters, including the
solvent composition, slurry formulation, and solidification conditions, the pore
morphology changes drastically. The freezing of suspensions containing water, waterdioxane mixture, and camphene solvents have resulted in the formation of lamellar,
columnar, and dendritic pores, respectively. The unidirectional freezing results in the
preferential orientation of the porosity, leading to anisotropic microstructure and
properties.
Freezing of aqueous suspensions is a traditional approach which utilizes ice as a
template to fabricate porous inorganic and polymeric structures. Lamellar-type pores with
the pore width of 10-40 µm were formed in the sintered HA constructs [67-69]. This type
of pore is a result of the crystallographic and crystal growth characteristics of ice. By
unidirectional freezing of the aqueous suspension, the ice front velocity parallel to the
crystallographic c axis is 100 to 1000 times lower than perpendicular to this axis (a or b
axis), which results in ice platelets of a large anisotropy [71]. The fast growth of the ice
crystals along the a or b axis, and slow along the c axis result in the formation of long
vertical lamellar crystals, which is evidenced by the oriented architecture in the sintered
ceramic constructs [67-69]. The structures developed by freezing aqueous suspensions
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have been confined to the production of lamellar–type microstructures due to the
hexagonal crystal structure of ice.
(a)

(b)

(c)

(d)

Figure 2.6. Typical porous scaffolds obtained by unidirectional freezing of suspensions:
(a) hydroxyapatite using water as a solvent69, (b) hydroxyapatite using water/glycerol (20
wt% glycerol) as a solvent69, (c) hydroxyapatite using waster/dioxane (60 wt% dioxane)
as a solvent69, (d) calcium phosphate using camphene as a solvent77.

Manipulation of the lamellar pore morphology resulting from the freezing of
aqueous suspension was investigated by adding different polar organic solvent to the
suspension prior to solidification. Certain liquids, such as glycerol and dioxane are
miscible with water, and when added to water modify the local structure of the aqueous
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liquid. As a result, they modify the nucleation and growth of the ice crystals, thereby
modifying the freezing behavior of the aqueous liquid. Glycerol effectively binds to
water molecules and disrupts the complete crystallization of ice. This leads to a localized
structure, resulting in a reduced size of the growing ice crystals and inhibiting solute
rejection [74]. The addition of glycerol (10–30 wt%) to the aqueous solvent reduced the
viscosity of Al2O3 suspensions stabilized with an anionic dispersant, ammonium
polymethacrylate, and produced more homogeneous microstructures after freeze casting
and sintering [74]. The effects were explained in terms of the ability of glycerol to both
enhance the colloidal stability of the suspensions and modify the freezing behavior of
water.
Dioxane is miscible with water at any composition under ambient conditions. A
study of the local solvent structure of dioxane–water mixtures [75] indicated that the
structure changed at three specific compositions when the mole fraction (χ) of dioxane in
the mixture was 0.13, 0.3, and 0.7. For χ < 0.13, the mixture consisted mainly of water
molecules with some water–dioxane complexes. For 0.13 < χ < 0.3, the system consisted
mainly of small clusters of water–dioxane molecules, whereas for χ > 0.3, the waterdioxane clusters gradually disappeared and the mixture evolved gradually to the inherent
solvent structure of pure dioxane. Lamellar-, columnar-, and rectangular-type
microstructures with a wider range of pore widths (10–100 µm) were obtained,
depending on the composition and the concentration of the organic liquid in the mixture.
Unidirectional freezing of suspensions containing organic solvents only, such as
camphene, also results in the formation of aligned pore architectures [76]. Camphene
dendrites were observed to grow preferentially along the <100> direction from the
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bottom to the top of the cast body. Large aligned pores were obtained by the continuous
overgrowth in the direction normal to the <100> direction [77]. Columnar pores of size
122 to 166 µm were obtained by the incubation of the cast body at 32ºC for various
times.
The nature of the solvent defines its crystallographic properties in the solid state
which determines the main pore morphology of the cast body. The choice of solvent with
different crystal structures may result in the different morphologies of the final ceramic
constructs.
2.2.3. Mechanical Properties. The compressive strength of the freeze-cast

ceramics is one of the most important properties, which has been widely investigated.
Marked improvements in the compressive strength of HA scaffolds were reported for
scaffolds formed by unidirectional freezing of aqueous suspensions. Compressive
strengths as high as 65 MPa (56% porosity) and 147 MPa (47% porosity) in the direction
parallel to the freezing direction were obtained (Figure 7). These strengths are well above
those for scaffolds obtained by more conventional methods such as foaming and polymer
foam replication. The strength of the porous HA is close to that of compact bone. The
high strength is attributed to the high anisotropy of the structure in the direction of
loading and the presence of inorganic bridges between the ceramic layers, which prevents
Euler buckling of the ceramic layers. The high strength makes it possible to use these
porous HA constructs for load-bearing applications. However, the strengths of freeze-cast
ceramics are shown to be highly dependent on the morphology of the pores. Ceramics
with columnar-type pores prepared by freezing of suspensions containing camphene and
water-dioxane solvents have shown strength close to usual cellular ceramics [70, 76, 77].
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HA constructs prepared from water-dioxane mixtures (60 wt% dioxane) with columnar
pores have a compressive strength of 7.5 MPa (porosity 65%, pore size 90-110 µm) [70].
Calcium phosphate scaffolds with the similar pore morphology and porosity (65%) but
larger pore size (122-166 µm) have a strength of 5-11 MPa [77].

Figure 2.7. Compressive strength vs. porosity of freeze-cast hydroxyapatite constructs.
Comparison with compact bone and literature values of porous HA for tissue
engineering67.
2.2.4. Physical Limits. In the case of the freeze casting of aqueous suspensions,

the limits of the technique are essentially dependent on the physics of ice. The ceramic
particle concentration in the suspension determines the final porosity of the ceramic
constructs. At lower particle concentration, the green body is too weak to handle after
sublimation of the solvent. Above a certain particle concentration, the solid/liquid
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interface moves into the interparticle space before the particle redistribution occurs, and
results in the entrapment of the particles within the ice.
The pore size of the final ceramic constructs is defined by the size of the crystals,
which is determined by several experimental parameters including the freezing rate, the
concentration of the suspension and the interaction between the solidification front and
the ceramic particles. By adjusting these parameters the pore size can be controlled to
some extent, but so far the freezing of the aqueous suspension results in the pore width of
only 10 - 40 µm [67, 69]. For the application of the porous ceramics in bone tissue
engineering, interconnected or unidirectional pores with a mean diameter (or width) of
100 µm or greater, and open porosity of >50% are generally considered to be the
minimum requirements to permit tissue ingrowth and function in porous scaffolds [25,
26]
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1.1. ABSTRACT

Freeze casting of aqueous suspensions on a cold substrate was investigated as a
method for preparing hydroxyapatite (HA) scaffolds with unidirectional porosity. In the
present paper, we report on the ability to manipulate the microstructure of freeze-cast
constructs by controlling the processing parameters. Constructs prepared from aqueous
suspensions (5–20 volume percent particles) on a steel substrate at –20°C had a lamellartype microstructure, consisting of plate-like HA and unidirectional pores oriented in the
direction of freezing. Sintering for 3 h at 1350°C produced constructs with dense HA
lamellas, porosity of ∼50%, and inter-lamellar pore widths of 5–30 µm. The thickness of
the HA lamellas decreased but the width of the pores increased with decreasing particle
concentration. Decreasing the cold substrate temperature from –20°C to –196°C
produced a finer lamellar microstructure. The use of water–glycerol mixtures (20 wt%
glycerol) as the solvent in the suspension resulted in the production of finer pores (1–10
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µm) and a larger number of dendritic growth connecting the HA lamellas. On the other
hand, the use of water–dioxane mixtures (60 wt% dioxane) produced a cellular-type
microstructure with larger pores (90–100 µm). The ability to produce a uniaxial
microstructure and its manipulation by controlling the processing parameters indicate the
potential of the present freeze casting route for the production of scaffolds for bone tissue
engineering applications.

Keywords: biomaterials; scaffolds; hydroxyapatite; freeze casting; porous ceramics

1.2. INTRODUCION

The development of new scaffolds and their processing into structures that have
properties tailored for specific applications, such as the repair of large defects in loadbearing bones are becoming increasingly important. In addition to the scaffold having
adequate mechanical properties for supporting physiological loads, tissue infiltration and
facile integration of the scaffold with surrounding tissue are required for ultimate clinical
application.
Certain synthetic and natural polymers, such as poly(lactic acid), PLA,
poly(glycolic acid), PGA, copolymers of PLA and PGA, and collagen are biodegradable,
so the scaffold can be gradually replaced by new bone matrix synthesized by tissueforming cells [1-4]. However, the use of degradable polymers for replacing load-bearing
bones is often challenging because of their relatively weak mechanical strength [1]. To
improve the load-bearing properties of biodegradable polymer scaffolds, attempts have
been made to reinforce the polymers with particles or short fibers. The use of reinforcing
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materials such as hydroxyapatite (HA) and bioactive glass provides scaffolds that are
biodegradable as well as bioactive [5-7].
Certain compositions of glasses, glass-ceramics, and ceramics, referred to as
bioactive ceramics, have been widely investigated for healing bone defects, due to their
ability to enhance bone formation and to bond to surrounding tissue [8]. Cell-seeded
bioactive ceramics are also of interest as potential scaffolds for bone tissue engineering
because they are osteoconductive as well as osteoinductive, and have the potential for
providing higher mechanical strength than the aforementioned polymers. As the main
mineral constituent of bone, hydroxyapatite (HA) has been widely investigated as a
scaffold material for bone tissue engineering. Scaffolds of HA, both synthetic and
natural, are biocompatible and osteoconductive. They produce no systemic toxicity or
immunological reactions, and show biological affinity for bony tissues [9]. A
disadvantage of HA is its brittleness, which limits the scaffolds to applications subjected
to mainly compressive loading. One approach to this mechanical limitation is the use of
HA as the bioactive phase in composites, mainly polymer composites [9, 10]. By
stiffening a compliant biocompatible synthetic polymer such as polyethylene (PE) with
HA particles (40 vol %), composites with mechanical properties comparable to those of
cortical bone, coupled with bone-bonding ability due to the HA phase, have been
developed [10].
A variety of methods have been used to produce porous scaffolds for bone repair
and regeneration, including consolidation with a pore-producing fugitive phase such as
starch or PVA [11, 12], the use of foaming agents [13,14],and solid freeform fabrication
[15,16].Freeze casting is a technique which has been used to produce polymeric and
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ceramic parts [17–25].It has been applied to the production of synthetic and natural
polymer scaffolds for tissue engineering applications[17–19],and its application to the
production of porous bioceramic scaffolds is now receiving some interest [26–29]. For
the production of porous bioceramic scaffolds, such as HA, the freeze casting route
involves rapid freezing of a colloidally stable suspension of HA particles in a nonporous
mold, and sublimation of the frozen solvent under cold temperatures in a vacuum. After
drying, the porous green samples are sintered to improve their mechanical strength. The
microstructure and, hence, the properties of the final sintered body are determined
essentially by the suspension parameters (such as particle size, particle concentration, and
colloid stability of the suspension), the freezing conditions (rate and direction of
freezing), and the sintering conditions (temperature and time). By controlling the growth
direction of the ice crystals during freezing, it is possible to achieve preferential
orientation of the porosity, leading to anisotropic microstructure and properties,
mimicking the structural characteristics of natural materials such as bone.
Recent investigations have explored how the processing conditions, such as
suspension concentration, freezing rate, and sintering conditions, influence the
microstructure and compressive strength of HA scaffolds [28]. Directional freezing of
aqueous HA suspensions in a cylindrical mold placed on a cold substrate produced
porous constructs with three distinct zones, each characterized by a different shape and
dimensions of the pores, described as fully dense, cellular, and lamellar. In the lamellar
region, which formed the major portion of the construct, an increase in the freezing rate
of the suspension, from 1ºC/min to 10ºC/min resulted in a reduction of the pore width
from ~40 µm to ~10 µm.
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A way to further manipulate the microstructure of the freeze cast construct is to
control the freezing (or solidification) behavior of the liquid in the suspension, but this
has received little attention. Certain liquids, such as glycerol and 1,4-dioxane (referred to
hereafter simply as dioxane), are miscible with water, and when added to water modify
the local structure of the aqueous liquid. As a result, they modify the nucleation and
growth of the ice crystals, thereby modifying the freezing behavior of the aqueous liquid.
Glycerol effectively binds to water molecules and disrupts the complete crystallization of
ice. This leads to a localized structure, resulting in a reduced size of the growing ice
crystals and inhibiting solute rejection [30, 31].The addition of glycerol (10–30 wt %) to
the aqueous solvent reduced the viscosity of Al2O3 suspensions stabilized with an anionic
dispersant, ammonium polymethacrylate, and produced more homogeneous
microstructures after freeze casting and sintering [23].The effects were explained in terms
of the ability of glycerol to both enhance the colloidal stability of the suspensions and
modify the freezing behavior of water. Dioxane is miscible with water at any composition
under ambient conditions. A study of the local solvent structure of dioxane-water
mixtures [32] indicated that the structure changed at three specific compositions when the
mole fraction (χ) of dioxane in the mixture was 0.13, 0.3, and 0.7. For χ < 0.13, the
mixture consisted mainly of water molecules with some water-dioxane complexes. For
0.13 < χ < 0.3, the system consisted mainly of small clusters of water-dioxane molecules,
whereas for χ > 0.3, the water-dioxane clusters gradually disappeared and the mixture
evolved gradually to the inherent solvent structure of pure dioxane.
The objective of the present work was to explore the microstructural manipulation
of freeze-cast HA constructs by controlling the processing parameters. Using aqueous
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suspensions as the basic system, the effects of particle concentration and temperature of
the cold substrate on the microstructure were studied. Further manipulation of the
microstructure was explored by controlling the freezing (solidification) of the liquid in
the suspension through the use of water–glycerol and water–dioxane mixtures. In Part II,
the microstructure of the sintered constructs and its effect on the mechanical behavior are
described. An understanding of the relationship between the processing parameters and
the resulting microstructure is useful for manipulating the microstructure and properties
of scaffolds for bone repair and replacement.

1.3. MATERIALS AND METHODS
1.3.1. Processing of HA Suspensions. HA powder (Alfa Aesar, Haverhill,

MA) with the particle size less than 0.5 µm, determined by a laser diffraction particle size
analyzer (Model LS 13 320; Beckman Coulter Inc., Fullerton, CA ), was used in the
present work. Aqueous suspensions were prepared by dispersing HA powder in deionized
water containing a dispersant and an organic binder to improve the rheological behavior.
Four anionic and one nonionic dispersants were investigated in an attempt to determine
an effective dispersant for the HA particles used in the present work. The anionic
dispersants were: ammonium polymethacrylate (Darvan C, molecular weigh MW =
10,000–16,000; R.T. Vanderbilt Co., Norwalk, CT), sodium polyacrylate (Darvan 811,
MW = 5000; R.T. Vanderbilt Co.), ammonium polyacrylate (Darvan 821A, MW = 3500;
R.T. Vanderbilt Co.), ammonium polycarbonate (Targon 1128, MW = 13000-15000; BK
Ladenburg GmbH, Ladenburg, Germany). The nonionic dispersant was an ethoxylated
acetylenic diol surfactant (Dynol 604, Air Products & Chemicals Inc., Allentown, PA).
The effectiveness of the dispersants for stabilizing the suspension against flocculation
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was investigated by measuring the viscosity of the suspensions as a function of dispersant
concentration, HA particle concentration, and shear rate using a rotating cylinder
viscometer (Model VT500; Haake Inc., Paramus, NJ).
Based on the viscosity data, suspensions containing 0.75 wt% of Dynol 604 and
1.5 weight percent (wt%) of an organic binder poly(vinyl alcohol), PVA, (DuPont
Elvanol® 90-50, DuPont, DE), based on the dry weight of the HA powder, and 5–20
vol% HA particles were prepared by ball-milling for 48 h in polypropylene containers
using Al2O3 grinding media. The suspensions were de-aired by ball-milling at a low
speed prior to freeze casting.
To explore the effects of a modifier on the solidification of the solvent during
freeze casting, aqueous suspensions containing 5–20 wt% of glycerol (Fisher Scientific,
Pittsburg, PA) or 40–70 wt% dioxane (Fisher Scientific), were also prepared using the
same procedure.
1.3.2. Freeze Casting of Suspensions. Freeze casting was performed by

pouring the suspensions into polyvinyl chloride (PVC) tubes (∼10 mm internal diameter
× 20 mm long) placed on a cold steel substrate kept at a fixed temperature using a freeze
dryer (Genesis 25 SQ Freeze Dryer, VirTis Co., Gardiner, NY) or cooled by liquid
nitrogen. Polyurethane foam was used to cover the PVC tubes to reduce heat transfer
from the surrounding environment to the slurry, ensuring optimum directional freezing of
the system. The arrangement did not provide a method for providing a fixed cooling rate.
Instead, it allowed the substrate to be kept at a fixed temperature. Three substrate
temperatures were used in the experiments: –196°C, –50°C and –20°C. The frozen
constructs were subjected to a vacuum of 4 Pa for 48 h in a freeze dryer (Genesis 25 SQ
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Freeze Dryer) to cause sublimation of the frozen solvent. The green bodies were sintered
in air for 3 h at temperatures between 1250°C and 1375°C, with a heating and cooling
rate of 3°C/min.

1.3.3. Microstructural Characterization of Porous HA Constructs. The

microstructure of the cross-sections of the green and sintered constructs, in the
microstructure of the cross-sections of the green and sintered constructs, in the planes
parallel to and perpendicular to the direction of freezing, was observed using scanning
electron microscopy, SEM (Hitachi S-4700, Hitachi Co., Tokyo, Japan). Since the green
bodies (after sublimation of the frozen liquid) were too weak for handling, most of the
characterization experiments were carried out on the sintered samples. The volume of
open porosity in the sintered samples was measured using the Archimedes method. In
addition, the porosity and pore size distribution of open pores were measured using
mercury intrusion porosimetry (Poremaster, Quantachrome, Boynton Beach, FL).
The width of the pores and the thickness of the HA lamellas in the sintered
constructs were determined from SEM micrographs of cross-sections in the plane parallel
to the direction of freezing. For each construct, at least 5 SEM micrographs were taken at
random positions of the cross-section, and at least 10 measurements of the pore width and
lamella thickness were made on each micrograph, to provide a mean value and a standard
deviation.
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1.4. RESULTS
1.4.1. Rheological Behavior of HA Suspensions Used for Freeze Casting.

Figure 1 shows data for the viscosity as a function of shear rate for aqueous HA
suspensions (20 vol% particles) stabilized with the dispersants Darvan 811, Darvan
821A, Darvan C, Targon 1128, and Dynol 604. The concentration of each dispersant was
1.0 wt%, based on the dry mass of the particles. At a given shear rate, and particularly at
shear rates < 100 s–1, Darvan 821A and Dynol 604 reduced the viscosity of the
suspension more effectively, indicating their ability to better stabilize the particles against
flocculation. As with other suspension-based forming methods, the colloidal stability of
the suspension is important for producing homogeneous green microstructures. In the
directional freeze casting route used in the present work, a high rate of flocculation can
lead to zones with different microstructures from the bottom to the top of the sample.
The optimum concentration of Darvan 821A or Dynol 604 required to stabilize
the HA particles was determined from data for the viscosity of the suspension (20 vol%
particles) as a function of the dispersant concentration at a constant shear rate of 100 s–1
(Figure 2). The data indicated a minimum viscosity at ∼0.75 wt% Dynol 604 and at ∼1.0
wt% Darvan 821A. Furthermore, at these minima, the viscosity of the suspension
stabilized with Dynol 604 was almost 3 times lower than the viscosity for the suspension
stabilized with Darvan 821A. Similar trends were found for suspensions containing 5–15
vol% particles, but the data are omitted for the sake of brevity. The data in Figure 2
indicated that the viscosity of the suspensions was reduced more effectively using Dynol
604, allowing the incorporation of a higher concentration of particles for the same given
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viscosity. Unless stated otherwise, henceforth the suspensions described are those
stabilized with 0.75 wt% Dynol 604.
Data for the relative viscosity of the suspensions (shear rate = 100 s–1) as a
function of HA particle concentration are shown in Figure 3. The particle concentration
had a limited effect on the viscosity for volume fractions lower than ∼30 vol% but above
this value, the viscosity started to increase steeply. The data can be well fitted by a
modified Krieger-Dougherty equation [33, 34] of the form:
⎛
φ
η r = ⎜⎜1 −
φm
⎝

⎞
⎟⎟
⎠

−n

(1)

with ηr, the relative viscosity, is defined as the viscosity of the suspension, η,
divided by the viscosity of the solvent (water) ηL, φ is the volume fraction of the
particles, φm is the volume fraction of particles at which the viscosity becomes practically
infinite, and n is a fitting parameter. The maximum HA particle concentration predicted
by this model was φm = 45 vol%, with n = 3.5. In the present experiments, the
suspensions became difficult to pour for particle volume fractions greater than ∼25 vol%.
As a result, the highest particle concentration used was 20 vol% (equal to 45 wt%).
1.4.2. Microstructure of Freeze-Cast HA Constructs
1.4.2.1 Constructs Prepared from Aqueous Suspensions. After freeze casting

and sintering, the constructs maintained a uniform cylindrical shape (Figure 4). The
green constructs, after sublimation of the frozen liquid, were too weak for handling, so
most of the microstructural characterization studies were performed on constructs after
they were sintered. As described later (Part II), sintering at temperatures between 1250°C
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and 1350°C produced an increase in the density of the HA phase of the constructs, but
did not alter the general features of the microstructure. The microstructural features are
therefore described for constructs sintered under the same sintering conditions (3 h at
1350 °C).
Figure 5 shows SEM images of constructs prepared from suspensions with 20
vol% HA particles on a substrate at –20°C. A uniform lamellar-type microstructure was
observed throughout the whole construct, with the pores oriented in the direction of
freezing. This lamellar-type microstructure is quite similar to the microstructures of
polymeric materials such as collagen prepared for tissue engineering applications [19,
20]. For the present system, the plate-like HA lamellas and the inter-lamellar macropores
were oriented in the direction of freezing. The HA lamellas had a thickness of 25±5 µm
and a length of 100–250 µm in cross section (Figure 5(a, b)) and extended from the
bottom of the construct to the top (Figure 5(c-d)). The average pore width, determined
from SEM micrographs, was 15±10 µm. Dendritic structures were present on the surfaces
of the HA lamellas, and in some cases, they formed bridges between adjacent HA
lamellas.
Mercury porosimetry data (Figure 6) for HA scaffolds sintered for 3 h at 1350ºC
showed a narrow pore size distribution, with pore widths in the range 5–30µm, in good
agreement with the pore widths found in the SEM images (Figure 5). From the total
volume of pores intruded, the open porosity was ∼55%, in good agreement with the
porosity (52%) found by the Archimedes method. The data showed that almost all the
open pores in the sample were in this narrow range, indicating the good homogeneity of
the microstructure produced by the present freeze casting process.
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A reduction of the particle concentration of the suspension or the temperature of
the cold substrate did not change the general lamellar-type microstructure, but produced
changes in the thickness of the HA lamellas, the porosity, and the pore width. With
decreasing particle concentration (from 20 vol% to 10 vol% and 5 vol%), the HA
lamellas became thicker, the porosity was higher, and the pore width increased (Figure
7). Decreasing the substrate temperature during freezing from –20°C to –50°C and –
196°C resulted in pores with finer cross sections (Figure 8). The lamellar thickness,
porosity, and pore width, determined from SEM micrographs of the sample crosssections, are summarized in Table I.
1.4.2.2 Constructs Prepared from Suspensions with Water-Glycerol and
Water-Dioxane Mixtures. Figure 9 shows the microstructure of sintered HA

constructs formed from suspensions (20 vol% HA particles) in which the solvent
constructs formed from suspensions (20 vol% HA particles) in which the solvent
consisted of a mixture of water with 5 and 20 wt% of glycerol. The freeze-cast green
bodies were sintered for 3 h at 1350°C. Compared to the constructs prepared without
glycerol addition (Figure 5), the presence of 5 wt% glycerol in the suspensions had the
effect of thickening the cross-section of the HA lamellas and reducing the homogeneity
of the microstructure (Figure 9(a, b)). With higher additions of glycerol, the
microstructure became finer and more uniform. In general, the glycerol additions had the
effect of increasing the number of dendritic bridges between the HA lamellas. This
increased to such an extent that the cross-section of the pores changed from a plate-like
morphology to a more rectangular shape. Consequently, with the increasing concentration
of glycerol in the aqueous solvent, the microstructure became more uniform, the pores
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became smaller, and the number of dendritic bridges between the HA lamellas increased
(Figure 9(c, d)). Mercury porosimetry data (Figure 10) of the construct prepared from
suspensions with 20 wt% glycerol confirmed the narrow size distribution of the pores.
The pore widths were in the range 1–10 µm, compared to values 5–30 µm for similar
constructs prepared without glycerol (Figure 6).
Microstructures of constructs prepared from suspensions (10 vol% particles) in
which the solvent consisted of water with 30 wt% and 60 wt% dioxane are shown in
Figure 11. With 30 wt% dioxane [Figure 11(a, b)], a coarse lamellar-type microstructure
is obtained. However, the microstructure changed with increasing dioxane concentration,
giving a cellular type microstructure [Figure 11(c, d)], with pore diameters of 100±10
µm, much larger than the pore width of constructs prepared from aqueous suspensions
(i.e., 100% water). Increasing the dioxane concentration to 70 wt% did not change the
general cellular microstructure, but the pore diameter decreased substantially, to 50±5
µm. Table II summarizes the microstructural parameters of the constructs prepared from
suspensions with aqueous solvent (100% water), water–glycerol mixtures, and water–
dioxane mixtures.

1.5. DISCUSSION

For freeze-cast constructs prepared from aqueous suspensions (no glycerol or
dioxane additions), the present work showed the ability to achieve a uniform lamellartype microstructure throughout the whole construct, with the lamellas oriented in the
direction of freezing. Compared to the recent work of Deville et al. [28], in which three
microstructural zones were observed from the bottom to the top of the sample (described
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as fully dense, cellular, and lamellar), no fully dense or cellular zones were observed. A
number of factors may be responsible for the difference in microstructure observed in this
study and the work of Deville et al. They include differences in the freeze casting method
and the colloidal properties of the HA suspensions used in the two investigations. For
example, in the present work, the freezing of the suspension was determined by the
temperature of the cold substrate, whereas Deville et al. used an arrangement that allowed
greater control of the freezing rate. The HA particle size in the present study (< 0.5 µm)
was much finer than that (2.4 µm) used by Deville et al., and a different dispersant was
used to achieve a stable suspension [35]. The finer particle size used in the present work,
coupled with the stable suspension, presumably reduced the tendency for particle settling
and improved the ease with which particles were expelled from the frozen liquid during
the freeze casting step, giving a homogeneous microstructure throughout the construct. It
should be noted that a homogenous microstructure, such as that obtained in the present
work, is desirable in many applications because it generally leads to more reliable and
controllable properties of the construct.
The results also showed the ability to manipulate the microstructure of the freeze
cast constructs by changing the processing conditions. For aqueous suspensions, lower
particle concentration resulted in the production of constructs with higher porosity, larger
pore width, and thinner HA lamellas (Table I). A lower HA particle concentration allows
larger separation distances between the HA lamellas since the dentritic growth of ice
crystals is relatively less hindered as the particles are pushed at the solidification front.
Particles in more dilute suspensions travel longer distances and become immobilized
when the highest particle packing density is achieved between two growing dentritic
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crystals. The lower HA particle concentration also resulted in the fewer particles rejected
by the ice lamella, leading to thinner lamellas in the sintered HA sample. From a
thermodynamic point of view, a lower substrate temperature means a larger driving force
for the nucleation of ice crystals, which results in the formation of a larger number of ice
nuclei and an increased growth rate of the formed ice crystals. The data indicate that by
adjusting the particle concentration and substrate temperature, changes in the scale of the
microstructural features can be achieved without drastically altering the general lamellartype microstructure.
Far greater changes in the microstructure of the constructs were obtained by
modifying the freezing (or solidification) behavior of the solvent through the use liquid
mixtures. Glycerol, with the ability to form hydrogen bonds, have been found to
influence the freezing behavior of aqueous suspension by destroying the molecular order
in water and reducing the size of ice crystals during freezing process [30]. Glycerol,
acting as a cryoprotectant, effectively binds to natural water molecules and disrupts the
complete crystallization of ice, which leads to a localized amorphous structure, resulting
in the reduced size of growing ice crystals and inhibiting solute rejection [23, 31]. A
small amount (5 wt%) of glycerol addition to the suspension was capable of reducing the
size of ice crystals and, hence, the pore diameter in the sintered construct, which in turn
resulted in the thickening of the HA lamellas [Figure 9(a, b)]. With increasing glycerol
addition, more localized ice crystals were formed with less solute rejection during the
solidification process. The large lamellar ice crystals eventually disappeared due to the
formation of the localized ice crystals and smaller crystals produced in the frozen
samples, which corresponded to fine dendritic pores in the sintered HA samples [Figure
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9(c, d)]. Furthermore, the well-dispersed HA suspension enabled the formation of the
uniform ice crystals in the frozen sample and, hence, the homogenous pore structure in
the sintered body.
Dioxane has been shown the break the hydrogen bonds in water [36, 37], forming
stable dioxane (Diox)–water (H2O) complexes (Diox)m•(H2O)n [38, 39]. According to
studies of the local structure [32], the these complexes are more prevalent when the mole
fraction of dioxane χ is between ∼0.13 and ∼0.30 (∼40–70 wt%). The change in
microstructure of the freeze-cast constructs may be attributed to the presence of these
complexes. Below 40 wt% dioxane, the structure of the solvent was dominated by
hydrogen-bonded water molecules, leading to a lamellar-type microstructure [Figures
11(a,b)], not drastically different from the microstructure observed for aqueous solvents.
For the suspension with 60 wt% dioxane, the freezing of the (Diox)m•(H2O)n complexes
resulted in a cellular microstructure with pore diameters of 100±10 µm.
The microstructures obtained in the present work for HA are similar in nature to
those observed in porous constructs prepared by unidirectional freezing of collagen
suspensions [17-19], solutions of biodegradable polymers, such as poly(lactic acid), PLA,
poly(glycolic acid), PGA, and their copolymers, PLGA [5], and suspensions of polymers
and particles, such as collagen and HA [20, 26 40]. The use of suspensions with a low
concentration of collagen (typically < 5 wt %) commonly resulted in lamellar or cellular
microstructures such as those shown in Figure 7 and Figure 11(c,d), but with higher
porosity (typically > 80–85%). Pore sizes (diameter or width) in the range 50–500 lm
have been reported, depending on the freezing rate [18, 41]. Unidirectional
microstructures with tubular pores were obtained using a thermally induced phase
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separation (TIPS) technique during freezing of PLA and PLGA solutions [5]. Constructs
with porosity of 88–97% and average pore diameter of 30–115 µm were produced,
depending on the concentration of the polymer solution (2.5–10 wt %) and the freezing
rate. To mimic the microstructure and mineral composition of bone, the production of
unidirectional composites of HA with collagen or a biodegradable polymer (PLA, PGA,
or PLGA) has also been investigated [20, 26, 40]. Typically, these composite scaffolds
have microstructures similar to those of the unreinforced polymer constructs.
Scaffolds intended for the repair and regeneration of large defects in load-bearing
bones must not only have sufficient strength to serve a mechanical function, but they
must also support tissue ingrowth into the pores. In Part II [42], the mechanical behavior
of the constructs prepared in the present work is reported. The microstructural parameters
that influence tissue ingrowth include the porosity, the pore diameter, the pore shape and
the pore interconnectivity. Interconnected pores with a mean diameter or width of 100
µm or greater, and open porosity of > 50% are generally considered the minimum
requirements to permit tissue ingrowth and function in porous scaffolds [43, 44]. For
constructs prepared from aqueous suspensions (5–20 vol % particles), the mean pore
widths obtained in the present work and by Deville et al [28], are <40 µm. The ability to
produce larger pores (100 ± 10 µm), by modifying the freezing behavior of the liquid, as
demonstrated in this work for water-dioxane mixtures (Table II), provides an important
approach for the production of HA scaffolds with the requisite microstructure forbone
repair and regeneration.
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1.6. CONCLUSIONS

Freeze casting of aqueous suspension of HA particles on a cold substrate
produced porous constructs with a uniform, lamellar-type microstructure in which platelike HA lamellas were oriented in the direction of freezing. Changes in the particle
concentration of the suspension and temperature of the cold substrate did not drastically
alter the lamellar-type microstructure but changed the porosity, the pore width, and
thickness of the HA lamellas. With increasing particle concentration in the suspension
(5–20 vol%), the porosity and pore cross section decreased, but the thickness of the HA
lamellas increased. A decrease in the temperature of the cold substrate (–20°C to –196°C)
caused a reduction in the size of the HA lamellas and the pore cross section. The addition
of glycerol (∼20 wt%) to the aqueous solvent used in the suspensions produced finer
pores and a larger number of dendritic structures connecting the HA lamellas. On the
other hand, the addition of 60 wt% dioxane produced a cellular microstructure with much
larger pores.
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Table I: Summary of lamellar thickness, porosity, and pore width for constructs prepared
from aqueous suspensions with 5, 10, and 20 wt% particles.

Lamellar thickness
HA concentration (vol %)

Pore width
Porosity (%)

(µm)

(µm)

5

8±2

85±2

50±10

10

15±5

70±5

25±5

20

25±5

55±2

15±10
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Table II: Comparison of porosity and pore widths for constructs prepared from aqueous
suspensions, suspensions with glycerol, and suspensions with dioxane.
Solvent

HA concentration

Pore width

Porosity (%)

General

composition

(vol%)

(µm)

10

25±5

70±5

Lamellar

20

15±10

55±2

Lamellar

Water-Glycerol (20

10

10±5

67±2

Rectangular

wt%)

20

4±2

46±2

Rectangular

Water-1,4-dioxane

10

100±10

65±2

Cellular

(60 wt%)

20

90±10

37±2

Cellular

microstructure

Aqueous
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Figure 1. Viscosity of aqueous HA suspension (20 vol%) as a function of shear rate for
different dispersants.
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Figure 2. Viscosity of aqueous HA suspension (20 vol%) as a function of dispersant
concentration for a shear rate of 100 s–1.
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Figure 3. Relative viscosity at a shear rate of 100 s-1 versus volume fraction of HA
particles stabilized by Dynol 604.
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Freeze direction
Figure 4. Optical image of a sintered HA sample, showing the shape uniformity. (Scale is
in inches.)
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Figure 5. SEM images of the HA sample cross section perpendicular (a, b) and parallel
(c, d) to the freezing direction. The sample was sintered for 3 h at 1350°C.
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Figure 6. Mercury porosimetry data for the sintered HA sample, showing the pore
volume and the pore size distribution as functions of the pore diameter.
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Figure 7. SEM images of the sintered HA sample fabricated from suspensions with
different particle concentrations: (a), (b), 10 vol%; (c), (d), 5 vol%. (The cross section is
perpendicular to the freezing direction.)
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Figure 8. SEM images of the cross section perpendicular (a), (c), and parallel (b), (d), to
the freezing direction, for sintered HA samples fabricated by freezing the suspension on
substrates at (a), (b) –50°C; (c), (d) –196°C.
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Figure 9. Effects of glycerol concentration on the microstructure of the sintered HA
sample (a), (b) 5 wt%; (c), (d) 20 wt%. (The cross section is perpendicular to the freezing
direction.)
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Figure 10. Mercury porosimetry data for the sintered HA sample prepared from
suspensions with 20 wt% glycerol, showing the pore volume and the pore size
distribution as functions of the pore diameter.
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Figure 11. Effects of dioxane concentration on the microstructure of the sintered HA
sample (a), (b) 30 wt%; (c), (d) 60 wt%. (The cross section is perpendicular to the
freezing direction.)
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2.1. ABSTRACT

In Part I, the influence of processing parameters on the general microstructure of
freeze-cast hydroxyapatite (HA) constructs was explored. This work is an extension of
Part I, to investigate the effect of sintering conditions on the microstructure and
mechanical behavior of freeze-cast HA. For constructs prepared from aqueous
suspensions (5–20 vol% HA), sintering for 3 h at temperatures from 1250°C to 1375°C
produced a decrease in porosity of <5% but an increase in strength of nearly 50%.
Constructs with a porosity of 52%, had compressive strengths of 12 ± 1 MPa and 5 ± 1
MPa in the directions parallel and perpendicular to the freezing direction, respectively.
The mechanical response showed high strain tolerance (5–10% at the maximum stress),
high strain to failure (>20%), and high strain rate sensitivity. Manipulation of the freezecast microstructure, achieved by additions of glycerol and 1,4-dioxane to the aqueous
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suspensions, produced changes in the magnitude of the mechanical response, but little
change in the general nature of the response. The favorable mechanical behavior of the
porous constructs, coupled with the ability to modify their microstructure, indicates the
potential of the present freeze casting route for the production of porous scaffolds for
bone tissue engineering.

Keywords: biomaterials; scaffolds; hydroxyapatite; freeze casting; mechanical behavior

2.2. INTRODUCTION

In Part I, the influence of processing parameters on the general microstructure of
porous hydroxyapatite (HA) constructs prepared by freeze casting of suspensions on a
cold substrate was explored [1]. The effects of particle concentration of the suspension,
temperature of the substrate, and modification of the solidification (freezing) behavior of
the solvent by the addition of glycerol or 1,4-dioxane were investigated. Freeze casting of
aqueous HA suspensions produced porous constructs with a uniform, lamellar-type
microstructure in which plate-like HA lamellas were oriented in the direction of freezing.
Changes in the particle concentration of the suspension and temperature of the cold
substrate did not severely alter the lamellar-type microstructure but changed the porosity,
the pore cross section, and thickness of the HA lamellas. With increasing particle
concentration in the suspension (5–20 vol%), the porosity and pore cross-section of the
constructs decreased, but the thickness of the HA lamellas increased. The addition of 5–
20 wt% of glycerol to the aqueous suspension resulted in sintered constructs with finer
pores and a larger number of dendritic structures connecting the HA lamellas. On the

61
other hand, the addition of 60 wt% of 1,4-dioxane to the aqueous suspension resulted in
constructs with a cellular microstructure and larger pores. This work is an extension of
Part I, to investigate the effect of sintering conditions on the final microstructure, and to
characterize the mechanical behavior of the fabricated HA constructs.
In addition to being biocompatible, scaffold materials should have the ability to
be formed into porous constructs with the relevant anatomical shape, as well as the ability
to be formed economically and reproducibly. The fabricated scaffold should have the
requisite microstructure to support tissue ingrowth. Interconnected or unidirectional pores
with a mean diameter (or width) of 100 µm or greater, and open porosity of >50% are
generally considered to be the minimum requirements to permit tissue ingrowth and
function in porous scaffolds [2,3] Scaffolds for load-bearing applications such as bone
repair and regeneration should also possess adequate mechanical properties to support
physiological loads.
Bone is generally classified into two types: cortical bone, also referred to as
compact bone, and trabecular bone, also referred to as cancellous or spongy bone.
Cortical bone, found primarily in the shaft of long bones and as the outer shell around
cancellous bone, is much denser, with a porosity of 5–10% [4]. Trabecular bone, found at
the end of long bones, in vertebrae, and in flat bones such as the pelvis, is much more
porous, with porosity in the range 50–90% [5]. The mechanical properties of bone vary
between subjects, from one bone to another, and within different regions of the same
bone. The mechanical properties are also highly anisotropic, as a result of the oriented
microstructure. However, based on the testing of large specimens, the compressive
strength and elastic modulus of cortical bone has been reported in the range 100–150

62
MPa and 10–20 GPa in the direction parallel to the orientation (long axis) axis [6-8]. The
strength and modulus in the direction perpendicular to the long axis are typically 1.5 to 2
times lower. A wide range has been reported for the Young’s modulus (0.1–5 GPa) and
compressive strength (2–12 MPa) of cancellous bone [7,8].
A variety of methods have been used to produce porous scaffolds for bone repair
and regeneration, including consolidation with a pore-producing phase such as NaCl,
starch, or PVA, [9-11], the use of foaming agents [12-14], and solid freeform fabrication
[15-17]. Table I provides a summary which is not meant to be exhaustive, but rather to
indicate representative approaches. Freeze casting has been widely used for the
production of synthetic polymer scaffolds, such as poly(lactic acid), PLA, poly(glycolic
acid), PGA, and their coploymers, PLGA, as well as natural polymer scaffolds, such as
collagen [21,23,35]. It has been applied more recently to the production of composites of
HA and polymers (collagen or biodegradable polymers) [20, 24], and to bioceramic (HA)
scaffolds [1,18,19]. The low strength (typically <1 MPa) of porous constructs of synthetic
and natural polymers, and HA–polymer composites is a limitation for the repair of loadbearing bones. Recent investigations have shown that porous HA scaffolds, with a
lamellar-type microstructure and unidirectional pores, can be obtained by freeze casting
of aqueous suspensions [18,19]. The microstructure and strength of the scaffolds can be
modified by altering the particle concentration of the suspension, freezing rate, and
sintering conditions. Compressive strengths as high as 65 MPa (56% porosity) and 147
MPa (47% porosity) in the direction parallel to the freezing direction were obtained by
testing small thin disks (4 mm × 5 mm × 5 mm) cut from the freeze-cast sample.

63
However, the pore width (or diameter) of these HA constructs (less than ∼20 µm) is too
low for tissue ingrowth.
The objective of the present work was to investigate the effect of sintering
conditions on the microstructure of the freeze –cast HA constructs, and to characterize
the mechanical behavior of the fabricated HA constructs. During sintering, it is expected
that the HA lamellas, consisting of a packing of fine particles and fine pores, will
undergo densification and grain growth, leading to an enhancement in strength. On the
other hand, the unidirectional pores separating the HA plates are expected to undergo
little change because the pore widths are much larger than the particle (or grain) size of
the HA plates [36]. Because the properties of the sintered constructs are controlled by
their microstructure, an understanding of the microstructural development during
sintering, as well as the influence of the microstructure on properties, is important.

2.3. MATERIALS AND METHODS

Cylindrical HA constructs (∼8 mm diameter × 16 mm) were prepared by freeze
casting suspensions (20 vol% particles) on a cold steel substrate (–20°C), and subliming
the frozen liquid. The solvent in the suspensions consisted of water, a mixture of water
and 5–20 wt% glycerol, or a mixture of water and 40-60 wt% 1,4-dioxane (referred to
henceforth as dioxane). The glycerol and dioxane additions were used to modify the
freezing (or solidification) of water, which provided an additional method for
manipulating the microstructure of the freeze cast constructs. The procedures were
identical to those described in detail in Part I [1].
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Sintering was carried out in air for 3 h at temperatures between 1250°C and
1375°C, with a heating and cooling rate of 3°C/min. The microstructures of the crosssection of the green and sintered constructs were observed using scanning electron
microscopy, SEM (Hitachi S-4700, Hitachi Co., Tokyo, Japan). X-ray diffraction, XRD
(D/mas 2550 v; Rigaku; The Woodlands, TX), was used to identify the phases present in
the starting powder and sintered samples, using Cu Kα radiation (λ=0.15406 nm) at a
scanning rate of 1.8°/min in the 2θ range of 10–80°. The volume of open porosity in the
sintered samples was measured using the Archimedes method. The grain size of sintered
constructs was measured using the linear-intercept method [24]. More than 200 grain
boundary intercepts were measured for the polished samples sintered at different
temperature to obtain a mean value and standard deviation.
The mechanical behavior of the sintered constructs (∼8 mm in diameter × 16 mm)
in compressive loading was measured according to ASTM-C773 using an Instron testing
machine (Model 4204, Norwood, MA) at a crosshead speed of 0.5 mm/min. Eight
samples were tested, and the average strength and standard deviation were determined.
The samples were tested in the directions parallel and perpendicular to the freezing
direction. The crosshead speed of 0.5 mm/min is typical for the testing dense specimens
according to ASTM-C773. To investigate the strain-rate sensitivity of the compressive
mechanical response, additional tests were performed at cross-head speeds of 0.05
mm/min and 5 mm/min. Cross-head speeds higher than 5 mm/min were impractical with
the instrument and the size of specimens used.
The flexural strength of the sintered constructs was measured by loading
unnotched cylindrical samples (∼8 mm in diameter × 25 mm) at a crosshead speed of 0.5
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mm/min in three-point bending (overall span = 20 mm) using an Instron testing machine
(Model 4204). Eight specimens were tested. The flexural strength was determined from
the equation

σ=

8 PL
πd 3

where P is the loading applied to the specimens, L is the overall span and d is the
diameter of the specimens.
Strength and porosity values were determined as means ± standard deviations.
Statistical analysis was carried our using one-way analysis of variance (ANOVA) and
Turkey’s post hoc test, with the level of significance set at p < 0.05.
2.4. RESULTS

Figure 1 shows the XRD patterns of the as-received HA powder, the powder
calcined for 1 h at 900°C, and of the freeze-cast material sintered for 3 h at 1375°C, the
highest sintering temperature used in the experiments. Each pattern corresponded to the
reference pattern of HA (JCPSD 72-1243). The XRD peaks for the as-received powder
were broader and had a lower intensity (peak height) than those for the sintered material,
which is an indication that the as-received powder may have a size in the nanocrystalline
range, incompletely crystallized, or a combination of both. Within the limits of detection
by the XRD (< 0.5 wt%), no additional peaks corresponding to any second phases could
be found in the patterns. It has been reported that HA decomposed into tricalcium
phosphate and tetracalcium phosphate at temperatures above ∼1300°C [37], and that this
decomposition resulted in a sharp drop in strength and affected the osteocalstic resorption
activity of HA [38,39]. However, for the HA powder used in the present work, the results
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indicated that sintering temperatures as high as 1375°C can be used without detectable
decomposition. In vitro cell culture experiments are currently being performed to
evaluate the effect of the sintered HA constructs on cell viability, and the ability of the
constructs to support cell infiltration into the unidirectional pores.
The effect of the sintering temperature on the open porosity and compressive
strength of HA constructs sintered for 3 h at temperatures between 1250°C and 1375°C is
shown in Figure 2. The constructs were prepared from aqueous suspensions containing
20 vol% HA. With increasing temperature, the porosity decreased slightly, from a value
of 55% at 1250°C to a limiting value of ∼52% at 1350°C. This is an indication that the
HA plates in the lamellar-type microstructure had reached their highest density at
1350°C. Sintering for much longer time at 1350°C or at higher temperatures will lead
primarily to grain growth in the HA lamellas, without any increase in density. Therefore,
sintering for 3 h at 1350°C can be taken as approximately the optimum sintering
conditions for the present system. The compressive strength in the direction of freezing
increased with sintering temperature (Figure 2), reaching its highest value of 12 ± 1 MPa
at 1350°C, and showed no further improvement as the sintering temperature was
increased to 1375°C. This increase in the compressive strength is a reflection of the
decrease in porosity, indicating that the strength improvement is controlled by the
increase in density of the HA lamellas.
As observed in Part I [1], the addition of glycerol to the aqueous solvent produced
a modification of the freeze-cast microstructure, giving smaller pore diameters and
resulting in a larger number of dendrites connecting the HA plates. Figure 3 shows the
effect of glycerol additions on the porosity and compressive strength of the constructs
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sintered for 3 h at 1350°C. The constructs were prepared from suspensions with 20 vol%
solids. The porosity decreased by ∼6%, from ∼52% to ∼46%, as the glycerol
concentration in the solvent increased from 0 to 20 wt%. On the other hand, the
compressive strength (in the direction of freezing) increased by ∼50%, from 12 ± 1 MPa
to 18 ± 2 MPa . This increase in the strength can be attributed to the finer pores, the lower
porosity, the larger number of dendrites connecting the HA lamellas or a combination of
the three.
Figure 4 shows stress–strain curves in compression testing for freeze-cast HA
constructs prepared from aqueous suspensions (20 vol% HA) without glycerol and
sintered for 3 h at 1350°C. The curves show the behavior of the constructs in the
direction parallel and perpendicular to the freezing direction. The data shown are
engineering stresses and strains, based on the initial cross-sectional area and length of the
test sample, and do not represent the true stresses and strains. An interesting feature of
the stress-strain response is the high strain tolerance of the constructs. Unlike common
ceramics which show brittle behavior with just an elastic response and failure at low
strain (typically <0.1%), the constructs produced in the present work showed three
distinct regions: an elastic regime in which the stress–strain response was linear, a stress
plateau region representing a region of highest sustainable loading, and a failure region of
decreasing load-beating ability. The elastic modulus, determined from the slope of the
linear region, was 0.2 GPa. While the three regions can be observed in both curves, the
stress-strain curve in the freezing direction had a different shape from that perpendicular
to the freezing direction. In the freezing direction, the curve had a more smoothly
varying, asymmetric bell shape, with a compressive strength (taken as the stress at the
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peak) of ∼10 MPa at a strain of ∼7%. In contrast, the curve for the perpendicular testing
direction had a large plateau region, in a strain range of 2–10%, with numerous bumps
and valleys. The average compressive strength in this plateau region was ∼4 MPa. The
small peaks and valleys in the curve presumably resulted from progressive breakage of
the HA lamellas and the dendrites between the lamellas.
Figure 5 shows the effect of strain rate on the compressive mechanical response
(in the direction of freezing) for constructs prepared from aqueous suspension (20 vol%
HA). The response was quite sensitive to the rate of loading (taken as proportional to the
cross-head speed). With increasing strain rate, the peak compressive stress increased in
magnitude and shifted to lower strain. For the same specimen length (16 mm), increasing
the cross-head speed from 0.05 mm/min to 0.5 mm/min and 5mm/min, produced an
increase in the peak compressive stress of ∼25 and ∼125% respectively. On the other
hand, the strain at the peak compressive stress decreased from 8% to 5% and 2%,
respectively.
Figure 6 shows the stress-strain curve in three-point bending for freeze-cast HA
constructs prepared from aqueous suspensions (20 vol% HA) without glycerol and
sintered for 3 h at 1350ºC. The constructs showed a high strain tolerance (~6%) in
flexure, similar in nature to the response observed in compression testing, indicating that
the high strain tolerance is not just restricted to compression. The small peaks and valleys
in stress–strain curve presumably resulted to crack deflection during delamination of the
HA lamellas. The flexural strength (taken as the stress at the peak of the stress–strain
curve) was 2.5 ± 0.9 MPa at a strain of ∼6%.
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The stress–strain behavior in compression for constructs prepared from
suspensions (20 vol% HA particles) with 20 wt% glycerol and sintered for 3 h at 1350°C
is shown in Figure 7. In general, the curves showed features similar to those for
constructs prepared without glycerol, but the load-bearing capacity was higher. The
compressive strengths in the directions parallel and perpendicular to the freezing
direction were 18 ± 2 MPa and 7 ± 1 MPa, respectively, compared to values of 12 ± 1
MPa and 5 ± 1 MPa for similar constructs prepared from suspensions without glycerol.
The elastic modulus in the direction of freezing, determined from the linear region of the
curve, was 0.6 GPa. The use of glycerol also improved the strain tolerance, with the
constructs able to support a stress of ∼6 MPa at a strain as high as 20%.
Figure 8 shows the stress-strain curves, in the direction of freezing, for constructs
prepared from suspensions (10 vol% HA particles) in which the solvent was 40 wt%
water and 60 wt% dioxane. The mechanical response of these constructs showed a higher
strain tolerance (∼60%) than constructs prepared from aqueous suspensions (Figure 4) or
from suspensions with glycerol (Figure 6). As observed for the testing of constructs
prepared from aqueous suspensions (Figure 5), the mechanical response is also sensitive
to the rate of loading. The stress–strain curve consisted of three distinct regions: an
approximately linear regime, a plateau region in which the stress was almost constant
with increasing strain, and a region of sharply rising stress. For testing at a cross-head
speed of 0.5 mm/min, the peak compressive stress was 7.5 MPa at a strain of 8%. The
elastic modulus, determined from the approximately linear region, was 0.1 GPa.
SEM images of the top and middle portions of an HA construct after completion
of the compressive strength testing are shown in Figure 9. The construct was prepared
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from aqueous suspensions (without glycerol or dioxane) containing 20 vol% HA, A
highly tortuous surface was observed at the top surface (Figure 9(a)), unlike the relatively
smooth fracture surface commonly observed for brittle materials. The middle portion of
the broken construct (Figure 9(b)), showed almost equally-spaced cracks, perpendicular
to the length of the HA lamellas. Furthermore, the cracks did not propagate across the
entire sample. Instead, they appeared to terminate after traversing each HA lamella.
The fractured surfaces, following compressive strength testing, for the sintered
constructs prepared from suspensions (20 vol% HA) with 20 wt% glycerol are shown in
Figure 10. The top part of the fractured surface (Figure 10(a)) appeared to show tortuous
crack patterns, not unlike those in Figure 9(a). Dendrites between the HA plates were also
observed. When compared to the HA constructs prepared from suspensions without
glycerol (Figure 9(b)), no cracks perpendicular to the length of the HA lamellas were
observed (Figure 10(b)).This is presumably due to the fine pores and the presence of a
larger number of dendrites between the HA lamellas, which provided an alternative
fracture mechanism.

2.5. DISCUSSION

The present freeze casting route relied on densifying the HA lamellas, with little
modification of the macropores between the lamellas, for developing the optimum
strength of the construct. The results indicated that the optimum strength was achieved
without any detectable change in the XRD pattern of the material by sintering for 3 h at
1350°C. For constructs prepared from aqueous suspensions (20 vol% HA) without
glycerol or dioxane, the compressive strength in the direction of freezing (12 ± 1 MPa)
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was at the upper limit of the values for cancellous bone (2–12 MPa) [8], whereas the
elastic modulus (0.2 GPa) was closer to the lower limit for cancellous bone (0.1–5 GPa)
[8]. The porosity (55%) was at the lower end for cancellous bone (50–90%), but the pore
size (15 ± 10 µm) was considered to be too low to support tissue ingrowth [40,41].
Because of differences in pore characteristics (such as porosity and pore size), a
true comparison cannot be made between the strength values obtained in the present work
and those summarized in Table I for constructs fabricated by a variety of methods.
Nevertheless, the compressive strengths of the HA scaffolds fabricated in the present
work were at least one order of magnitude higher than the values for polymer scaffolds or
polymer–ceramic composites prepared by a unidirectional freeze casting method [20-24].
The strengths obtained in the present work were also one order of magnitude higher than
those for porous bioceramic constructs with a more isotropic microstructure, such as
those fabricated by infiltration of a polymer sponge or by a gas foaming technique
[12,25-27,28-30]. Furthermore, the strengths were comparable to the values for porous
bioceramic constructs fabricated by solid freeform fabrication routes and by more
conventional methods [15-17,31-34].
When compared to the results of Deville et al. [18,19], who reported compressive
strengths of 65 MPa (56% porosity) and 147 MPa (47% porosity) for HA constructs in
the direction of freezing, the strengths obtained in this work were far lower. One factor
which might contribute to the difference is the cooling rate of the suspension. The results
of Deville et al. [18] showed a large increase in strength with increasing cooling rate, and
the high strengths reported were for the highest cooling rate used. Faster cooling rates
lead to the production of constructs with finer pores. While the strength was higher, the
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finer pores were less favorable for supporting tissue ingrowth. In the present work, the
suspensions were frozen on a substrate at a fixed temperature (–20°C), and the cooling
rate corresponded approximately to the lowest cooling rates used by Deville et al. [18].
The compressive strengths obtained in the present work are comparable to the values
reported by Deville et al. for the lowest cooling rates used in their work. There was also a
difference between the sizes of the specimens used in the two studies. Deville et al. [18]
used test samples (4 × 5 × 5 mm) cut from the sintered material in which the height to the
cross-sectional width was only 0.8. In the present work, the as-fabricated specimens were
tested according to ASTM-C773 in which the height to diameter ratio was >2.
An interesting property of the HA constructs prepared in this work was the high
strain tolerance, leading to a high strain to failure (Figure 4). SEM images of the
constructs after compressive strength testing (Figure 9(a)) showed a highly tortuous crack
path. This type of tortuous fracture surface provided a large increase in the crack path,
and has been proposed as an effective toughening mechanism in biological composites
[42]. Furthermore, deflection, branching, and blunting of the cracks were also observed in
the constructs after testing (Figure 9(b)). These toughening mechanisms, coupled with the
fine, homogeneous microstructure presumably resulted in delocalized failure, which
provided the high strain tolerance observed in the stress–strain curves.
Similar to the behavior of bone [43,44] and other natural materials, the
mechanical response of the HA constructs fabricated in this work was quite sensitive to
the rate of loading (Figure 5). The elastic modulus and the compressive strength were
observed to increase with higher loading rate but the strain to failure decreased. Since HA
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itself is brittle, the strain rate sensitivity resulted from the lamellar-type microstructure
developed by the freeze-casting route.
The use of glycerol to modify the freezing behavior of the solvent resulted in the
production of HA constructs with higher compressive strength and higher strain tolerance
(Figure 7). The enhanced mechanical response presumably resulted from the lower
porosity, smaller pores, and the larger number of dendrites between the HA lamellas [1].
More numerous peaks and valleys were also observed in the stress–strain curves (Figure
7), particularly in testing parallel the freezing direction, which presumably resulted from
the progressive rupture of the larger number of dendrites between the HA lamellas. The
additional work required to rupture these dendrites presumably provided a strong
contribution to the increase in compressive strength and strain tolerance [45].
As described in Part I [1], addition of dioxane (60 wt%) to the aqueous
suspension resulted in the production of HA constructs with a cellular microstructure and
larger pores. Constructs prepared from suspensions with 10 vol% HA had a porosity of
65% and an average pore diameter of (100 ± 10 µm). These pore characteristics are
considered to be more favorable for tissue ingrowth [2,3] when compared to the fine
pores obtained in constructs prepared from aqueous suspensions with or without glycerol
additions. The mechanical response of the HA constructs (Figure 8) was similar in nature
to the response of bone and other natural materials such as wood and cork [46], as well as
the response of synthetic scaffolds with an oriented microstructure prepared by solid
freeform fabrication techniques [31]. Furthermore, for a cross-head speed of 0.5 mm/min,
the compressive strength (7.5 MPa), taken as the value at the peak stress, and the strain
(8%) at the peak compressive stress were in upper range of values for human cancellous
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bone (compressive strength = 2–12 MPa and strain to failure = 5–7%) [8]. Based on their
microstructure and mechanical response, these porous HA constructs prepared from
aqueous suspensions with 60 wt% dioxane may provide favorable substrates for tissue
engineering of bone. Experiments are currently being performed to evaluate the
biocompatibility of the constructs, and to optimize their mechanical response.

2.6. CONCLUSIONS

The compressive strength of freeze-cast HA constructs was strongly dependent on
the sintering temperature used to densify the HA. Optimum strength was obtained after
sintering for 3 h at 1350°C, presumably due to the HA lamellas in the porous structure
reaching nearly full density. XRD indicated that no new phase was formed in the HA
constructs after sintering at 1350°C. Constructs prepared from aqueous suspensions had
compressive strengths of 12 ± 1 MPa and 5 ± 1 MPa in the directions parallel and
perpendicular to the freezing direction, respectively, a flexural strength of 2.5 ± 0.9 MPa,
and strain to failure of >20%. However, the porosity (52%) and pore size (5–30 µm) were
considered to be too low to support tissue ingrowth. Constructs prepared from aqueous
suspensions with 20 wt% glycerol had higher strength, but lower porosity and finer pores.
HA constructs prepared from aqueous suspensions (10 wt% particles) with 60 wt%
dioxane had a compressive strength of 7.5 MPa, strain to failure of 60%, and favorable
microstructure for tissue ingrowth (porosity ~ 65% and pore size = 100 ± 10 µm). The
mechanical response of the HA constructs was similar in nature to that for bone and other
natural materials (high strain to failure and strain rate sensitivity). The favorable
mechanical response of the porous constructs, coupled with the ability to modify the
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microstructure and mechanical properties indicates the potential of the present freeze
casting route for the fabrication of porous scaffolds for bone tissue engineering.
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Table I. Summary of pore characteristics and compressive strength of porous scaffolds
fabricated by a variety of methods.
Technique

Material

Freeze casting

HA
HA
HA
PLLA/HA (50:50)
PLGA
PDLLA/Biolgass®
PLGA

Open
porosity
(%)
47-52
50-65
40-65
90
93-94
93.5-94
90-96

HA/Collagen
HA
Glass reinforced
HA
HA
45S5 Bioglass®
Ca2MgSi2O7
HA
HA

TIPS

Polymer sponge

Gel casting
Solid free-form
fabrication
Slip casting
Gas foaming
Fiber compacting

Pore size or
dimension (µm)

Compressive
strength (MPa)

Reference

5-30
80-110
20
50-200
50-60
114-137

12-18
7.5-20
40-145
0.4
0.38-0.58
0.07-0.08
0.2-0.9

Present
work
[18, 19]
[20]
[21]
[22]
[23]

95

200-500

0.03

[24]

86

420-560

0.21

[25]

85-97.5

420-560

0.01-0.175

[26]

70-77
89-92
63-90
76-80
72-90

200-400
510-720
300-500
20-1000
17-122

0.55-5
0.27-0.42
0.53-1.13
4.4-7.4
1.6-5.8

[27]
[28]
[29]
[17]
[30]

PCL

61

360×430×620

3.1

[15]

HA
HA
13-93 glass
HA
PLGA
HA

35
41
40-45
85
85-96
13-33

334×469
250-350
100-300
200-500
193-439
50-500

30
34
21-23
1.09-1.76
0.16-0.29
6-13

[16]
[17]
[31]
[32]
[33]
[34]

79

Figure 1. X-ray diffraction (XRD) patterns of the as-received HA powder, the powder
heated for 1 h at 900°C, and the freeze-cast construct sintered for 3 h at 1375°C.
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Figure 2. Influence of sintering temperature on the porosity and compressive strength (in
the direction of freezing) for HA constructs prepared from aqueous suspensions with 20
vol% particles. All pairs of the porosity were significantly different except the pair
between HA constructs sintered at 1350 and 1375 ºC (p = 0.99); all pairs of compressive
strength were significantly different except the pairs between 1250 and 1275 ºC, 1300
and 1325, 1350 and 1375 ºC (p = 0.97, 0.22, 1.0 respectively).
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Figure 3. Effect of glycerol addition to the aqueous suspension (20 vol% particles) on the
porosity and compressive strength of constructs sintered for 3 h at 1350°C. All pairs of
the porosity of the HA constructs with different glycerol addition were significantly
different; all pairs of the compressive strength of HA construct were significantly
different except the pairs between HA constructs prepared from 0 and 5, 5 and 10, 15 and
20 wt% glycerol (p = 0.69, 0.28, 0.50 respectively).
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Figure 4. Stress-strain behavior in compression testing parallel and perpendicular to the
freezing direction, for HA constructs prepared from aqueous suspensions (20 vol%
particles) and sintered for 3 h at 1350°C. Three different regions are outlined for the
curve corresponding to the parallel testing direction: I, elastic region; II, stress plateau
region; III, failure region.
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Figure 5. Effect of loading rate on the compressive mechanical response of HA constructs
prepared from aqueous suspension with 20 vol% particles.
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Figure 6. Stress-strain behavior in three-point bending for HA constructs prepared from
aqueous suspensions (20 vol% particles) and sintered for 3 h at 1350°C.
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Figure 7. Stress-strain behavior of HA constructs prepared from suspensions with 20 wt%
glycerol and sintered fro 3 h at 1350°C. The load was applied in compression, parallel
and perpendicular to the freezing direction.
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Figure 8. Effect of loading rate on the mechanical response of the HA constructs prepared
from aqueous suspensions (10 vol% particles) containing 60 wt% dioxane.
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Figure 9. Fractured surfaces, after compression testing, of HA constructs prepared from
suspensions without glycerol: (a) top surface, perpendicular to the freezing direction; (b)
surface parallel to the freezing direction.
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Figure 10. Fractured surfaces, after compression testing, of HA constructs prepared from
suspensions with 20 wt% glycerol: (a) top surface, perpendicular to the freezing
direction; (b) surface parallel to the freezing direction.
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3.1. ABSTRACT

Freeze casting of aqueous suspensions was investigated as a method for preparing
porous hydroxyapatite (HA) scaffolds for eventual application to bone tissue engineering.
Suspensions of HA particles (10–20 volume percent) were frozen unidirectionally in a
cylindrical mold placed on a cold steel substrate (–20°C). After sublimation of the ice,
sintering for 3 h at 1350°C produced constructs with dense HA lamellae, porosity of
∼50%, and inter-lamellar pore widths of 5–30 µm. These constructs had compressive
strengths of 12 ± 1 MPa and 5 ± 1 MPa in the direction parallel to and perpendicular to
the freezing direction, respectively. Manipulation of the microstructure was achieved by
modifying the solvent composition of the suspension used for freeze casting. The use of
water–glycerol mixtures (20 wt% glycerol) resulted in the production of constructs with
finer pores (1–10 µm) and a larger number of dendritic growth connecting the HA
lamellae, and higher strength. On the other hand, the use of water–dioxane mixtures (60
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wt% dioxane) resulted in a cellular-type microstructure with larger pores (90-110 µm).
The mechanical response showed high strain tolerance (5–10% at the maximum stress),
high strain for failure (>20%), and sensitivity to the loading rate. The favorable
mechanical behavior of the porous constructs, coupled with the ability to modify their
microstructure, indicates the potential of the present freeze casting route for the
production of porous scaffolds for bone tissue engineering.

Keywords: biomaterials; scaffolds; hydroxyapatite; freeze casting; porous ceramics

3.2. INTRODUCTION

Tissue engineering, involving the implantation of cells and tissues, or stimulating
host cells to grow in an implanted scaffold, has emerged as a promising approach for the
repair or regeneration of lost or damaged tissues [1-2]. The applicability of the tissueengineered construct is critically dependent on the composition and structure of the
porous three-dimensional scaffold which guides the growth of new tissue in vitro and in
vivo [3-5]. For bone tissue engineering, the scaffold material should possess certain
desirable properties, such as biocompatibility, the ability to be formed into porous, threedimensional constructs with the relevant anatomical shape and with the appropriate
mechanical properties to support physiologic loads, and the ability to be formed
economically and reproducibly [6-8].
Bioactive ceramics have been widely investigated for repairing bone defects,
because of their good biocompatibility and ability to bond to surrounding tissues [3, 910]. A variety of methods has been used to produce porous scaffolds for tissue
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engineering, including consolidation with a pore-producing fugitive phase such as starch
or PVA [11, 12], the use of foaming agents [4, 5, 13, 14], thermally induced phase
separation, TIPS, [15-17], solid freeform fabrication [18-20], slip casting, foam
replication and fiber packing methods, [21-23]. Freeze casting has been widely applied
to the production of synthetic and natural polymer scaffolds for tissue engineering
applications [15-17, 24], and its application to the production of porous bioceramic
scaffolds is now receiving interest [25-29]. Recent investigations have shown the ability
to prepare porous HA scaffolds with a lamellar-type microstructure and oriented pores by
unidirectional freezing of aqueous suspensions [27-29]. The microstructure and strength
of the scaffolds were modified by altering the particle concentration of the suspension,
freezing rate, and sintering conditions. However, the average pore diameter or width was
10–40 µm, which is too small to support tissue ingrowth.
Another way to manipulate the microstructure of the freeze cast construct is to
control the freezing (or solidification) behavior of the liquid in the suspension, but this
has received little attention. Certain liquids, such as glycerol and 1,4-dioxane (referred to
hereafter simply as dioxane), are miscible with water, and when added to water modify
the local structure of the aqueous liquid. As a result, they modify the nucleation and
growth of the ice crystals, thereby modifying the freezing behavior of the aqueous liquid.
Glycerol has been shown to lead to a localized structure, resulting in a reduced size of the
growing ice crystals and inhibiting solute rejection [25]. A study of the local solvent
structure of dioxane–water mixtures indicated that structural changes of the mixture
occurred at three specific compositions [30].
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The objective of the present work was to explore how key processing factors
influenced the microstructure of freeze cast HA constructs, and to characterize the effect
of the microstructure on the mechanical properties of the fabricated constructs. HA was
chosen as the material system because of its biocompatibility, being the main mineral
constituent of bone. The processing parameters investigated were the solids content of the
suspension, the freezing rate, and the composition of the solvent in the suspension. The
effects of sintering conditions on the microstructure and mechanical behavior of the
fabricated HA constructs were investigated. An understanding of the relationship
between the processing parameters and the resulting microstructure and mechanical
strength is useful for controlling the microstructure and properties of scaffolds for bone
repair and replacement.

3.3. MATERIALS AND METHODS
3.3.1. Freeze Casting of Suspensions. Suspensions containing 5–20 vol% HA

particles (average particle size <1 µm; Alfa Aesar, Haverhill, MA), 0.75 wt% of a
dispersant, Dynol 604 (Air Products & Chemicals, Inc., Allentown, PA), and 1.5 weight
percent (wt%) of an organic binder poly(vinyl alcohol), PVA, (DuPont Elvanol® 90-50,
DuPont, DE), based on the dry weight of the HA powder, were prepared by ball-milling
for 48 h in polypropylene containers using Al2O3 grinding media. The preparation and
characterization of the HA suspension are described in detail elsewhere [29]. The
suspensions were de-aired by ball-milling at a low speed prior to freeze casting. To
explore the effects of solvent composition, aqueous suspensions containing 5–20 wt% of
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glycerol (Fisher Scientific, Pittsburg, PA) or 40–70 wt% dioxane (Fisher Scientific), were
also prepared using the same procedure.
Unidirectional freeze casting was performed by pouring the suspensions into
polyvinyl chloride (PVC) tubes (∼10 mm internal diameter × 20 mm long) placed on a
cold steel substrate kept at –20°C using a freeze dryer (Genesis 25 SQ Freeze Dryer,
VirTis Co., Gardiner, NY). Polyurethane foam was used to cover the PVC tubes to
reduce heat transfer from the surrounding environment to the slurry, ensuring optimum
directional freezing of the system. The frozen constructs were subjected to a vacuum of 4
Pa for 48 h in a freeze dryer (Genesis 25 SQ Freeze Dryer) to cause sublimation of the
frozen solvent. The green bodies were sintered in air for 3 h at temperatures between
1250 and 1375°C, with a heating and cooling rate of 3°C min-1.
The microstructure of the surfaces and cross-section of the green and sintered
constructs was observed using scanning electron microscopy, SEM (S-4700; Hitachi,
Tokyo, Japan). X-ray diffraction, XRD (D/mas 2550 v; Rigaku; The Woodlands, TX),
was used to identify the phases present in the starting powder and sintered samples, using
Cu Kα radiation (λ=0.15406 nm) at a scanning rate of 1.8°/min in the 2θ range of 10–80°.
The volume of open porosity in the sintered samples was measured using the Archimedes
method. The compressive strength of cylindrical samples (8 mm in diameter × 16 mm) in
the directions parallel and perpendicular to freezing was measured according to ASTMC773 using an Instron testing machine (Model 4204; Instron Inc., Norwood, MA) at a
crosshead speed of 0.5 mm min-1. Eight samples were tested, and the mean strength and
standard deviation were determined. To investigate the effect of loading (strain) rate on
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the compressive mechanical response, testing was also performed at cross-head speeds of
0.05 and 5 mm min-1.

3.4. RESULTS AND DISCUSSION
3.4.1. Microstructure of Constructs Prepared from Aqueous Suspensions.

Figure 1 shows the XRD patterns of the as-received HA powder and freeze-cast material
sintered for 3 h at 1350°C. Both patterns corresponded to the reference pattern of HA
(JCPDS 72-1243). Within the limits of detection by XRD (< 0.5 wt%), no additional
peaks corresponding to any second phases were found in the patterns.
After freeze casting and sintering, the constructs maintained a uniform cylindrical
shape. The green constructs, after sublimation of the frozen liquid, were weak, so most
of the microstructural characterization studies were performed on constructs after they
were sintered. Figure 2 shows SEM images of constructs prepared from suspensions with
20 vol% HA particles. A uniform lamellar-type microstructure was observed throughout
the construct, with the pores oriented in the direction of freezing. The lamellar-type
microstructure shown in Figure 2 is quite similar to the microstructures of polymeric
materials such as collagen prepared for tissue engineering applications [24]. For the
present system, the HA lamellae and the macropores between them were oriented in the
direction of freezing. The lamellae had a thickness of 20–30 µm and a length of 100–250
µm in cross section (Figure 2(a)) and extended from the bottom of the construct to the top
(Figure 2(b)). A higher magnification image (Figure 2(c)) indicated that the average pore
width was ~20 µm, and that the lamellae were almost fully dense, with some dendritic
bridges between the lamellae. Determination of the porosity by the Archimedes method
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and by mercury intrusion porosimetry, reported elsewhere [29], showed that the pores in
the sintered constructs were interconnected with the porous surface (Figure 2(d)).
For aqueous suspensions, a reduction of the particle concentration produced a
higher porosity, pores with a larger cross section, and thinner HA lamellae (Table 1),
which was due to fewer nucleation sites for ice nuclei and fewer barriers for water
molecules to diffuse to the surface of the formed crystals. On the other hand, lowering the
substrate temperature during freezing resulted in pores with finer cross sections. From the
thermodynamic point of view, a lower substrate temperature means a large driving force
for nucleation of ice crystals, which results in the formations of a larger number of ice
nuclei and the decreased growth of the formed ice crystals, and therefore to smaller interlamellar pores. By adjusting the particle concentration and substrate temperature, the
microstructure of the construct can be controlled over a wide range.

3.4.2. Effects of Sintering Conditions. The effect of the sintering temperature

on the open porosity and compressive strength (in the freezing direction) of HA
constructs sintered for 3 h at temperatures between 1250°C and 1375°C is shown in
Figure 3. With increasing temperature, the porosity decreased slightly, but the
compressive strength increased significantly. Both the porosity and mechanical strength
reached their limiting values at 1350°C, which is an indication that the HA lamellae in
the microstructure had reached their highest density. Sintering for 3 h at 1350°C
represented approximately the optimum sintering conditions for the present system.
Sintering for much longer times at 1350°C or at higher temperatures will lead primarily
to grain growth in the HA lamellae. The compressive strength of the HA constructs in the
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direction of freezing reached its highest value of 12 ± 1 MPa at 1350°C. While this value
is far lower than the compressive strength of cortical bone (100-150MPa) [31], it is equal
to the highest values reported for trabecular (or cancellous) bone (2-12 MPa) [32].

3.4.3. Effect of Solvent Composition on Microstructure. Figure 4 shows the

microstructure of sintered HA constructs formed from suspensions (10 vol% HA
particles) in which the solvent consisted of water, water + 20 wt% glycerol, and water +
60 wt% dioxane. When compared to the microstructure of the construct formed from the
aqueous suspension (Figure 4(a)), the addition of glycerol to the solvent had the effect of
increasing the number of dendritic bridges between the HA lamellas (Figure 4(b)). This
increased to such an extent that the cross-section of the pores changed from a plate-like
morphology to a more dendritic shape. The microstructure was quite uniform, the pores
became smaller, and the number of dendritic bridges between the HA lamellas increased.
The pore widths were in the range 1–10 µm, compared to values 20–30 µm for similar
constructs prepared without glycerol. Glycerol addition to the suspension was capable of
reducing the size of ice crystals [25, 29]. The large lamellar ice crystals disappeared due
to the formation of the localized ice crystals and smaller crystals produced in the frozen
samples, which corresponded to fine dendritic pores in the sintered HA samples (Figure
4(b)). The addition of dioxane to the aqueous solvent resulted in the production of
constructs with a cellular type microstructure (Figure 4(c)). The pore diameter, 100 ± 10
µm, was much larger than the pore width of the constructs prepared from the aqueous
suspensions. The change in microstructure of the freeze-cast constructs may be attributed
to the presence of stable dioxane–water complexes [33, 34].
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3.4.4. Mechanical Response of HA Constructs. Figure 5 shows stress–strain

curves in compression testing for freeze-cast HA constructs prepared from aqueous
suspensions with 20 vol% particles. The curves show the behavior of the constructs in the
direction parallel and perpendicular to the freezing direction. The data shown are
engineering stresses and strains, based on the initial cross-sectional area and length of the
test sample, and do not represent the true stresses and strains. An interesting feature of
the stress-strain curves is the high strain tolerance (high strain for failure) of the
constructs. Unlike common ceramics which show brittle behavior with just an elastic
response and failure at low strain (typically < 0.1%), the constructs produced in the
present work showed three distinctive regions: an ‘elastic’ regime in which the stress–
strain response is linear, a ‘stress plateau’ region representing a region of highest
sustainable loading, and a ‘failure’ region of decreasing load-bearing ability.
While the three regions can be observed in both curves, the stress-strain curve in
the freezing direction had a different shape from that perpendicular to the freezing
direction. The curve for the response in the freezing direction had a more smoothly
varying, asymmetric bell-shaped curve, indicating a compressive strength (taken as the
stress at the peak) of ∼10 MPa at a strain of ∼7%. In contrast, the curve for the
perpendicular testing direction had a large plateau region, in a strain range of 2–10%,
with numerous bumps and valleys. The average compressive strength in this plateau
region was ∼4 MPa.
The mechanical response of the fabricated constructs showed a high dependence
on the loading (or strain) rate (Figure 6). Typically, a high stain rate led to a high
compressive strength of the constructs. An increase in the strain rate from 0.05 mm min-1
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to 0.5 and 5 mm min-1, resulted in an increase in the compressive strength of the
constructs of 25 and 125% respectively. On the other hand, the failure strain decreased
from 8% to 5 and 2%, respectively.
The mechanical response of the HA constructs prepared from suspensions with
glycerol or dioxane addition was similar in nature to that shown in Figure 5 for constructs
prepared from aqueous suspensions, but the magnitude of the response was different. The
nature of the observed mechanical response was attributed to the anisotropic
microstructure produced by the unidirectional freeze-casting process. This type of
mechanical behavior with a high strain tolerance has been found in natural materials with
anisotropic structure such as bone, and it is considered to be important for the remodeling
of bone structure in response to the applied load [35, 36].
The mechanical response of porous materials, such as brittle foams, has been
modeled by Gibson and Ashby [35]. According to the model, the compressive crushing
strength σcr of brittle foams is given by:
⎛ ρ ⎞
σ cr
= C ⎜⎜ ⎟⎟
σ fs
⎝ ρo ⎠

3/ 2

1 + (ti / t )

2

1 − (ti / t )

2

= C (1 − P )

3/ 2

1 + (ti / t )

2

1 − (ti / t )

2

(1)

where σfs is the modulus of rupture of the solid struts, C is a constant of
proportionality, ρ and ρo are the densities of the porous cellular material and the fully
dense solid phase, respectively, P is the porosity of the cellular material, and ti/t is the
ratio of width of the box-like void in the struts to the thickness of the solid strut. In the
case of brittle foams [35], C = 0.2. For HA, the reported values for σfs are in the range
115–200 MPa [3]. In the present work, the struts were almost fully dense, so ti/t = 0.
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Using these values, the strength predicted by the model is in the range 5–8 MPa for a
porosity P = 0.65. This value is not vastly different from the measured compressive
strengths (7.5–18 MPa) for the constructs investigated in the present work with P = 0.65–
0.70, and tested under a loading rate of 0.5 mm min-1 along the pore orientation direction.
Scaffolds intended for bone repair and regeneration should have not only
adequate mechanical properties to support physiologic loads but also favorable pore
characteristics for supporting tissue ingrowth into the scaffolds to allow strong bonding
and facile integration with surrounding tissues. Interconnected pores with a mean pore
diameter or width of 100 µm or greater, and open porosity of >50% are generally
considered the minimum requirements to permit tissue ingrowth and function in porous
scaffolds [37, 38]. Scaffolds prepared in this work from aqueous suspensions and from
suspension with glycerol additions had pores (1–30 µm) that were too small to support
tissue ingrowth. On the other hand, the pore diameter or width (100 ± 10 µm) of the
scaffolds prepared from suspensions with dioxane additions was more favorable. Further
work is in progress to (1) prepare freeze-cast scaffolds with larger pore size, while
retaining strength and porosity, and (2) evaluate the cell proliferation and differentiation
on the surface and within the porous scaffolds.

3.5. CONCLUSION

Freeze casting of aqueous suspension of HA particles on a cold substrate
produced porous constructs with a uniform, lamellar-type microstructure in which platelike HA lamellas were oriented in the direction of freezing. The sintering conditions had

100
a marked effect on the microstructure and mechanical behavior of the fabricated
constructs. An increase in the sintering temperature from 1250°C to 1375°C produced a
small (5%) decrease in porosity, but an increase in the compressive strength of nearly
50%. Constructs with a porosity of 52%, formed by sintering for 3 h at 1350°C had
compressive strengths of 12 ± 1 MPa and 5 ± 1 MPa in the directions parallel and
perpendicular to the freezing direction, respectively. Significant changes in
microstructure and properties were achieved by modifying the solvent composition of the
suspensions used in the freeze-casting process. The addition of glycerol (∼20 wt%) to the
aqueous solvent used in the suspensions produced finer pores and a larger number of
dendritic structures connecting the HA lamellas. On the other hand, the addition of 60
wt% dioxane produced a cellular microstructure with much larger pores. The fabricated
constructs showed gradual failure behavior in compression, high strain tolerance (∼5% at
the maximum stress), high strain for failure (>20%), and sensitivity to the loading rate.
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Table 1: Comparison of porosity, pore width, microstructure and compressive
mechanical properties of HA constructs prepared from aqueous suspensions, suspensions
with glycerol, and suspensions with dioxane.
HA
Solvent

Porosity (%)

Microstructure

Compressive

Strain (%)

Pore width
concentration

composition

strength
(µm)

(vol%)

(MPa)

10

25±5

70±5

Lamellar

--

--

20

15±10

55±2

Lamellar

12 ± 1

7

67±2

Rectangular

10±5

18 ± 2

5

10

65±2

Cellular

7.5

8

10

100±10

Aqueous

Water–Glycerol
(20 wt%)
Water–dioxane
(60 wt%)

Relative intensity (CPS)

104

1350 °C

as-received

JCPSD 72-1243, Ca10(PO4)6(OH)2
20

30

40

50

60

70

2θ (degree)

Figure 1. X-ray diffraction (XRD) patterns of as-received HA powder, the freeze-cast
constructs sintered for 3 h at 1350ºC. The pattern for a reference HA (JCPDS 72-1243) is
also shown.
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Figure 2. SEM images of the HA sample cross section (a) perpendicular, and (b) parallel
to the freezing direction; (c) higher magnification image of the cross section in (b),
showing the pore structure; (d) surface of the sample. The sample was sintered for 3 h at
1350°C.
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Figure 3. Influence of sintering temperature on porosity and compressive strength of HA
samples.
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Figure 4. Effects of solvent composition on the microstructure of HA constructs prepared
from 10 vol% suspension: (a) water; (b) water + 20 wt% glycerol; (c) water + 60 wt%
dioxane.
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Figure 5. Stress-strain response in compression testing parallel and perpendicular to the
freezing direction, for HA constructs prepared from aqueous suspensions (20 vol%
particles) and sintered for 3 h at 1350°C. Three different regions are outlined for the
curve corresponding to the parallel testing direction: I, elastic region; II, stress plateau
region; III, failure region.
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Figure 6. Effect of strain (or strain) rate on the mechanical response of the HA constructs
prepared from aqueous suspension (20 vol% particles).
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4. PROLIFERATION AND FUNCTION OF MC3T3-E1 CELLS ON FREEZECAST HYDROXYAPATITE SCAFFOLDS WITH ORIENTED PORE
ARCHITECTURES
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4.1. ABSTRACT

Previous work by the authors showed that hydroxyapatite (HA) scaffolds with
different types of oriented microstructures and a unique ‘elastic–plastic’ mechanical
response could be prepared by unidirectional freezing of suspensions. The objective of
the present work was to evaluate the in vitro cellular response to these freeze-cast HA
scaffolds. Unidirectional scaffolds with approximately the same porosity (65–70%) but
different pore architectures, described as ‘lamellar’ (pore width = 25 ± 5 µm) and
‘cellular’ (pore diameter = 100 ± 10 µm), were evaluated. Whereas both groups of
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scaffolds showed excellent ability to support the proliferation of MC3T3-E1 preosteoblastic cells on their surfaces, scaffolds with the cellular-type microstructure showed
far better ability to support cell proliferation into the pores and cell function. These
results indicate that freeze-cast HA scaffolds with the cellular-type microstructure have
better potential for bone repair applications.

Keywords: scaffolds; hydroxyapatite; cell culture; porous ceramics

4.2. INTRODUCTION

Bioactive glass, glass-ceramics, and ceramics, such as 45S5 bioactive glass and
hydroxyapatite (HA), referred to collectively as ‘bioactive ceramics’, are an important
category of biomaterials that have promising potential for use in bone repair and
regeneration [1–3]. Several methods have been used to produce porous scaffolds of
bioactive ceramics, such as incorporation of a pore-producing fugitive phase such as
starch or PVA [4, 5], the use of foaming agents [6, 7], polymer foam replication
techniques [8–10], slip casting [11], and solid freeform fabrication [12, 13]. A limitation
of scaffolds prepared by current methods is that they often lack the combination of high
strength and high porosity for skeletal substitution of load-bearing bones. They are
limited to low-stress applications instead, such as filling of contained bone defects, where
adjacent, intact bone provides mechanical rigidity and support. The repair of large defects
in load-bearing bones requires scaffolds with far higher strengths. Situations in which
long bone discontinuity is encountered include traumatic injuries suffered in war or in
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automobile accidents, bone resection for tumors, and bone loss from complex, revision
total hip or total knee surgery.
Recently, a method based on unidirectional freezing of aqueous suspensions has
been shown to produce porous HA constructs with an oriented, lamellar-type
microstructure and high compressive strength in the direction of orientation [14–18].
Compressive strengths as high as 65 MPa (56% porosity) in the direction parallel to the
freezing direction were reported for testing of small HA disks [14, 15]. However, the
pore width of these lamellar-type HA constructs was only 10–40 lm, a value that is
considered too low for tissue ingrowth. A porosity of >50% with pore size (diameter or
width) of 100 µm or larger are the minimum values reported for scaffolds capable of
supporting cell proliferation and function [19, 20].
Our previous work [16–18] using a unidirectional freezing method showed that
the addition of polar organic solvents such as 1,4-dioxane (referred to simply as dioxane)
and glycerol to aqueous suspensions of HA resulted in drastic changes to the
microstructure. Compared to the lamellar-type microstructure (pore width 10–40 µm)
obtained from aqueous suspensions, scaffolds with approximately the same porosity (65–
70%) prepared from suspensions with 60 wt% dioxane had a cellular-type microstructure
with nearly cylindrical pores of diameter 90–110 µm. When compared to the common
brittle failure of ceramics, the deformation of the freeze-cast scaffolds in compression
showed a unique ‘elastic–plastic’ response. The freeze-cast constructs were deformed to
large strains (>20–50%) without disintegrating in a brittle manner.
Based on the unique mechanical response and the favorable pore characteristics of
the HA constructs with the cellular-type microstructure [17], this in vitro investigation
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was undertaken to evaluate the ability of these oriented constructs to support cell
proliferation and function. For comparison, the in vitro cellular response to the lamellartype constructs was also studied. The mouse MC3T3-E1 cell line chosen for this study is
a well-characterized preosteoblastic cell line that has been used extensively in previous in
vitro investigations of biomaterials for bone repair and tissue engineering [21, 22].

4.3. MATERIALS AND METHODS
4.3.1. Preparation of HA Scaffolds. Methods for preparing HA scaffolds

with an oriented microstructure by unidirectional freezing of HA suspensions are
described in detail elsewhere [16]. Briefly, the suspensions contained 10 vol% HA
particles (average particle size <1 µm; Alfa Aesar, Haverhill, MA), 0.75 wt% dispersant
(Dynol 604; Air Products & Chemicals, Inc., Allentown, PA), and 1.5 wt% binder
(DuPont Elvanol® 90-50; DuPont, Wilmington, DE). Aqueous suspensions, as well as
suspensions containing 60 wt% dioxane (Fisher Scientific, St. Louis, MO), were prepared
using the same method. A concentration of 60 wt% dioxane was used because it resulted
in the preparation of HA scaffolds with larger pore width than the scaffolds prepared
from aqueous suspensions. Unidirectional freezing was performed by pouring the
suspensions into poly(vinyl chloride), PVC, tubes (~10 mm internal diameter × 20 mm
long) placed on a cold steel substrate at -20ºC in a freeze dryer (Genesis 25 SQ Freeze
Dryer, VirTis Co., Gardiner, NY). After sublimation of the frozen solvent in the freeze
dryer, the constructs were sintered in air, for 3 h at 1350 C (heating and cooling rate =
3ºC/min). Scaffolds for cell culture experiments were prepared by sectioning the sintered
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constructs using a diamond-coated blade, washing three times with de-ionized water and
ethanol, and drying at 100ºC.

4.3.2. Cell Culture. HA scaffolds (8 mm in diameter × 2 mm thick) were dry

heat sterilized for 24 h at 500ºC prior to cell culture. The established MC3T3-E1 line of
mouse pre-osteoblastic cells was obtained from ATCC and cultured in α-MEM medium
supplemented with 10% fetal bovine serum plus 100 U/ml penicillin and 100 µg/ml
streptomycin sulfate. The scaffolds were seeded with 60,000 MC3T3-E1 cells suspended
in 100 µl of complete medium, and incubated for 4 h to permit cell attachment. The cellseeded constructs were then transferred to a 24-well plate containing 2 ml of complete
medium per well. The control group consisted of the same number of cells seeded in
wells containing 2 ml of complete medium. All cultures were maintained at 37ºC in a
humidified atmosphere of 5% CO2, with the medium changed every 2 days.
4.3.3. MTT Staining of Viable Cells. Cell-seeded scaffolds (four from each

group) were placed in 400 µl serum-free medium containing 100 µg of the tetrazolium
salt MTT for the last 4 h of incubation to permit visualization of metabolically active
cells on and within the porous HA constructs. After the incubation, the constructs were
briefly rinsed in PBS and blotted dry. Images of the constructs were obtained using a
stereomicroscope fitted with a digital camera to qualitatively assess the distribution of
insoluble purple formazan, a product of mitochondrial reduction of MTT by viable cells.
The MTT-labeled constructs were then frozen at -70ºC, and fractured with a cooled
microtome blade, and the fracture cross-section was visually examined to assess the
presence of purple formazan within the interior of the constructs. Finally, the formazan
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product was extracted from the HA constructs with 1.0 ml ethanol and measured
spectrophotometrically at 550 nm in a BMG FLUORstar Optima plate reader.
4.3.4. Cell Morphology. At culture intervals of 2, 4 and 6 days, HA scaffolds

with attached cells were removed, washed twice with warm PBS, and soaked overnight in
2.5% glutaraldehyde in PBS. The fixed samples were then washed with PBS three times,
dehydrated with a graded ethyl alcohol series, and soaked for 10 min in
hexamethyldisilazane (HMDS). After a second soak in HMDS, the samples were allowed
to dry in air for 12 h at room temperature for the liquid to fully evaporate, sputter-coated
for 60 s with Au/Pd, and observed in a scanning electron microscope, SEM (Hitachi S4700), at 5 kV accelerating voltage.
4.3.5. Quantitative Protein Assay. Total protein in lysates recovered from the

cell-seeded scaffolds was measured to assess cell proliferation on the scaffolds. The
scaffolds were placed in 500 µl of 1% Triton X-100 and the cells lysed by two freezethaw cycles (-80/37ºC). Aliquots of the released lysate were mixed with a working
reagent prepared from a micro-BCA Protein Assay Kit (Piece Biotechnology, Rockford,
IL) and incubated at 50ºC for 20 min. Sample absorbance values were measured at 550
nm in a BMG FLUORstar Optima plate reader with bovine serum albumin used as a
standard for comparison.
4.3.6. Alkaline Phosphatase Activity. MC3T3-E1 cells were seeded onto HA

constructs and plastic control wells with a density of 60,000 cells/scaffold or well. Cell
cultures were stopped at the intervals of 2, 4 and 6 days, and washed twice with PBS.
Cells were lysed twice using freeze-thaw cycle at -80/37ºC with 500 µl of 1 % Triton X100 in PBS. 120 µl of lysate were placed in a 96-well plate for quantitation of alkaline
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phosphate (ALP) using 0.5 M 2-amino-2-methyl-l-propanol (AMP) buffer containing 50
mM p-nitrophenyl phosphate (p-NPP) according to a previously described method [23].
ALP activity is expressed as nanomoles of p-NP released per min.
4.3.7. Statistical Analysis. All biological experiments (4 samples in each group)

were run either in duplicate or triplicate. The data are presented as the mean ± standard
deviation. Statistical analysis was performed using Student’s t-test. Values were
considered to be significantly different when P<0.05.

4.4. RESULTS AND DISCUSSION

Table 1 summarizes the microstructural characteristics of the two groups of HA
scaffolds used in the experiments. SEM images of the cross-sections perpendicular to the
direction of freezing (Fig. 1a, b) showed no marked changes in the microstructure along
the length of the sample, so each cross-section was, in general, representative of the
whole construct. The two groups of scaffolds contained approximately the same total
porosity (65–70%), but their microstructure and pore size (diameter or width) were
different. Scaffolds prepared from aqueous suspensions had a lamellar-type
microstructure (Fig. 1a), resulting from the hexagonal crystal structure of ice [24]. The
inter-lamellar pores were 100–250 µm long and 25 ± 5 µm wide in cross section.
Addition of dioxane to the aqueous suspension produced drastic changes in the
microstructure, resulting from phase separation of the binary water–dioxane mixture
during freezing and modification of the hydrogen bonding of water by the polar dioxane
molecules [24]. Scaffolds prepared from suspensions with 60 wt% dioxane had a cellular-
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type microstructure, approximately cylindrical pores, and pore diameters of size 100 ± 10
µm (Fig. 1b).
We were unable to prepare cellular- and lamellar-type scaffolds with comparable
pore diameters (or widths). Freezing of aqueous suspensions of ceramic particles
typically leads to the production of scaffolds with narrow lamellar-type pores (typically
<40 µm wide) [14–18]. The primary objective of the present work was to evaluate the in
vitro cell culture response to scaffolds with the cellular-type microstructure because these
scaffolds had the requisite porosity and pore size reported for scaffolds capable of
supporting cell proliferation and function [19, 20]. Scaffolds with the lamellar-type
microstructure were evaluated for comparison because they were reported to have high
strength and potential for bone repair applications despite their narrow pore widths [14,
15].
SEM images in Fig. 1a–f show the morphology of MC3T3-E1 cells after 2, 4, and
6 days of culture on the scaffolds with the lamellar- and cellular-type microstructures.
Cells grown on the lamellar constructs were elongated and appeared to align along the
walls of the construct at low cell density after culturing for 2 and 4 days (Fig. 1a, c). A
high magnification image (Fig. 1a, inset) shows the formation of numerous cell
projections along the walls of the lamellae, features that indicated firm cell attachment to
the surface. After culturing for 6 days (Fig. 1e), the cell number increased, and the cells
bridged the lamellae and covered the surface of the constructs. After 2 and 4 days, the
morphology of cells grown on the cellular constructs was generally similar to that
observed on lamellar constructs. The cells were attached to the constructs with cell
projections at day 2 interval (Fig. 1b, and inset). The cell density increased with culture
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time and, after 4 days, the cells colonized the surface of the constructs (Fig. 1d). After 6
days, the surface was almost completely covered with cells (Fig. 1f). However, instead of
bridging the pores and concentrating on the surface as observed for the lamellar
constructs (Fig. 1e), the cells apparently grew along the pore walls of the cellular
constructs and were observed down into the pores. The cells were aggregated, and
appeared to maintain physical contact with each other by multiple extensions with
neighboring cells.
Results of the quantitative assay of total protein in cell lysates recovered from the
HA constructs with the lamellar and cellular microstructures and from the control wells
after incubations for 2, 4, and 6 days are shown in Fig. 2. The amounts of protein
recovered from both types of scaffolds showed a nearly linear increase in cell
proliferation during the 6-day incubation, a finding that complemented the progressive
increase in cell density seen in the SEM images. The cell proliferation kinetics on the HA
constructs were faster than on the control wells. Furthermore, cell proliferation on the
cellular constructs was higher than on the lamellar constructs.
Photographic images of cell-seeded scaffolds treated with MTT during the last 4 h
of incubation are shown in Fig. 3. The purple pigment visible on the scaffold was the
result of mitochondrial reduction of MTT to an insoluble formazan product, an indication
of viable cells. The increase in intensity of the purple color on the surface of both types of
constructs with culture time indicated the proliferation of viable, metabolically active
cells on the scaffolds (Fig. 3a, c). The relative amount of purple formazan visible on the
freeze-fracture face of the scaffolds cultured for 6 days indicated that most of the
metabolically active cells were predominantly near the surface of the lamellar construct
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(Fig. 3b). On the other hand, purple formazan covered a larger area of the freeze-facture
surface and extended almost halfway into the interior of the cellular construct, indicating
far higher cell proliferation into the interior.
Figure 4 shows results of spectrophotometric measurement of the amount of the
formazan extracted from the constructs described in Fig. 3. The optical density (OD)
value of the extraction was an indication of the amount of formazan and hence the viable
cells in the constructs. The higher OD value indicated a larger amount of viable cells. The
data showed that HA constructs with the cellular microstructure had larger OD values
than the lamellar constructs at day 4 and 6, indicating that the cellular constructs had a
better ability to support cell growth, a finding complemented by the higher amount of
protein measured in the cellular constructs than the lamellar ones.
Results of spectrophotometric measurement of alkaline phosphatase activity of
MC3T3-E1 cells cultured on the HA constructs for 2, 4 and 6 days are presented in Fig.
5. The alkaline phosphatase activity increased with the duration of incubation. This
finding is an indication that the seeded cells were able to function as osteoblasts on the
HA constructs. The higher alkaline phosphatase activity of the HA constructs with the
cellular microstructure indicated that these constructs were better able to support cell
function than the lamellar constructs.
In addition to being bioactive and providing adequate mechanical strength,
scaffolds intended for the repair of large defects in load-bearing bones should also
support the ingrowth of cells and new tissues. Oriented bioceramic microstructures
prepared by unidirectional freezing of aqueous suspensions have shown the ability to
develop higher strength in the orientation direction, when compared to more random
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microstructures prepared by conventional freezing and other methods [14–18]. However,
scaffolds prepared by unidirectional freezing of aqueous suspensions typically have a
lamellar-type microstructure with narrow slot-like pores (width = 10–40 µm). The results
of the present work showed that these lamellar-type scaffolds have limited ability to
support cell infiltration and, therefore, the ingrowth of new tissues.
Scaffolds with the cellular-type microstructure (pore width = 100 ± 10 µm),
prepared from HA suspensions with dioxane (60 wt%), not only had better ability to
support the proliferation and function of MC3T3-E1 cells but also supported the
proliferation of the cells down the porosity into the interior of the scaffolds. This coupled
with the ability of the scaffolds to develop high compressive strength and large strain for
failure shown in our previous work [16–18] indicates that these freeze-cast scaffolds may
have potential applications in bone repair. Additional work is presently underway to
evaluate the performance of these scaffolds for use in the repair of large defects in loadbearing bones in vivo.

4.5. CONCLUSIONS

The ability of two groups of hydroxyapatite (HA) scaffolds with different oriented
pore architectures to support the proliferation and function of MC3T3-E1 pre-osteoblastic
cells in vitro was evaluated. While both groups of scaffolds supported greater cell
proliferation and differentiation when compared to control wells, scaffolds with the
cellular-type microstructure (pore diameter = 100 ± 10 µm) showed better ability to
support cell proliferation and function than lamellar-type scaffolds with slot-like pores of
width 25 ± 5 µm. Cells proliferated predominantly on the surface of the lamellar scaffolds
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with little growth into the pores. On the other hand, cells proliferated both on the surfaces
as well as deeper into the interior of the pores for the cellular microstructure. HA
scaffolds with the oriented, cellular microstructure should have potential applications as
biological scaffolds for bone repair and regeneration.
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Table 1. Microstructural characteristics of HA scaffolds prepared by a unidirectional
freezing of suspensions (10 vol% particles).

Solvent composition

Microstructure

Pore width (µm)

Porosity (%)

Water

Lamellar

25 ± 5

70 ± 5

Water + dioxane (60

Cellular

100 ± 10

65 ± 2

wt %)
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Figure 1. SEM images of MC3T3-E1 cell morphology on freeze-cast constructs with a, c,
e lamellar-type and b, d, f cellular-type microstructures after culturing for a, b 2 days; c, d
4 days; e, f 6 days

125

800
Control well
Lamellar-type HA scaffold
Cellular-type HA scaffold

∗

600

Total protein (µg)

∗
∗

∗
400

p=0.1053

∗
200

0
2

4

6

Time (day)

Figure 2. Quantitative measurement of total protein content of cell-seeded scaffolds or
control incubated for 2, 4, and 6 days. Mean ± sd; n = 4. *Significant increase in total
amount of protein on the porous HA constructs with increasing culture duration (p<0.05).
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Figure 3. Cell-seeded HA constructs treated with MTT: (left) surface of constructs with a
lamellar-type and c cellular-type microstructure after culture intervals of 2, 4, and 6 days
(left to right, respectively); (right) freeze-fracture section of scaffold cultured for 6 days,
showing considerably greater infiltration of MTT-labeled cells into the interior of the
cellular microstructure d than in the lamellar microstructure b.
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Figure 4. Quantitative analysis of the purple formazan on the HA constructs with
lamellar- and cellular-type microstructures. Mean ± sd; n = 4. *Significant increase in
formazan extracted from the porous HA constructs with increasing culture duration
(p<0.05).
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Figure 5. Alkaline phosphatase activity in MC3T3-E1 cells cultured on two types
(lamellar- and cellular-type) of freeze-cast HA scaffolds and control wells. Enzyme
activity is expressed as nmol of p-NP formed per min. Mean ± sd; n = 4. *Significant
increase in enzyme activity on the porous HA constructs with increasing culture duration
(p<0.05).
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5.1. ABSTRACT

The objective of the present work was to evaluate the in vitro cellular response to
hydroxyapatite (HA) scaffolds with oriented pore architectures. Hydroxyapatite scaffolds
with approximately the same porosity (60–70%) but two different microstructures,
described as ‘columnar’ (pore diameter = 90–110 µm) and ‘lamellar’ (pore width = 20–
30 µm), were prepared by unidirectional freezing of suspensions. The response of murine
MLO-A5 cells, an osteogenic cell line, to these oriented scaffolds was evaluated using
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assays of MTT hydrolysis, alkaline phosphatase (ALP) activity, and alizarin red staining.
While the cellular response to both groups of scaffolds was better than control wells, the
columnar scaffolds with the larger pore width provided the most favorable substrate for
cell proliferation and function. These results indicate that HA scaffolds with the columnar
microstructure could be used for bone repair applications in vivo.

Keywords: Scaffold; Hydroxyapatite; Cell culture; Oriented microstructure

5.2. INTRODUCTION

Unidirectional freezing of suspensions provides a method for preparing porous
bioceramic scaffolds with an oriented microstructure [1–9]. The method involves rapid
unidirectional freezing of an aqueous suspension of fine particles in a nonporous mold,
and sublimation of the frozen solvent under cold temperatures in a vacuum. After drying,
the porous construct is sintered to densify the solid phase, thereby improving the
mechanical strength without significantly altering the porosity between the solid phase
which resulted from sublimation of the frozen liquid. The microstructure and, hence, the
properties of the final sintered construct are determined essentially by the concentration
of particles in the aqueous suspension and the freezing rate.
Because of the hexagonal crystal structure of the growing ice columns,
unidirectional freezing of aqueous suspensions typically result in a lamellar-type
microstructure, in which the lamellae and inter-lamellar pores are oriented in the
direction of freezing [3,6]. Hydroxyapatite (HA) constructs with inter-lamellar pore
widths in the range 10–40 µm have been prepared from aqueous suspensions. Our recent
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work showed that by manipulating the solvent composition of the HA suspensions,
porous constructs with drastically different oriented microstructures could be obtained by
the unidirectional freezing method [6]. The addition of 5–20 weight percent (wt%)
glycerol to the suspension resulted in the formation of a rectangular-type microstructure
with finer pores (pore width = 5–20 µm). On the other hand, the addition of 60 wt% 1–4
dioxane resulted in a columnar-type microstructure with much larger pores,
approximately circular in cross section (diameter = 90–110 µm). The formation of these
different oriented microstructures is discussed in detail elsewhere [8].
These oriented HA microstructures obtained by unidirectional freezing of
suspensions mimicked those of natural materials, such as trabecular bone, cork, and wood
[10]. When tested in the direction of pore orientation, the HA constructs (porosity = 65–
70%) showed compressive strengths of up to 15–20 MPa, far higher than the compressive
strengths reported for trabecular bone (2–12 MPa). The constructs also showed a unique
‘elastic–plastic’ response in compression, with a large deformation for failure (>20%),
and strain rate sensitivity [7,8]. This type of mechanical response, which is unlike the
brittle response of ceramics, is more characteristic of natural materials [11–16].
Based on the unique mechanical response and the favorable pore characteristics of
the HA constructs with the columnar microstructure, this in vitro investigation was
undertaken to evaluate the ability of these oriented constructs to support cell proliferation
and function. For comparison, the cellular response to the lamellar constructs was also
evaluated. MLO-A5 cells, an established osteogenic cell line, was chosen for these
experiments because of its highly elevated expression of osteogenic phenotype traits such
as alkaline phosphatase activity and mineralization [17,18]. The ability of the constructs
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to support the attachment, infiltration, proliferation, and differentiation of MLO-A5 cells
was evaluated to assess the potential application of these constructs as scaffolds for bone
repair and replacement.
5.3. MATERIALS AND METHODS
5.3.1. Preparation of HA Scaffolds. Hydroxyapatite scaffolds with an oriented

microstructure were prepared by unidirectional freezing of suspensions as described in
detail elsewhere [6]. Briefly, the suspensions contained 10 vol% HA particles (average
particle size <1 µm; Alfa Aesar, Haverhill, MA), 0.75 wt% dispersant (Dynol 604; Air
Products & Chemicals, Inc., Allentown, PA), and 1.5 wt% binder (DuPont Elvanol® 9050; DuPont, Wilmington, DE). Aqueous suspensions, as well as aqueous suspensions
containing 60 wt% dioxane (Fisher Scientific, St. Louis, MO) were used to prepare HA
scaffolds with approximately the same porosity (65–70%) but with widely different pore
characteristics. Unidirectional freezing was performed by pouring the suspensions into
poly(vinyl chloride), PVC, tubes (∼10 mm internal diameter × 20 mm long) placed on a
cold steel substrate at –20°C in a freeze dryer (Genesis 25 SQ Freeze Dryer, VirTis Co.,
Gardiner, NY). After sublimation of the frozen solvent in the freeze dryer, the constructs
were sintered in air for 3 h at 1350°C (heating and cooling rate = 3°C/min). Scaffolds (~8
mm in diameter × 2 mm thick) for cell culture experiments were prepared by sectioning
the sintered constructs using a diamond-coated blade, washing 3 times with deionized
water and ethanol, and dry heat sterilized for 24 hours at 500°C.
5.3.2. Cell Culture. The established MLO-A5 post-osteoblast/pre-osteocyte

murine cell line, kindly provided by Professor Lynda F. Bonewald, University of
Missouri-Kansas City, was used in this study. The stock cells were maintained in
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collagen-coated plates (rat tail collagen type I, 0.15 mg/ml) containing α-MEM medium
supplemented with 5% fetal bovine serum (FCS) and 5% newborn calf serum (NCS) plus
100 U/ml penicillin. The dry-heat sterilized constructs (8 mm in diameter × 2 mm thick)
were seeded with 60,000 MLO-A5 cells suspended in 100 µl of complete medium and
incubated for 4 h to permit cell attachment. The cell-seeded constructs were then
transferred to a 24-well plate containing 2 ml of complete medium per well. The control
group consisted of the same number of cells seeded in wells containing 2 ml of media.
All cell cultures were maintained at 37 ºC in a humidified atmosphere of 5% CO2, with
the medium changed every 2 days. For induction of mineralization, some scaffolds and
control wells were incubated in mineralizing media, α-MEM with 10% FCS, 5 mM βglycerol phosphate (βGP), 100 µg/ml ascorbic acid, following the method described
elsewhere [18].
5.3.3. Cell Morphology. After selected intervals, HA scaffolds with attached

cells were removed, washed twice with warm PBS, and placed in 2.5% glutaraldehyde in
PBS. After an overnight soak in glutaraldehyde, the fixed samples were washed
extensively with PBS and dehydrated through a graded series of ethyl alcohol, followed
by two soaks in hexamethyldisilazane (HMDS) for 10 min each. The samples were
allowed to fully evaporate, sputter-coated with Au/Pd, and then observed in a scanning
electron microscope, SEM (Hitachi S-4700), at 5 kV accelerating voltage.
5.3.4. MTT Detection of Viable Cells. To visualize the metabolically active

cells on and within the porous HA constructs, the cell-seeded constructs were placed in
400 µl serum-free medium containing 100 µg of the tetrazolium salt MTT for the last 4 h
of incubation. After incubation, the constructs were briefly rinsed in PBS, blotted, and
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allowed to dry. Images of the constructs were obtained using a stereomicroscope fitted
with a digital camera to qualitatively assess the distribution of insoluble purple formazan,
a product of mitochondrial reduction of MTT by viable cells. The MTT-labeled
constructs were then frozen at –80ºC and fractured with a cooled microtome blade. The
fracture cross-section was visually examined to assess the presence of purple formazan
within the interior of the constructs. Finally, the formazan product was extracted from the
HA constructs with 1.0 ml ethanol and measured spectrophotometrically at 550 nm in a
BMG FLUORstar Optima plate reader.
5.3.5. Quantitative Protein Assay. The amount of protein in lysates recovered

from the cell-seeded scaffolds was measured to assess the cell proliferation on the
scaffold. The scaffolds were placed in 500 µl of 1% Triton X-100 and the cells lysed by
two freeze-thaw cycles (–80/37ºC). Aliquots of the released lysate were mixed with
working reagent prepared from a micro-BCA Protein Assay Kit (Piece Biotechnology,
Rockford, IL). Resultant absorbance values were measured at 550 nm in a BMG
FLUORstar Optima plate reader with bovine serum albumin used as standard for
comparison.
5.3.6. Alkaline Phosphatase (ALP) Activity. The cell-seeded constructs were

removed at the intervals of 2, 4, 6 and 8 days and washed twice with PBS. The samples
were placed in 500 µl of 1 % Triton X-100 and cells were lysed using two –80/37ºC
cycles. Aliquots of lysate were placed in a 96-well plate for spectrophotometric
measurement of alkaline phosphatase (ALP) activity with p-nitrophenyl phosphate (pNPP) substrate as described elsewhere [18].
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5.3.7. Alizarin Red S staining for Mineralization and Quantitation. After

incubating for 3, 6, 9 and 12 days, the cell-seeded constructs and control wells were
washed twice with PBS. The cells with adherent mineralized nodules were removed from
the constructs and control wells with trypsin-EDTA, washed with isotonic NaCl, and
stained with 4 nM alizarin red S (pH = 4.2) for 2 minutes. The stained cells were then
rinsed with nanopure water and centrifuged 5 times to remove the nonspecific stain. The
pellets of stained cells were placed into a 96-well plate and observed using a
stereomicroscope fitted with a digital camera. The bound alizarin red S stain was
extracted by sonicating for 10 min with 10 mM HCl in 70% ethanol. The extracts were
then diluted with 5 volumes of PBS and the absorbance measured at 550 nm in a BMG
FLUORstar Optima plate reader for the determination of mineralization.
5.3.8. Statistical Analysis. All biological experiments (4 samples in each

group) were run either in duplicate or triplicate. The data are presented as the mean ±
standard deviation. Statistical analysis was performed with one-way analysis of variance
(ANOVA) followed by a Tukey’s post hoc test, with the level of significance set at
p<0.05.

5.4. RESULTS
5.4.1. Microstructure of HA Scaffolds. The microstructure and pore

characteristics of the HA scaffolds used in the present work are summarized in Table 1.
SEM images in Fig. 1 show microstructures of scaffolds sectioned perpendicular to the
freezing direction. There were no marked changes in the microstructure along the length
of the sample, so each cross-section was, in general, representative of the whole
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construct. Unidirectional freezing of suspensions containing dioxane (60 wt%) resulted in
a columnar microstructure (Fig. 1a) with pores approximately circular in cross section
(diameter = 90−110 µm) aligned in the direction of freezing. In contrast, a lamellar
microstructure was obtained by freezing aqueous suspensions, with the lamellae and the
inter-lamellar pores oriented in the direction of freezing (Fig. 1b). The lamellar pores had
a length of 100−300 µm and a width of 20−30 µm.
5.4.2. SEM Examination of Cultures. SEM images in Fig. 2 show the

morphology of MLO-A5 cells grown on the surface of the columnar and lamellar
scaffolds for 2, 4 and 6 days. The cells seeded on the columnar scaffolds appeared to be
attached to the scaffolds by slender cell projections at day 2 (Fig. 2a), and show a large
increase in density with the duration of culture. It is apparent that the cells had grown
along the walls of the columnar-type pores and down into the interior of these scaffolds.
After 4 days, cell colonization of the walls of the scaffolds was evident (Fig. 2b) and after
6 days, the walls were completely covered with cells (Fig. 2c). The cells showed
evidence of physical contact and aggregation with neighboring cells via multiple
extensions. The cells visible in the micrographs of the lamellar scaffolds were elongated
and appeared to align along the walls of the scaffolds at low cell density after culturing
for 2 and 4 days (Figs. 2d and 2e). After culturing for 6 days (Fig. 2f), there was greater
cell density on the surface of the scaffolds, with more cells bridging the lamellar pores.
5.4.3. MTT Assay. Photographic images of cell-seeded scaffolds treated

with MTT during the last 4 h of incubation are shown in Fig. 3. The purple pigment
visible on the scaffold was the result of mitochondrial reduction of MTT to an insoluble
formazan product and an indication of viable cells. The increase in intensity of the purple
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color on the surface of the scaffolds with culture time indicated the proliferation of
viable, metabolically active cells on the surface of the scaffolds (Figs. 3a and c). The
purple staining visible on the freeze-fracture surface of the scaffolds cultured for 6 days
(Figs. 3b and d) indicated the relative density of metabolically active MLO-A5 cells
within the interior of the construct. The larger and more uniform purple area on the
fracture surface of the columnar scaffolds, relative to that seen on the lamellar scaffolds,
indicated the proliferation of more metabolically active cells into the columnar scaffolds.
Results of the quantitative measurement of the amounts of the purple formazan
extracted from the scaffolds are presented in Fig. 4. The results show a linear increase in
the absorbance values with the incubation time, indicative of a larger number of cells
present in the scaffolds. The results of the absorbance measurements also show that a
higher amount of the formazan extract was recovered from cells cultured on columnar
HA scaffolds at all time intervals. This is additional evidence of greater cell growth in the
columnar scaffolds, and is consistent with the photographic images of the MTT labeled
scaffolds.
The proliferation MTT-labeled of MLO-A5 cells into the pores of the columnartype scaffolds is shown in Fig. 5. A linear growth rate of ~150 µm/day was determined.
The pores of the scaffold were completely covered by MTT-labeled cells after culturing
for 12 days (Fig. 5; inset image). The ability of the columnar-type scaffolds to support
live cell ingrowth was further investigated by dipping one end of an as-fabricated
scaffold (to a depth of < 1mm) in a cell suspension (150,000 cells/ml) and monitoring the
cell migration into the scaffold. As a result of the capillary pressure of the pores, the cell
suspension was pulled up to completely fill the pores within <5 s. After incubation for 4
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h, the scaffolds were treated with MTT for another 4 h. Photographic images of the
MTT-labeled construct are shown in Fig. 6. The coverage of the purple color on the
surface of the constructs (Figs. 6a and 6b) indicates that viable cells are able to migrate
along the pores at the surface. The color within the cross section of the constructs is
evidence that the columnar pores are large enough for cell to migrate through the
constructs and to provide enough nutrients for the cells.
5.4.4. Quantitation of Protein. Results of the quantitative assay of total

protein in cell lysates recovered from the HA scaffolds and the control wells after
incubation for 2, 4, 6, and 8 days are shown in Fig. 7. The amounts of protein recovered
the HA scaffolds showed a nearly linear increase in cell proliferation during the 6-day
incubation, a finding that complements the progressive increase in cell density seen in the
SEM images. The amount of protein recovered from the lamellar HA scaffolds and the
control wells reached a plateau at 6 days. In comparison, the amount of protein recovered
from the cultures on the columnar HA scaffolds continued to increase. This is evidence
that the columnar scaffolds are capable of supporting continuous ingrowth of the cells, a
finding that complemented the SEM observation of the cell morphology (Fig. 2). The
higher amounts of protein on the columnar scaffolds, compared with that recovered from
the lamellar scaffolds, indicated that the cells were better able to grow in scaffolds with
pores of size ~100 µm rather than in those with smaller lamellar-type pores. These data
also indicate that the MLO-A5 cells were able to grow at a higher rate on the HA
scaffolds than they did on the surface of plastic culture vessels.
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5.4.5. Alkaline Phosphatase Activity. Results of spectrophotometric

measurement of alkaline phosphatase activity of MLO-A5 cells cultured on the HA
scaffolds for 2, 4, 6 and 8 d are presented in Fig. 8. As shown, alkaline phosphatase
activity increased with the duration of incubation. This finding is an indication that these
cells were able to carry out osteogenic function on the HA scaffolds. The higher alkaline
phosphatase activity of the columnar scaffolds than that of the lamellar scaffolds
indicates the better ability of the columnar scaffolds to support cell differentiation.
5.4.6. Mineralization. To assess the ability of the scaffolds to support

mineralization by MLO-A5 cells, the cells and extracellular materials were removed from
the HA constructs by trypsinization after various culture intervals and stained with
alizarin red S to test for the presence of calcium deposits. The stained nodules recovered
from the columnar-type scaffolds are shown in Fig. 9. At day 3, almost no nodules were
observed. An increasing amount of stained nodules was seen as the culture time increased
from 6 to 12 days. A higher magnification image of the red stained bone nodules is
shown in Fig. 10. Quantification of the mineralization from the HA scaffolds was done
by spectrophotometric measurement of the amount of dye extracted from the stained
nodules. Fig. 11 shows the absorbance of alizarin red S extracted from cells and nodules
on the HA scaffolds and control wells. Higher absorbance values measured for cell
lysates recovered from the columnar HA scaffolds demonstrate a greater capacity of these
scaffolds for supporting mineralization.
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5.5. DISCUSSION

Our previous work showed that HA scaffolds with oriented microstructures and
unique mechanical properties could be prepared by unidirectional freezing of suspensions
[6-8]. The method is applicable not just to HA, but also to other inorganic materials. In
the present work, the potential applicability of oriented HA scaffolds for repairing bone
defects was evaluated using MLO-A5 cells as an in vitro model of newly forming bone
tissue.
The results showed that while both groups of scaffolds supported the cell
attachment and cell proliferation on their surfaces, the columnar scaffolds with larger
pore widths (diameter = 100 ± 10 µm were favored by the MLO-A5 cells. The ability to
support cell proliferation into the pores in the interior of the scaffold is a major
requirement for a scaffold [19]. The considerably greater amount of purple color seen on
the freeze-fracture surface of the columnar scaffolds (Fig. 3) indicated much more viable
cells within the interior of these scaffolds. This is an indication that the pore size of the
columnar scaffolds is sufficient to allow enough nutrient to permeate the scaffolds to
keep the cells metabolically viable. The cell infiltration experiment (Fig. 6) provides
additional evidence that the columnar scaffolds have the capacity to allow cells to
migrate through it.
Alkaline phosphatase is one of the most widely recognized biochemical markers
for bone progenitor cell activity and is believed to play a role in bone mineralization [20].
Scaffolds for bone tissue engineering applications must support the differentiation of
bone progenitor cells to functional bone tissue. The results of the study shows that MLOA5 cell cultured on both groups of HA scaffolds expressed higher levels of this enzyme
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than those on control wells, and the activity level continued to increase with incubation
time up to 8 days. The columnar scaffolds expressed the highest level of alkaline
phosphatase activity, evidence of a more optimal structure for support of bone progenitor
cell function.
In addition to the initial evaluation of the alkaline phosphatase activity as
indicative of differential function of the MLO-A5 cells, the identification of alizarin redpositive nodules is evidence of mineralization, a late event in bone differentiation
[18,21]. The production of mineralized matrix and nodules by bone progenitor cells is an
important evaluation criteria for the development of scaffolds for bone tissue engineering.
Columnar HA scaffolds showed enhanced ability to support MLO-A5 cells to mineralize
when compared with the lamellar- and celllar-type pores and the control wells (Fig. 11).
This is an indication of the improved cell response of the HA constructs with columnartype pores.
The in vitro cell culture response observed in the present work, coupled with the
favorable pore characteristics, microstructure, and mechanical response described in our
previous work [6-8], indicates the potential usefulness of the columnar HA constructs for
eventual application in bone repair and regeneration. The in vivo evaluation of these
scaffolds in an animal model is currently underway.

5.6. CONCLUSION

Hydroxyapatite (HA) scaffolds with two different oriented microstructures
(columnar and lamellar) were prepared by unidirectional freezing of suspensions. The
ability of the constructs to support cell proliferation and function was evaluated in vitro
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using murine MLO-A5 cells, an osteogenic cell line. Whereas both groups of scaffolds
showed the ability to support cell proliferation, differentiated function, and
mineralization, the columnar scaffolds were most favored by these progenitor cells. The
columnar scaffolds also supported ingrowth of cells throughout the unidirectional pores
during culture, and were rapidly infiltrated with a cell suspension by capillary action of
the pores. These in vitro cell culture results suggest that freeze-cast constructs with the
columnar microstructure could be potentially used as scaffolds for bone repair and
regeneration.
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Table 1. Microstructural characteristics of HA scaffolds prepared by unidirectional
freezing of suspensions (10 vol% particles) and used in this work.

Solvent composition

Microstructure

Pore width (µm)

Porosity (%)

Water

Lamellar

25 ± 5

70 ± 5

Water + dioxane (60 wt%)

Columnar

100 ± 10

65 ± 2
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(a)

Figure 1. SEM images of HA constructs prepared by unidirectional freezing of
suspensions (10 vol% particles) with three different microstructures: (a) columnar; (b)
lamellar.
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Figure 2. SEM images of MLO-A5 cell morphology on freeze-cast HA constructs with
(a-c) columnar-type, (d-f) lamellar-type, after culturing for (a, d) 2 days; (b, e) 4 days; (c,
f) 6 days.
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Figure 3. Cell-seeded HA constructs treated with MTT: surface of constructs with (a)
columnar-type, (c) lamellar-type microstructure after culture intervals of 2, 4, and 6 days
(left to right, respectively); (b, d) freeze-fracture face of scaffolds cultured for 6 days,
showing clusters of MTT-labeled cells within the interior.
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Figure 4. Quantitative measurement of the amount of the formazan present in the cellseeded constructs after MTT labeling. Except where indicated, all pairs are significantly
different (p<0.05).
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Figure 5. Proliferation of MLO-A5 cells into the unidirectional pores of the columnartype scaffolds as a function of culture time. The ingrowth of cells was determined by
measuring the depth of the purple color visible on the fracture face. The inset image
indicates the ingrowth of cells throughout the porous construct after 12 days of culture.
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Figure 6. HA constructs with a columnar-type microstructure after they were dipped
slightly (< 1 mm) in a cell suspension, and then treated with MTT: (a, b) surface and (c,
d) cross section of construct, showing the MTT-labeled cell clusters on and within the
scaffolds.
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Figure 7. Quantitative measurement of total protein content per scaffold or well in MLOA5 cell cultures incubated for 2, 4, 6 and 8 days on HA constructs with different pore
morphology, and in control wells. Mean ± sd; n = 4. Except where indicated, all pairs are
significantly different (p<0.05).
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Figure 8. Alkaline phosphatase activity in MLO-A5 cells cultured on HA scaffolds with
different pore morphology and control well for 2, 4, 6 and 8 days. Mean ± sd; n = 4.
Except where indicated, all pairs are significantly different (p<0.05).
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Figure 9. Optical images of bone nodules recovered from HA constructs with the
columnar-type microstructure cultured for (a) 3, (b) 6, (c) 9 and (d) 12 days, and stained
with alizarin red S.
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Figure 10. Optical image of bone nodules recovered by trypsinization from HA
constructs with a columnar-type microstructure stained with alizarin red S. The construct
was cultured for12 days.
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Figure 11. Quantitative analysis of the mineralization by measuring the absorbance of the
extracted alizarin red dye. Except where indicated, all pairs are significantly different
(p<0.05).
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6.1. ABSTRACT

Bioactive glass (13-93) scaffolds with oriented microstructures, referred to as
‘columnar’ and ‘lamellar’, were prepared by unidirectional freezing of suspensions, and
evaluated in vitro for potential use in the repair and regeneration of load-bearing bones in
vivo. Both groups of scaffolds showed an ‘elastic–plastic’ mechanical response in
compression, large strain for failure (>20%), and strain rate sensitivity, but the columnar
scaffolds had the additional advantages of higher strength and larger pore width. At the
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equivalent porosity (55–60%) and deformation rate (0.5 mm/min), the columnar scaffolds
had a compressive strength of 25 ± 3 MPa and pore width of 90–110 µm, compared to
values of 10 ± 2 MPa and 20–30 µm, respectively, for the lamellar scaffolds. Cellular
response to the scaffolds was evaluated using murine MLO-A5 cells, an osteogenic cell
line. While the cellular response to both groups of scaffolds was better than control wells,
the columnar scaffolds with the larger pore width provided the most favorable substrate
for cell proliferation and function. These results indicate that 13-93 bioactive glass
scaffolds with the columnar microstructure could be used for the repair and regeneration
of load-bearing bones in vivo.

Keywords: bioactive glass; scaffold; freeze casting; cell culture; mineralization

6.2. INTRODUCTION

The demand for synthetic scaffolds to repair damaged or diseased bone in humans
and animals is increasing because of concerns associated with current treatments using
bone autograft, bone allograft, or metal implants (e.g., limited supply, donor site
morbidity, immune rejection, potential transmission of pathogens, unpredictable longterm durability, uncertain healing to host bone, and high costs). However, synthetic
scaffolds prepared by current methods from biodegradable polymers, bioactive ceramics,
and bioactive glasses often lack the combination of high strength and high porosity for
skeletal substitution at load-bearing sites. They are limited to low-stress applications
instead, such as filling of contained bone defects, where adjacent intact bone provides
mechanical rigidity and support.
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The repair and regeneration of large defects in load-bearing bones of the limbs,
remains an unsolved clinical problem. Situations in which long bone discontinuities are
encountered include traumatic injuries suffered in war or in automobile accidents, bone
resection for tumors, and bone loss from complex, revision total hip or total knee surgery.
When compared to bone allografts and custom metal augments currently used to address
segmental skeletal deficiency, porous scaffolds that mimic bone would be ideal bone
substitutes. However, such porous scaffolds should have mechanical strengths far higher
than those obtained with currently-used fabrication methods. The scaffolds should also
support tissue growth into the porous scaffolds, to allow strong bonding and facile
integration with apposing host bone and surrounding soft tissues.
Bioactive glass, glass-ceramics, and ceramics, referred to collectively as
‘bioactive ceramics’, are attractive scaffold materials for repairing diseased or damaged
bone because of their ability to bond to surrounding tissue and to. enhance bone
formation 1 As the main mineral constituent of bone, hydroxyapatite (HA) has been
widely investigated for bone repair applications.1 There is a growing interest in the use of
bioactive glass as scaffolds for bone repair.1,2 Bioactive glasses have a widely recognized
ability to support the growth of bone cells3,4 and to bond strongly with hard and soft
tissue.1,5 Upon implantation, bioactive glasses convert to HA, which is responsible for
their strong bonding with surrounding tissue.1 Bioactive glasses are also reported to
release ions that activate expression of osteogenic genes,6,7 and to stimulate
angiogenesis.8,9 The bioactivity of glass, as measured by its conversion rate to HA, can be
varied over a wide range, from hours to months, depending on the glass composition.10,11
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Because of the compositional and fabrication flexibility of glass, scaffolds with a wide
range of chemical and physical properties as well as porous architectures can be prepared.
Unidirectional freezing of suspensions has been used to produce porous constructs
with oriented microstructures,13–15 and the method has been applied recently to the
production of porous bioceramics, such as HA.16–19 Unidirectional freezing of aqueous
suspensions resulted in the production of HA constructs with a lamellar-type
microstructure and high compressive strength (e.g., 65 MPa; 56% porosity) in the
direction parallel to the freezing direction, but the inter-lamellar pores were only 10–40
µm wide.16,17 These pore widths are considered too small to support cell ingrowth into the
interstices of the scaffold. A porosity of >50% with pore size (diameter or width) of 100
µm or larger are the minimum values reported for scaffolds capable of supporting cell
proliferation and function.20,21
Our previous work18,19,22 showed that the addition of polar organic solvents such
as 1,4–dioxane (referred to simply as dioxane) and glycerol to aqueous suspensions of
HA resulted in drastic changes to the oriented microstructure obtained by unidirectional
freezing. In particular, the addition of 60 wt% dioxane to the aqueous suspensions
resulted in the formation of a columnar microstructure, with pores approximately circular
in cross section, and with pore widths (diameters) of 100 ± 10 µm. When tested in the
direction of pore orientation, the HA scaffolds (porosity = 65–70%) had compressive
strengths of up to 15–20 MPa, higher than the compressive strength of trabecular bone
(2–12 MPa). The HA scaffolds also showed a unique ‘elastic–plastic’ response in
compression, with a large deformation for failure (>20%), and strain rate sensitivity.19
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This type of mechanical response, which is unlike the brittle response of ceramics, is
more characteristic of natural materials.24,25
Based on the promising microstructure and mechanical behavior observed for
freeze-cast HA scaffolds,18,19 this investigation was undertaken to assess the performance
of bioactive glass scaffolds prepared by the unidirectional freezing method for potential
bone repair applications. The assessment included the evaluation of the mechanical
properties of the scaffolds plus performance with cell cultures in vitro. We hypothesized
that bioactive glass scaffolds with a columnar microstructure would have compressive
strengths superior to that of trabecular bone plus the ability to support cell proliferation
into the pores in the interior of the scaffold as well as cell function.
Bioactive glass with the 13-93 composition was used because of its proven
bioactivity,26 capability of supporting cell proliferation,27 and ability to be formed into
porous constructs with relevant anatomical shapes by viscous flow sintering.28,29 The 1393 glass is also approved for in vivo use in the United States and elsewhere. Mouse
MLO-A5 cells, an established osteogenic cell line, were chosen for these experiments
because of their highly elevated expression of osteogenic phenotype traits such as
alkaline phosphatase activity and mineralization.30,31

6.3. MATERIALS AND METHODS
6.3.1. Preparation of Porous 13-93 Glass Scaffolds. Glass with the 13-93

composition (wt%): 53 SiO2, 6 Na2O, 12 K2O, 5 MgO, 20 CaO, 4 P2O5, was prepared by
melting a mixture of the appropriate quantities of analytical grade Na2CO3, K2CO3,
MgCO3, CaCO3, SiO2 and NaH2PO4.2H2O (Fisher Scientific, St. Louis, MO) in a
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platinum crucible for 2 h at 1300°C, and quenching the molten glass between stainless
steel plates. Particles of size <5 µm were obtained by crushing, grinding, and sieving the
glass to a size <106 µm, followed by wet attrition milling (Model 01-HD, Union Process,
Akron, OH).
Except for the sintering conditions, the procedure for preparing 13-93 bioactive
glass scaffolds was similar to that used in our previous work for HA.18 Briefly, the
suspensions contained 5–20 vol% glass particles, 0.5 wt% Easysperse as dispersant (ISP,
Wayne, NJ), and 1 wt% poly(vinyl alcohol), PVA, (DuPont Elvanol® 90-50) as binder.
The solvent consisted of either water, or a mixture of water and 60 wt% dioxane (Fisher
Scientific, St. Louis, MO). The suspensions were balled-milled for 48 h in polypropylene
containers using Al2O3 grinding media, and de-aired by milling at a low speed prior to the
freezing step.
Unidirectional freezing was performed by pouring the suspensions into poly(vinyl
chloride), PVC, tubes (∼10 mm internal diameter × 20 mm long) placed on a cold steel
substrate at –20°C in a freeze dryer (Genesis 25 SQ Freeze Dryer, VirTis Co., Gardiner,
NY). After sublimation of the frozen solvent in the freeze dryer (Genesis 25 SQ), the
sample was heated at 1°C/min to 500°C in flowing O2 gas to decompose the organic
binder and dispersant, then at 5°C/min to 690°C, and kept at this temperature for 1 h to
densify the glass network and form a porous, cylindrical glass construct without
crystallizing the glass.
6.3.2. Characterization of Porous 13-93 Glass Constructs. The microstructure

of the cross-sections of the sintered constructs, in the planes parallel to and perpendicular
to the direction of freezing, was observed using scanning electron microscopy, SEM
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(Hitachi S-4700, Hitachi Co., Tokyo, Japan). The volume of open porosity in the sintered
samples was measured using the Archimedes method. The pore size was determined from
SEM micrographs of the cross sections. For each construct, at least 5 samples were used
for pore size evaluation, and at least 10 measurements were done on each sample to get a
mean pore size and standard deviation.
The mechanical behavior of cylindrical samples (8 mm in diameter × 16 mm) in
compressive loading was measured according to ASTM-C773 using an Instron testing
machine (Model 4881; Instron Corp., Norwood, MA) at a crosshead speed of 0.5
mm/min. Eight samples were tested, and the average strength and standard deviation
were determined. A crosshead speed of 0.5 mm/min is typical for the testing of dense
specimens according to ASTM-C773. To investigate the strain rate sensitivity of the
compressive mechanical response, additional tests were performed at crosshead speeds of
0f 0.05 and 5.0 mm/min. Crosshead speeds higher than 5 mm/min were impractical with
the instrument and size of specimens used.
6.3.3. Cell Culture. The established MLO-A5 post-osteoblast/pre-osteocyte

murine cell line, was kindly provided by Professor Lynda F. Bonewald, University of
Missouri-Kansas City. The stock cells were maintained in collagen-coated plates (rat tail
collagen type I, 0.15 mg/ml) containing α-MEM medium supplemented with 5% fetal
bovine serum (FCS) and 5% newborn calf serum (NCS) plus 100 µg/ml penicillin. Dryheat sterilized scaffolds (8 mm in diameter × 2 mm thick) were seeded with 60,000
MLO-A5 cells suspended in 100 µl of complete medium and incubated for 4 h to permit
cell attachment. The cell-seeded scaffolds were then transferred to a 24-well plate
containing 2 ml of complete medium per well. The control group consisted of the same
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number of cells seeded in wells containing 2 ml of media. All cell cultures were
maintained at 37 ºC in a humidified atmosphere of 5% CO2, with the medium changed
every 2 days.
6.3.4. Cell Morphology. After selected intervals, 13-93 bioactive glass scaffolds

with attached cells were removed, washed twice with PBS, and placed in 2.5%
glutaraldehyde in PBS. After an overnight soak in glutaraldehyde, the fixed samples were
washed with PBS and dehydrated through a graded series of ethyl alcohol, followed by
two soaks in hexamethyldisilazane (HMDS) for 10 min each. The samples were allowed
to fully evaporate, sputter-coated with Au/Pd, and observed in a SEM (Hitachi S-4700) at
5 kV accelerating voltage.
6.3.5. Cell Viability and Growth. To visualize the metabolically active cells on

and within the porous scaffolds, the cell-seeded scaffolds were placed in 400 µl serumfree medium containing 100 µg of the tetrazolium salt MTT for the last 4 h of incubation.
After incubation, the constructs were rinsed in PBS, blotted, and allowed to dry. Images
of the constructs were obtained using a stereomicroscope fitted with a digital camera to
qualitatively assess the distribution of insoluble purple formazan, a product of
mitochondrial reduction of MTT by viable cells. The MTT-labeled constructs were then
frozen at –80ºC and fractured with a cooled microtome blade. The fracture cross-section
was visually examined to assess the presence of purple formazan within the interior of the
constructs. Finally, the formazan product was extracted from the HA constructs with 1.0
ml ethanol and measured spectrophotometrically at 550 nm in a BMG FLUORstar
Optima plate reader.
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The ability of the scaffold to support cell infiltration was assessed by dipping one
end of a scaffold (~8 mm in diameter × 10 mm) to a depth of ∼1 mm into a cell
suspension (150,000 cells/ml), and allowing the suspension to be drawn up into the pores
by capillary pressure. After incubation for 4 h to permit cell attachment, the scaffolds
were treated with MTT for another 4 h.
6.3.6. Quantitative Protein Assay. The amount of protein in lysates recovered

from the cell-seeded scaffolds was measured to assess the extent of cell proliferation on
the scaffold. The scaffolds were placed in 500 µl of 1% Triton X-100 and the cells lysed
by two freeze-thaw cycles (–80/37ºC). Aliquots of the released lysate were mixed with
working reagent prepared from a micro-BCA Protein Assay Kit (Piece Biotechnology,
Rockford, IL). Resultant absorbance values were measured at 550 nm in a BMG
FLUORstar Optima plate reader with bovine serum albumin used as standard for
comparison.
6.3.7. Alkaline Phosphatase (ALP) Activity. The cell-seeded constructs were

removed at intervals of 2, 4, 6 and 8 days of incubation and washed twice with PBS. The
samples were placed in 500 µl of 1% Triton X-100 and cells were lysed using two –
80/37ºC cycles. Aliquots of the lysate were placed in a 96-well plate for spectrophotometric measurement of alkaline phosphatase (ALP) activity with p-nitrophenyl
phosphate (p-NPP) substrate as described elsewhere.32
6.3.8. Alizarin Red S Staining for Mineralization and Quantitation. MLO-A5

cells were seeded as described above onto the glass scaffolds and into control wells, and
were cultured for 3 days in standard α-MEM medium supplemented with 5% FCS and
5% NCS. After 3 days, the standard media was removed, and the scaffolds and control
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wells were incubated in mineralization media, α-MEM with 10% FCS, 5 mM β-glycerol
phosphate (βGP) and 100 µg/ml ascorbic acid, following the method described
elsewhere.31
After incubation for 3, 6, 9 and 12 days in mineralization media, the cell-seeded
constructs and control wells were washed twice with PBS. The cells with adherent
mineralized nodules were removed from the constructs and control wells with trypsinEDTA, washed with isotonic NaCl, and stained with 4 nM alizarin red S (pH = 4.2) for 2
minutes. The stained cells were then rinsed with nanopure water and centrifuged 5 times
to remove the nonbound dye. The pellets of stained cells were placed into a 96-well plate
and observed using a stereomicroscope fitted with a digital camera. The bound alizarin
red S stain was extracted by sonicating for 10 min with 10 mM HCl in 70% ethanol. The
extracts were then diluted with 5 volumes of PBS and the absorbance measured at 550
nm in a BMG FLUORstar Optima plate reader for the determination of mineralization.
6.3.9. Statistical Analysis. All biological experiments (4 samples in each group)

were run either in duplicate or triplicate. The values are presented as means ± standard
deviations. Statistical analysis was performed with one-way analysis of variance
(ANOVA) followed by a Tukey’s post hoc test, with the level of significance set at
p<0.05.

6.4. RESULTS
6.4.1. Microstructure of the Freeze-cast 13-93 Glass Scaffold. SEM images

(Fig. 1) show microstructures of bioactive glass scaffolds that were sectioned
perpendicular to the freezing direction. The scaffolds shown were prepared from
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suspensions containing 15 vol% particles. There were no marked changes in the
microstructure along the length of the sample, so each cross-section was, in general,
representative of the whole construct. Unidirectional freezing of suspensions containing
dioxane (60 wt%) resulted in a columnar microstructure (Figs. 1a and 1b) with the pores
approximately circular in cross section with diameters of 90−110 µm aligned in the
direction of freezing. In contrast, freezing aqueous suspensions yielded a lamellar
microstructure with the lamellae and the inter-lamellar pores oriented in the direction of
freezing (Fig. 1c and 1d). The lamellar pores have a length of 100−300 µm and a width of
20−30 µm. Varying the particle concentration of the suspension (5–20 vol%) caused no
change in the type of microstructure, but did change the porosity and pore size. Lower
porosity and smaller pore size were obtained with higher particle concentration.
6.4.2. Mechanical Behavior of the Freeze-cast 13-93 Glass Scaffold. The

effect of the particle concentration of the suspensions on the porosity and compressive
strength (in the direction parallel to the freezing direction) of the columnar and lamellar
scaffolds is shown in Fig. 2. For both groups of scaffolds, the strength increased and the
porosity decreased with increasing particle concentration. The compressive strength
(taken as the peak stress on the stress vs. deformation curve) increased from ∼10 MPa to
∼50 MPa as the porosity of the columnar scaffolds decreased from 70% to 35% (Fig. 2a).
In comparison, the compressive strength of the lamellar scaffolds increased from ∼5 MPa
to ∼20 MPa for the same decrease in porosity.
Figure 3 shows data for the compressive stress vs. deformation for the columnar
and the lamellar scaffolds tested in the direction parallel to the freezing direction at three
different deformation rates (0.05–5 mm/min). The scaffolds were prepared from
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suspensions containing 15 vol% particles. The data shown are the engineering stress and
deformation, based on the initial cross-sectional area and length of the test samples, and
do not represent the true stress and strain. Both groups of scaffolds showed an ‘elastic–
plastic’ response, with a deformation for failure of >20% (deformation rate = 0.5
mm/min), as well as a gradual failure mode. The response of the scaffolds also showed a
strong strain-rate dependence. With increasing deformation rate, the peak stress increased
and shifted to lower strain.
6.4.3. SEM Examination of Cultures. Scaffolds used in the cell culture

experiments were prepared from suspensions containing 15 vol% particles (Fig. 1 and
Table 1). SEM images (Fig. 4) show the morphology of MLO-A5 cells grown on the
surface of the columnar and lamellar scaffolds for 2, 4 and 6 days. The cells visible in the
micrographs of the columnar scaffolds appeared to be attached by slender cell projections
at day 2 (Fig. 4a), and show a large increase in density with the duration of culture. It is
apparent that the cells had grown along the walls of the columnar pores and down into the
interior of these scaffolds. After 4 days, cell colonization of the walls of the scaffolds was
evident (Fig. 4b), and after 6 days, the walls were completely covered with cells (Fig. 4c).
The cells on the columnar scaffolds showed evidence of aggregation and physical contact
with neighboring cells via multiple cytoplasmic extensions. The cells seeded on the
lamellar scaffolds also show a large increase in density (Figs. 4d–4f), although this
increase appears mostly on the surface of the scaffolds with cells completely bridging the
lamellar pores after 6 days (Fig. 4f).
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6.4.4. Cell Proliferation and Cell Infiltration. Figure 5 shows the photographic

images of cell-seeded scaffolds treated with MTT after culture intervals of 2, 4 and 6
days . The purple pigment visible on the scaffold, the result of mitochondrial reduction of
MTT to an insoluble formazan product by metabolically viable cells. The increase in
intensity of the purple color with culture time is evidence of increased number of
metabolically active cells on the surface of both groups of scaffolds (Figs. 5a and 5c).
The purple staining visible on the freeze-fracture surface of the scaffolds cultured for 6
days (Figs. 5b and 5d) indicated the relative density of metabolically active MLO-A5
cells within the interior of the scaffold. The larger purple area on the fracture surface of
the columnar scaffolds indicated the presence of greater number of metabolically active
cells within these scaffolds. Furthermore, the larger depth of the purple staining into the
columnar scaffolds indicated that these scaffolds had better capacity to support the
proliferation of viable cells into the pores.
Quantitative measurement of the amount of the formazan present in the scaffolds
(Fig. 6) showed a linear increase in the absorbance value with the incubation time,
indicating an increasing number of cells present in both groups of scaffolds. The larger
amount of formazan extract recovered from the cells cultured on columnar scaffolds
provides additional evidence of better cell growth into the columnar scaffolds, and is
consistent with the photographic images of the MTT labeled scaffolds.
Figure 7 shows the growth rate of MLO-A5 cells into the pores of the columnar
scaffolds, determined by the measuring of the depth of purple formazan present on the
fractured surface. A linear growth rate of ~ 130 µm/day was determined. The full
coverage of the cross section was obtained after culturing for 15 days (Fig. 7 inset). The
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ability of the columnar scaffolds to support live cell ingrowth was further investigated by
dipping one end of an as-fabricated scaffold (to a depth of < 1mm) in a cell suspension
and monitoring the cell migration into the scaffold. The pores of the scaffold were
completely infiltrated with the cell suspension by capillary action in less than 5 s. Figure
8 shows the photographic images of the MTT-labeled constructs after infiltration. Both
the surface and cross section of the scaffold were covered with the purple color,
indicating that the columnar pores were large enough to permit cell migration and to
provide enough nutrients for the cells.
Figure 9 shows the results of the quantitative assay of total protein in cell lysates
recovered from the columnar and lamellar scaffolds and the control wells after 2, 4 and 6
days. An increase in the amount of protein recovered from both groups of scaffolds was
observed during the 6-day incubation, a finding that complements the progressive
increase in cell density observed in the SEM images (Fig. 4). The higher amount of
protein recovered from the columnar scaffolds after 4 and 6 days indicates the better
ability of the these scaffolds to support cell proliferation than the lamellar scaffold. The
data also show a higher growth rate of MLO-A5 cells on the bioactive glass constructs
than on the surface of plastic culture vessels.
6.4.5. Cell Function. The results of alkaline phosphatase (ALP) activity of

MLO-A5 cells cultured on the bioactive glass scaffolds (Fig. 10) indicated a linear
increase of ALP activity during the 6-day incubation. This result demonstrates the ability
of the bioactive glass scaffolds to support ostogenic cell function. The higher ALP
activity of the cells on columnar scaffolds after 4 and 6 days is evidence that the
columnar scaffolds are better able to support cell differentiation.
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The MLO-A5 cells and extracellular materials were removed from the glass
scaffolds by trypsinization, and stained with alizarin red S to test for the presence of
calcium deposits, an indication of mineralization.31,34 Figure 11 shows the morphology of
the stained bone nodules. The dark red areas were an indication of a higher amount of
calcium deposits, a sign of the formation of the mineralized bone nodules. Figure 12
shows the absorbance of alizarin red S dye extracted from cells on the glass scaffolds and
control wells. The increase in absorbance values for the scaffolds and control wells is
evidence of the increasing number of mineralized nodules. The higher absorbance values
measured for the cell lysates recovered from the columnar scaffolds after 9 days in the
mineralization media indicates a greater capacity of these scaffolds to support
mineralization.

6.5. DISCUSSION

The 13-93 bioactive glass microstructures obtained in this work (Fig. 1) were
generally similar to those obtained in our earlier work for HA prepared by a similar
process.18 In the unidirectional freezing process, the particles in the suspensions are
pushed aside by the growing ice crystals. The particles play a passive role, and are mainly
along for the ride, so for a stable suspension of fine particles, the resulting freeze-cast
microstructure should be independent of the particle composition, as observed. The
formation of different freeze-cast microstructures by manipulating the solvent
composition of the suspension is discussed in our previous work.22
While differences in the shapes of the stress vs. deformation curves existed, the
mechanical response in compression for the 13-93 bioactive glass scaffolds showed
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trends similar to those observed in our earlier work for freeze-cast HA scaffolds.19 The
stress vs. deformation curves showed an elastic–plastic response, consisting of three
regions: an approximately linear region at low deformation, a region of peak stress, and a
plateau region (or a region of slowly decreasing stress) at higher deformation. Both
groups of scaffolds showed a large strain for failure (>20% at a deformation rate = 0.5
mm/min), and strain rate sensitivity.
The results presented in Figs. 3 and 4 show that at equivalent porosities columnar
scaffolds of 13-93 bioactive glass have higher strength than the lamellar scaffolds. In
particular, at a deformation rate of 0.5 mm/min, columnar scaffolds with a porosity of
55–60% have a compressive strength of 25 ± 3 MPa, compared to a value of 10 ± 2 for
the lamellar scaffolds. The strength of these columnar bioactive glass scaffolds is more
than 2 times the highest strength reported for trabecular bone (2-12 MPa), and is also
approximately 2 times the strength of columnar HA scaffolds prepared in our earlier
work.19 The higher strength of the bioactive 13-93 glass scaffolds, when compared to the
strength of HA scaffolds, resulted presumably from thicker walls of the columnar
microstructure plus the ability of glass to sinter more easily than HA, thereby providing a
nearly fully-dense glass network that was better able to withstand the applied load.
While the rates of growth and function of MLO-A5 cells on both groups of
scaffolds were greater than the control wells, the columnar scaffolds with the larger pore
width provided the most favorable substrate for cell proliferation and function. Scaffolds
intended for bone tissue engineering applications should support cell growth into the
interstices of the scaffolds and differentiation of progenitor cells to functional bone
tissues.33 The columnar scaffolds with the larger pore width supported far greater cell
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ingrowth into the pores in the interior of the scaffolds (Figs. 4 and 5), and allowed rapid
cell migration and the flow of nutrients into the interior of the scaffolds (Fig. 7). The
highest level of ALP activity and mineralization expressed by the columnar scaffolds
indicates the optimal structure of these scaffolds to support bone progenitor cell function
(Fig. 10). The columnar scaffolds also showed enhanced ability to support MLO-A5
cells to mineralize (Fig. 12).
Results of the present investigation provide support for the potential use of 13-93
bioactive glass scaffolds with the columnar microstructure in the repair and regeneration
of large defects in load-bearing bones in vivo. In addition to the bioactivity of the glass,
the columnar scaffolds have high strength (25 ± 3 MPa; porosity = 55–60%). The
scaffolds did not fail in a brittle manner characteristic of ceramics and glass. Instead, they
showed a unique elastic–plastic response, with a high strain for failure (>20% at a
deformation rate of 0,5 mm/min). In addition to providing a favorable substrate for the
proliferation and differentiated function by MLO-A5 osteoblastic cells, the columnar
scaffolds with pore diameters of 100 ± 10 µm supported cell ingrowth into the pores in
the interior of the scaffolds, and the rapid migration of a cell suspension by capillary
action of the pores to completely fill the porosity. Follow-up in vivo evaluation of these
scaffolds is currently underway in an animal model.

6.6. CONCLUSIONS

Results of the mechanical testing of 13-93 bioactive glass scaffolds with a
columnar microstructure, prepared by a unidirectional freezing method, provided
encouraging data to support potential use of these scaffolds in the repair of load-bearing
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bones in vivo. When tested in compression (deformation rate = 0.5 mm/min), columnar
scaffolds (porosity = 55−60%; pore diameter = 90−110 µm) had a strength of 25 ± 3 MPa
in the direction of pore orientation, and showed an ‘elastic–plastic’ response with a large
strain for failure (>20%). These columnar scaffolds also showed better ability to support
the proliferation and differentiated function by MLO-A5 cells as compared to plastic
control wells or scaffolds with a lamellar microstructure of narrow, slot-like pores.
Bioactive glass scaffolds with the columnar microstructure also supported proliferation of
MLO-A5 cells down into the interior pores of the scaffolds, as well as rapid migration of
a MLO-A5 cell suspension by capillary to completely fill the interior pores.
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Table 1. Microstructural characteristics of 13-93 bioactive glass scaffolds prepared by
unidirectional freezing of suspensions (15 vol% particles) which were used in cell culture
experiments.
Solvent composition

Microstructure

Pore size (µm)

Porosity (%)

Water + 60 wt% dioxane

Columnar

100 ± 10

55 ± 2

Water

Lamellar

100 – 300 (length)

62 ± 3

25 ± 5 (width)

176

(a)

(c)

500µm

500µm
(d)

(b)

50µm

50µm

Figure 1. SEM images of the cross sections of 13-93 bioactive glass scaffolds prepared
with different microstructures from suspensions containing 15 vol% particles: (a, b)
columnar microstructure (solvent: water + 60 wt% dioxane); (c, d) lamellar
microstructure (aqueous solvent). The cross sections are perpendicular to the freezing
direction.
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Figure 2. Compressive strength (in the direction of pore orientation) and porosity of 1393 bioactive glass scaffolds with (a) columnar microstructure and (b) lamellar
microstructure, prepared from suspensions containing different concentrations of
particles.
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Figure 3. Compressive stress vs. deformation for 13-93 bioactive glass scaffolds tested at
the deformation rates shown: (a) columnar scaffolds; (b) lamellar scaffolds.
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Figure 4. SEM images showing the cell growth on (left) columnar scaffolds, and (right)
lamellar scaffolds after (a, b) 2 days, (c, d) 4 days, and (e, f) 6 days of culture.
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Figure 5. Cell-seeded glass scaffolds treated with MTT: surface of (a) columnar
scaffolds, and (c) lamellar scaffolds after culture intervals of 2, 4, and 6 days (left to
right, respectively); (b, d) freeze-fracture cross section of the corresponding scaffolds
cultured for 6 days, showing MTT-labeled cells within the interior.
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Figure 6. Quantitative analysis of the purple formazan extracted from cell-seeded
columnar and lamellar scaffolds. Mean ± sd; n = 4. *Significant increase in formazan
extracted from the porous glass constructs with increasing culture duration (p<0.05).
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(a)

(b)

2mm

Figure 7. Bioactive glass scaffold with the columnar microstructure after one end was
dipped slightly (< 1 mm) in a suspension of MLO-A5 cells, and treated with MTT: (a)
surface and (b) cross section, showing the MTT-labeled cells on and within the scaffolds.
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Figure 8. Proliferation of MLO-A5 cells into the pores in the interior of the columnar
scaffolds, determined by measuring the depth of the purple color across a fracture cross
section. The inset image shows complete cell proliferation into scaffold after 15 days of
culture.
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Figure 9. Total protein content in MLO-A5 cells cultured on columnar and lamellar
scaffolds and in control wells. Mean ± sd; n = 4. *Significant increase in total amount of
protein on the porous 13-93 glass constructs with increasing culture incubation (p <
0.05).

185

ALP activity (nmol pNP/min)

25

20

Control well
Lamellar-type glass scaffold
Columnar-type glass scaffold

∗
15

∗

p=0.3861

p=0.1589

10
p=0.6874

5

p=0.7568

0
2

4

6

Time (day)

Figure 10. Alkaline phosphatase activity in MLO-A5 cells cultured on columnar and
lamellar scaffolds and in control wells for 2, 4 and 6 days. Mean ± sd; n = 4. *Significant
increase in alkaline phosphatase activity on the porous 13-93 glass constructs with
increasing culture incubation (p < 0.05).
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Figure 11. Bone nodule formation by MLO-A5 cells cultured on columnar scaffold for 9
days.
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Figure 12. Quantitative analysis of mineralization in columnar and lamellar scaffolds and
in control wells, by measuring the absorbance (optical density) of the extracted alizarin
red staining dye using an Optima plate reader at 520 nm. *Significant increase in the
extracted red staining dye on the porous 13-93 glass constructs with increasing culture
incubation (p < 0.05).
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7. IN VIVO EVALUATION OF 13-93 BIOACTIVE GLASS SCAFFOLDS WITH
TRABECULAR AND ORIENTED MICROSTRUCTURES IN A
SUBCUTANEOUS RAT IMPLANTATION MODEL
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7.1. ABSTRACT

The ability of two groups of 13-93 bioactive glass scaffolds to support tissue
ingrowth was evaluated after implantation for 4 weeks into subcutaneous pockets in the
dorsum of Fisher 344 rats. One group of scaffolds (porosity = 85%; pore size = 100–500
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µm) had a ‘trabecular’ microstructure similar to that of dry human trabecular bone,
whereas the other group had a ‘columnar’ microstructure of oriented pores (porosity =
65%; pore width = 90–110 µm). Despite the lower porosity and pore width, the columnar
scaffolds supported abundant soft tissue ingrowth (glycosaminoglycan and collagen),
whereas the trabecular scaffolds showed only limited tissue ingrowth. When seeded with
mesenchymal stem cells (MSCs), both groups of scaffolds supported abundant tissue
infiltration. Bone-like tissue was formed in both groups of scaffolds seeded with MSCs,
but not in the scaffolds without MSCs. The new tissues integrated with the
hydroxyapatite-like surface layer of the scaffolds which resulted from the conversion of
the bioactive glass in the body fluids. The results indicate that the trabecular bioactive
glass scaffolds seeded with MSCs, as well as the columnar bioactive glass scaffolds,
seeded with MSCs or unseeded, could serve as substrates for bone repair and
regeneration.

Keywords: Scaffold; Bioactive glass; Subcutaneous implantation; Histology; Bone repair

7.2. INTRODUCTION

There is a growing need for the creation of synthetic scaffolds with the requisite
properties for bone repair and regeneration because of an aging population and
shortcomings of current treatments based on the use of bone autografts (limited supply
and donor site morbidity) and bone allografts (immune rejection and possible
transmission of pathogens. In addition to being biocompatible, scaffolds for bone repair
and regeneration should have mechanical properties comparable to the tissue they are
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intended to replace. Scaffolds should also have a porous three-dimensional structure with
an interconnected pore network and surface characteristics suitable for supporting tissue
ingrowth and integration of the scaffolds with surrounding tissues [1-5].
Although brittle, bioactive glass is of interest as a scaffold material for bone repair
because of its proven ability to bond strongly with surrounding bone and tissues, and to
promote new bone formation. Bioactive glass reacts in the body fluids to form a
hydroxyapatite-like phase, similar in composition to the main mineral constituent in
living bone, which is responsible for the strong chemical bond between bioactive glass
and bone [6]. Bioactive glass has a widely recognized ability to support the growth of
bone cells [7,8], and the glass is reported to release ions that activate expression of
osteogenic genes [9,10]. More recent work indicates that bioactive glass has the ability to
stimulate angiogenesis [11,12].
In our previous work, we created bioactive glass (13-93) scaffolds with
anatomically relevant microstructures, unique mechanical properties, and promising in
vitro response to cells. [13, 14]. One group of scaffolds, prepared by a polymer foam
infiltration technique, had a microstructure similar to that of dry human trabecular bone.
Another group of scaffolds, prepared by unidirectional freezing of suspensions, had an
oriented microstructure of columnar pores. Mechanical testing of these ‘trabecular’ and
‘columnar’ bioactive glass scaffolds showed promising as well as unique properties for
bone repair. Trabecular bioactive glass scaffolds (porosity = 85%; pore size = 100–500
µm) had a compressive strength of 10–12 MPa, and an elastic modulus of 2.5–3.5 GPa,
approximately equal to the highest values reported for trabecular bone [15]. The
columnar bioactive glass scaffolds had a unique ‘elastic–plastic’ mechanical response
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with large strain for failure (>20%), and strain rate sensitivity. At the same deformation
rate used for the trabecular scaffolds, the columnar scaffolds (porosity = 65%; pore width
= 90–110 µm) had an elastic modulus of 1–1.5 GPa and a compressive strength of 22–28
MPa, more than twice the highest compressive strength reported for trabecular bone. In
vitro cell culture showed that both the trabecular scaffolds and the columnar scaffolds
had the ability to support the attachment, proliferation, and function of MLO-A5 cells, an
osteogenic cell line. Furthermore, both groups of scaffolds supported the proliferation of
cells into the interior pores of the scaffolds.
In view of the promising in vitro performance of these trabecular and columnar
bioactive glass (13-93) scaffolds, this study was undertaken to evaluate the ability of
these two groups of scaffolds to support tissue ingrowth in vivo. A rat subcutaneous
implantation model was used because of the widely accepted validity of the model.
Scaffolds seeded with rat bone marrow-derived stem cells or unseeded were implanted
into subcutaneous pockets in the dorsum of rats. After implantation, tissue ingrowth into
the scaffolds was evaluated using histology and scanning electron microscopy (SEM).
We hypothesized that because of their larger porosity and pore size, the trabecular
scaffolds would be better able to support new tissue ingrowth than the columnar
scaffolds, and that seeding the scaffolds with MSCs would enhance new tissue ingrowth.

7.3. MATERIALS AND METHODS
7.3.1. Preparation of Trabecular and Columnar Scaffolds. Scaffolds of 13-93

bioactive glass bioactive glass (composition in wt%: 53 SiO2, 6 Na2O, 12 K2O, 5 MgO,
20 CaO, 4 P2O5) with the trabecular and columnar microstructures were prepared using
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procedures described in detail elsewhere [13, 14]. Trabecular scaffolds (6 mm in diameter
× 2 mm) were prepared using a polymer foam infiltration technique, whereas columnar
scaffolds (9 mm in diameter × 2 mm) were prepared unidirectional freezing of
suspensions (Table 1). The scaffolds were washed twice with water and ethanol, and
sterilized by heating for 24 h at 500ºC, prior to seeding with cells and implantation.
7.3.2. Seeding of Scaffolds with Mesenchymal Stem Cells. Scaffolds, either

seeded with rat bone marrow-derived stem cells (MSCs) or unseeded (no MSCs), were
used in the animal implantation experiments. The MSCs were harvested from the femurs
and tibias of Fisher 344 rats. Briefly, two 6-week-old Fisher rats were sacrificed by CO2
inhalation. Both ends of the femurs and tibias of each rat were removed at the level of the
epiphysis, and marrow plugs were flushed out from the epiphysis using 10 ml of a culture
medium expelled from a syringe through a 23-gauge needle. The culture medium
consisted of α-minimum essential medium (α-MEM) containing 10% fetal bovine serum,
100 U/ml penicillin, 50 µg/ml ascorbic acid, 10 mM β-glycerolphosphate, 10–8 M
dexamethasone, 0.25 µg/ml amphotericin. Marrow samples were collected and
mechanically disrupted by passing through successively smaller-gauge needles attached
to the 10-ml syringe, starting with 16-gauge and ending with 20-gauge. The resulting
cells were collected in two culture plates, each containing 10 ml medium. The medium
was changed after the first 24 h to remove non-adherent cells and,subsequently, every 2
days. Cultures were maintained in a humidified atmosphere of 95% air with 5% CO2 at
37ºC. Typically, cells were maintained for 7–14 days as primary culture or upon
formation of large colonies.
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Sterilized trabecular and columnar scaffolds were each seeded with 60,000 MSCs,
and incubated for 4 h to permit cell attachment. The cell-seeded scaffolds were then
transferred to a 24-well plate containing 2 ml of complete medium per well, and cultured
for 24 h prior to implantation. The control group consisted of the same types of scaffolds
but without seeding with MSCs.
7.3.3. Animal Implantation. Fisher 344 rats (4–6 weeks old) were used for

the implantation. All procedures were approved by the institutional animal care and use
committee. The rats were anesthetized by isofluorance inhalation. Trabecular and
columnar bioactive glass scaffolds, seeded with MSCs or unseeded, were implanted into
subcutaneous pockets in the dorsum of syngenic rats under sterile conditions. For each
animal, two unseeded and two MSC-seeded scaffolds were implanted into four sites in
the dorsum.
7.3.4. Histology. Scaffolds were harvested 4 weeks after implantation,

photographed, and fixed in 10% buffered formalin. After dehydration through a serial of
graded ethyl alcohol, the specimens were embedded in poly(methyl methacrylate),
PMMA, and stained at the Department of Surgical Sciences, School of Veterinary
Medicine, University of Wisconsin, Madison, WI. Specimens were sectioned along the
axial direction, and polished to give 50 µm sections. The sections were stained with
toluidine blue and Goldner’s trichrome to detect the formation of glycosaminoglycan
(GAG) and collagen, respectively, and examined using transmitted light microscopy. The
quantity of tissue infiltrated into the implant, as well as the amount of toluidine blue
stained matrix (GAG), and the amount of trichrome stained matrix (collagen) within the
implant were subjectively evaluated by a ‘blinded’ observer with no previous knowledge
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of the implants, using the following scale: 0 – none; 1 – small amount; 2 – moderate
amount; 3 – abundant.
The sections were also stained at Missouri University of Science and Technology
with SandersonTM Bone Stain (Surgipath Medical Industries, Richmond, IL), and then
counterstained for ∼40 s with a solution consisting of 1 g acid fuchsin, 99 ml distilled
water, and 1 ml acetic acid. This technique provides sufficient contrast to differentiate
between soft tissue (blue), bone tissue (red), and osteoid production (purple) [16].
7.3.5. SEM Observation. Scanning electron microscopy, SEM (S-4700, Hitachi

Co., Tokyo, Japan) Co., Tokyo, Japan) in the backscattered electron (BSE) and secondary
electron (SE) modes, as well as X-ray mapping in the SEM, was used to identify the
compositional change of the glass scaffolds and the morphologies of the tissues formed
inside the scaffolds after implantation. Cross sections of the implants were ground with
SiC paper, polished with diamond paste, and examined at an accelerating voltage of 5 kV
and a working distance of 12 mm.
7.3.6. Statistical Analysis. Four samples in each group were used for the

implantation. The data are presented as the mean ± standard deviation. Statistical analysis
was carried out using one-way analysis of variance (ANOVA) and Tukey’s post hoc test,
with the level of significance set at p < 0.05.

7.4. RESULTS
7.4.1. Microstructure of As-prepared Scaffolds. Figure 1 shows typical

Microstructures of the as-prepared trabecular and columnar scaffolds. The trabecular
scaffold (Fig. 1a) consisted of an interconnected porous network, with pores of size 100–
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500 µm, and porosity = 85 ± 2%, and had a microstructure similar to that of dry human
trabecular bone. In comparison, the columnar scaffolds (Fig. 1b) consisted of an oriented
microstructure of columnar pores, with a pore diameter of 90–110 µm and porosity = 65
± 2%. The two groups of scaffolds were prepared using different techniques, which did
not allow a closer match of the pore characteristics. Table 1 summarizes the
characteristics of the scaffolds used in this work.
7.4.2. Morphological and Compositional Changes of Scaffolds In vivo.

Examination of the scaffolds after subcutaneous implantation for 4 weeks (Fig. 2)
indicated that both groups of scaffolds maintained their original shapes. The implants
were surrounded by a band of fibrovascular tissue, with blood vessels apparently more
frequently present in the scaffolds seeded with MSCs (Figs. 2c, 2d) than in the unseeded
scaffolds (Figs. 2a, 2b). Backscattered electron (BSE) images of cross sections of the
implants (Fig. 3) revealed morphological changes in the bioactive glass resulting from the
implantation. The light-gray areas (labeled G) in the images represented the glass
scaffold, whereas the medium-gray areas (labeled T) showed the tissue infiltrated into the
implants, and the dark-gray areas (P) show the PMMA. Qualitatively, it is clear that there
is little tissue infiltrated into the unseeded trabecular scaffolds (without MSCs) (Fig. 3a),
but more abundant tissue in the MSC-seeded trabecular scaffold and the columnar
scaffolds (MSC-seeded or unseeded).
A high magnification BSE image of the cross section of an unseeded trabecular
scaffold after implantation (Fig. 4a) showed differences in contrast across the glass phase
which resulted from in vivo degradation of the bioactive glass. The glass cross section
consisted of three regions: a light-gray core (C), a darker-gray transition layer (S), and a
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light-gray surface layer (H). Several microcracks are present in the glass cross section,
which presumably resulted from the method used to prepare the section. Compositional
information (Figs. 4b–4d), obtained from X-ray maps for Ca(K), P(K), and Si(K) of the
area in Fig. 4a, showed that the surface layer H was rich in Ca and P. Energy dispersive
X-ray (EDS) analysis in the SEM showed that the Ca:P atomic ratio of this surface layer
was ∼1.6, which is close to the value of 1.67 for hydroxyapatite (HA). Presumably, the
surface layer (∼20 µm thick) was a HA-type product formed by conversion of the
bioactive glass in vivo. The core (C), rich in Ca and Si, is presumably the unconverted
core, whereas the Si-rich transition layer (∼5 µm thick) is a SiO2-layer commonly
observed in the conversion of silicate bioactive glass to HA.
7.4.3. Histological Evaluation of Tissue Infiltration of Implants. Figures 5

and 6 show transmitted light images of the toluidine-blue stained matrix and the
trichrome stained matrix (stained red) in the bioactive glass implants with the trabecular
and columnar microstructures. There is only a small amount of toluidine stained matrix
(glycosaminoglycan, GAG) and trichrome stained matrix (collagen) in the unseeded
trabecular scaffold (Figs. 5a1, 5a2, 6a1, 6a2), whereas abundant toluidine stained matrix
and trichrome stained matrix have infiltrated the MSC-seeded trabecular scaffolds (Figs.
5b1, 5b2, 6b1, 6b2). In comparison, abundant toluidinestained matrix and trichrome
stained matrix have infiltrated both the unseeded and MSC-seeded columnar scaffolds
(Figs. 5c1–5d2, 6c1–6c2).
A semi-quantitative analysis of the amount of tissue infiltrated into the implants,
as well as the amount of toluidine stained matrix (GAG) and trichrome stained matrix
(collagen) is given in Table 2. Statistical analysis showed significantly higher amount of
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tissue, GAG, and collagen infiltrated into the trabecular scaffolds with MSCs when
compared to the trabecular scaffolds without MSCs. For the columnar scaffolds, a higher
amount tissue was formed within the scaffolds seeded with MSCs, when compared to the
unseeded columnar scaffolds. However, for these columnar scaffolds, seeding with MSCs
did not produce a significant enhancement of the amount of GAG and collagen
infiltrated. A comparison of the histological data for the two groups of scaffolds without
MSCs (Table 2) showed a significantly higher amount of tissue, GAG, and collagen
infiltrated into the columnar scaffolds than in the trabecular scaffolds. However, for the
scaffolds seeded with MSCs, there was no significant difference in the amount of tissue,
GAG, and collagen between the two groups of scaffolds.
Figure 7 shows images of sections stained with SandersonTM Bone Stain and
counter stained with acid fuchsin for the bioactive glass implants with the trabecular and
columnar microstructures. In both groups of scaffolds, seeded with MSCs or unseeded,
tissue was found to be in close contact with the bioactive glass surface. A small amount
of soft tissue (stained blue) was formed adjacent to the surface of the bioactive glass (G)
in the unseeded trabecular scaffolds (Fig. 7a), whereas abundant osteoid deposition
(stained purple), along with a number of osteoids (stained blue within the purple-stained
deposition) was found within the MSC-seeded trabecular scaffold (Fig. 7b). Whereas soft
tissue ingrowth was observed in the pores of the unseeded columnar scaffolds (Fig, 7c),
abundant osteoid deposition (stained purple) was observed in the pores of the MSCseeded scaffolds (Fig. 7d), and osteoids were also found within the purple-stained
depositions.
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7.5. DISCUSSION

The results showed that in addition to tissue infiltration into the scaffolds,
degradation of the bioactive glass scaffolds occurred during the 4-week subcutaneous
implantation. The degradation of silicate-based bioactive glass, such as 45S5 and 13-93,
in an aqueous phosphate solution has been widely investigated [17, 18]. Upon immersion
of the glass into the phosphate solution, an amorphous SiO2-rich layer (typically 1 to a
few microns thick) first forms on the surface of the glass, after which a growing HA-type
layer forms on the surface of SiO2-rich layer as the SiO2-rich layer migrates into the
glass. At a nearly constant temperature, such as the body temperature (37°C), the rate at
which a bioactive glass converts to HA depends on several factors, such as the glass
composition, the curvature of the glass surface, the concentration of the aqueous
phosphate solution, and the presence of polyanions in the phosphate solution [19, 20].
In the present work, the thickness of the HA layer formed on the trabecular
bioactive glass scaffolds in vivo, after subcutaneous implantation for 4 weeks, was ∼20
µm (Fig. 4). Our previous in vitro work on the conversion of similar 13-93 bioactive
glass scaffolds in a simulated body fluid (SBF) showed the formation of a HA layer of
thickness ~7 µm after 2 weeks, and ~ 10 µm after 4 weeks [21]. This comparison
indicates that the conversion of the 13-93 bioactive glass scaffold in the present in vivo
experiments was approximately twice as fast as the in vitro conversion in a SBF. The
faster conversion could be attributed to the more ‘dynamic’ in vivo conditions, when
compared to more ‘static’ conditions present in the in vitro experiments involving only
intermittent stirring of the SBF. Another factor that could contribute to the enhanced in
vivo conversion of the 13-93 bioactive glass scaffolds is the presence of proteins,
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polysaccharides, and other polymeric species in the extracellular matrix which contain
electron-donating moieties such as carboxyl and hydroxyl groups. Some polyanion
species added to a SBF in vitro have been shown to markedly enhance the conversion of
13-93 bioactive glass to HA [20].
For the unseeded 13-93 bioactive glass scaffolds (no MSCs), abundant amount of
soft tissue, GAG, and collagen infiltrated the columnar scaffolds, whereas only limited
amount of tissue was formed in the trabecular scaffolds. The total porosity and range of
pore sizes of the trabecular scaffolds were far larger than those for the columnar scaffolds
(Table 1), so these two pore parameters cannot account for the limited amount of tissue
infiltrated into the trabecular scaffolds. Instead, the orientation or topography of the
pores, random for the trabecular scaffolds vs. oriented for the columnar scaffolds,
appeared to have a marked influence.
The oriented pores in the columnar scaffolds could serve as guiding pattern for
the directional migration of cell and tissues, allowing faster vascularization of the
implants. On the other hand, the tortuous path of the randomly arranged pores in the
trabecular scaffolds could provide an increased path for cell and tissue migration, leading
to a reduce rate of tissue infiltration. Oriented poly(L-lactic acid) (PLLA) scaffolds have
shown better ability to support in vitro osteoblastic cell growth and formation into neotissue than scaffolds with the same porosity but with a random three-dimensional pore
architecture [22]. The enhanced neo-tissue formation in the oriented scaffolds was
attributed to the improved mass transport or/and cell–cell interaction. The importance of
pore orientation on their in vitro and in vivo performance of scaffold is widely recognized
in axonal and nerve regeneration [23-29]. The extent of neurite outgrowth and Schwann
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cell migration in vitro, and the number of regenerated axons per cross section in vivo are
both found to be significantly higher in oriented fiber scaffolds than in random scaffolds
[28]. The topographical cue (i.e. oriention) has been suggested to have a vastly
influencing on endogenous repair mechanisms for promoting nerve regeneration across
challenging gaps.
Although soft tissue infiltration (GAG and collagen) into the trabecular glass
scaffolds was limited, the results of the present work showed that the ability this group of
scaffolds to support tissue ingrowth was markedly enhanced by seeding the trabecular
scaffolds with MSCs prior to subcutaneous implantation. Previous investigations have
also shown that the incorporation of MSCs into scaffolds can play an important role in
promoting the formation of tissues and extracellular matrix in vitro [30-33]. The higher
amount of tissue, GAG, and collagen formation was believed to be the triggered by the
seeded MSCs which were initially on the surface, but then grew within the scaffolds.
For the columnar scaffolds, seeding with MSCs did not produce as marked an
enhancement of tissue infiltration as that observed for the trabecular scaffolds (Table 2).
A possible reason for this difference is that the unseeded columnar scaffolds were by
themselves able to support moderate tissue infiltration, so the potential of seeding with
MSCs to further enhance new tissue formation was limited.
The seeding of both groups of scaffolds with MSCs induced the formation of
osteoid deposition (stained purple in Fig. 7). The MSCs have intrinsically different
responses to osteoinductive agents and can be differentiated into osteoblastic lineage
[33,34]. Seeding porous calcium carbonate, HA and β-tricalcium phosphate with MSCs
has been reported to result in the bone formation upon subcutaneous implantation
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[36,37]. In the present work, a HA-type layer was observed to form on the surface of the
implanted glass scaffolds (Figure 4). The formation of the HA layer has been shown to be
osteoinductive [6], which may be responsible for the differentiation of MSCs into the
bone-like tissue. Furthermore, the ions released from bioactive glass have been shown to
induce the expressions of genes relevant to osteoblast metabolism and bone homeostasis
[9, 10]. The release of ions such as Si, Ca, P and Na at critical concentrations due to the
surface reaction of bioactive glasses has been reported to induce specific intracellular and
extracellular responses at the interface of glass with its cellular environment [38]. The
ions release from the 13-93 bioactive glass scaffolds may contribute to the formation of
osteoid deposition from the MSCs.
As outlined earlier, the trabecular and columnar bioactive glass scaffolds used in
the present work were shown to be biocompatible in vitro and to have promising
mechanical properties. The present results showed the in vivo biocompatibility of both
groups of scaffolds, and their ability to support abundant soft tissue infiltration and
osteoid deposition when seeded with MSCs. Current work is investigating the ability of
these scaffolds to repair contained and segmental defects in bone in an animal model.

7.6. CONCLUSION

After subcutaneous implantation for 4 weeks in the dorsum of rats, trabecular
scaffolds (porosity = 85%; pore size = 100–500 µm), with a microstructure similar to that
of dry human trabecular bone, showed limited ability to support ingrowth of soft tissue
(glycosaminoglycan; collagen). On the other hand, columnar scaffolds with oriented
pores (porosity = 65%; pore width = 90–110 µm) supported moderate to abundant soft
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tissue infiltration. Seeding with mesenchymal stem cells (MSCs) prior to implantation
vastly improved the amount of soft tissue infiltrated into the trabecular scaffolds, and the
amount of bone-like tissue formed in both groups of scaffolds. The implants were
surrounded by a band of fibrovascular tissue (100–300 µm thick), indicating good
integration with surrounding tissue. These in vivo results, coupled with previous in vitro
mechanical and cell culture results, indicate considerable potential for the use of these
MSC-seeded trabecular and columnar scaffolds in bone repair and regeneration.
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Table 1. Characteristics of the 13-93 bioactive glass scaffolds with trabecular and
columnar microstructure

Pore size
Scaffold group

Porosity

Strength (MPa)

Fabrication method

11 ± 1

Polymer foam replication

(µm)
Trabecular

85 ± 2

100–500

Unidirectional freezing of
Columnar

65 ± 2

90–110

25 ± 3
suspensions
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Table 2. Tissue ingrowth scores# for total amount of tissue, glycosaminoglycan (GAG),
and collagen infiltrated into the trabecular and columnar implants seeded with
mesenchymal stem cells (MSCs) or unseeded (without MSCs).

Implants

Tissue

GAG

Collagen

1.0

1.0

0.5 ± 0.5

3.0*

1.8 ± 1.0*

1.8 ± 1.2*

2.3 ± 0.5†

2.5 ± 0.6†

1.5 ± 1.0†

2.8 ± 0.5*

1.8 ± 0.5

2.3 ± 0.5

Trabecular scaffold
without MSCs
Trabecular scaffold
with MSCs
Columnar scaffold
without MSCs
Columnar glass with
MSCs

#

Note: Scores based on the following scale: 0: none, 1: small amount, 2: moderate

amount, and 3: abundant.
* p < 0.05 when compared with the score for the same group of implants without MSCs.
†

p < 0.05 when compared with the score for the trabecular group of implants without

MSCs.
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Figure 1. SEM images of 13-93 bioactive glass scaffolds with (a) trabecular
microstructure, similar to the microstructure of dry human trabecular bone, and (b)
columnar microstructure of oriented pores (cross section perpendicular to the pore
orientation direction).
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Trabecular scaffold

Columnar scaffold

Without MSCs

With MSCs

Figure 2. Gross appearance of bioactive glass scaffolds 4 weeks after subcutaneous
implantation in the dorsum of rats.
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Figure 3. SEM backscattered electron images of trabecular implants (a) without MSCs
and (b) seeded with MSCs; and columnar implants (c) without MSCs and (d) seeded with
MSCs, after subcutaneous implantation for 4 weeks. G denotes glass; T denotes tissue; P
denotes PMMA.
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Figure 4. SEM backscattered electron image of bioactive glass in trabecular scaffold
(without MSCs) after subcutaneous implantation for 4 weeks (a), and corresponding Xray maps for Ca(K) (b), P(K) (c), and Si(K) (d). C denotes unconverted glass core; S
denotes SiO2-rich layer; H denotes hydroxyapatite layer.
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Figure 5. Transmitted light images of toluidine blue stained sections for trabecular
implants (a) without MSCs, (b) seeded with MSCs, and for columnar implants (c)
without MSCs, and (d) seeded with MSCs, after implantation for 4 weeks.
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Figure 6. Transmitted light images of Goldner’s trichrome stained sections for trabecular
implants (a) without MSCs, (b) seeded with MSCs, and for columnar implants (c)
without MSCs, and (d) seeded with MSCs, after implantation for 4 weeks.
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Figure 7. Transmitted light images of thin sections stained with SandersonTM Bone Stain
for trabecular implants (a) without MSCs, and (b) seeded with MSCs, and columnar
implants (c) without MSCs, and (d) seeded with MSCs, after subcutaneous implantation
for 4 weeks. G denotes bioactive glass; S denotes soft tissue; O denotes osteoid
production.
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3. CONCLUSIONS

This section summarizes the overall conclusions drawn from the research reported
in the seven manuscripts that make up the body of the dissertation.
1. Freeze casting of aqueous hydroxyapatite (HA) suspension on a cold substrate
produced porous constructs with a lamellar-type microstructure (pore width 5-30
µm) in which plate-like HA lamellas were oriented in the direction of freezing.
Varying the processing parameters, such as that the particle concentration in the
suspension, the temperature of the cold substrate (the freezing rate), and the
addition of glycerol to the aqueous solvent changed the porosity and pore size to a
limited extent with no significant change in pore morphology. On the other hand,
the addition of 60 wt% 1,4-dioxane to the aqueous solvent drastically changed the
pore width and pore morphology, giving scaffolds with columnar-type pores of
width 90-110 µm.
2. The compressive strength of the freeze-cast HA constructs was strongly
dependent on the sintering temperature, and optimum strength was obtained by
sintering for 3 hr at 1350ºC without the formation of secondary crystal phases.
The mechanical response of the porous HA constructs showed a unique ‘elasticplastic’ response, similar in nature to that of bone and other natural materials,
with high strain tolerance ~5% at the maximum stress, high strain for failure
>20%, and strain rate sensitivity.
3. HA scaffolds with approximately the same porosity (65-70%) but different pore
architecture (lamellar, pore width = 20-30 µm; columnar, pore diameter = 90-110
µm) were able to support the proliferation of MC3T3-E1 pre-osteoblastic cells on
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their surfaces. HA scaffolds with the columnar-type microstructure showed far
better ability to support cell growth into the interior pores and cell function than
those with lamellar-type microstructure.
4. HA scaffolds with columnar microstructure showed better ability than the
lamellar scaffolds to support the proliferation, differentiation and mineralization
of MLO-A5 cells, an osteogenic cell line. The scaffolds also supported the
ingrowth of cells throughout the unidirectional pores during culture, and were
rapidly infiltrated with a cell suspension by capillary action of the pores. These
results indicated that freeze-cast HA constructs with the columnar microstructure
could serve as scaffolds for bone repair and regeneration.
5. Bioactive 13-93 glass scaffolds with unidirectional microstructures were prepared
using the same freeze casting technique as for HA scaffolds. Columnar glass
scaffolds (porosity=55-60%; pore diameter=90-110 µm) showed encouraging
mechanical properties, including a compressive strength of 22-28 MPa in the
direction of pore orientation and an “elastic-plastic” response with a large strain
for failure (>20%).
6. 13-93 glass scaffolds with columnar microstructure showed better ability in
supporting the proliferation and differentiated function by MLO-A5 cells as
compared to scaffolds with a lamellar microstructure. The columnar glass could
also support the proliferation of MLO-A5 cells down into the interior pores as
well as rapid migration of cell suspension by capillary. These results indicate that
13-93 bioactive glass scaffolds with the columnar microstructure could be used
for the repair and regeneration of load-bearing bones in vivo.
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7. 13-93 glass scaffolds with columnar microstructure integrated well with the
surrounding tissues upon subcutaneous implantation in the dorsum of rats. The
scaffolds supported the ingrowth of significant amount of extracellular matrix
(glycosaminoglycan and collagen) formation. The preseeding of mesenchymal
stem cells (MSCs) on the columnar glass scaffolds increased the amount of tissue
infiltration and resulted in the deposition of osteoid production. These results
indicate that the porous 13-93 glass columnar scaffolds may be a desirable
substrate for the bone tissue engineering applications.
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4. FUTURE WORK

Based on the research discussed in the present work, there are many interesting
possibilities for future work.
1. Toughening mechanism: The present study investigated the relationship between
the microstructure and mechanical behavior of the freeze-cast HA and bioactive
glass scaffolds with unidirectional porosity. The scaffolds showed an interesting
“elastic-plastic” mechanical responses in compression parallel to the freezing
direction. Along with the knowledge gained from the present work and the
literature report on the toughening mechanism for natural materials such as bone
and nacre, a proper toughening mechanism should be proposed to explain the
mechanical behavior of such ceramic materials.
2. Modeling of crystal size control: Processing parameters including the particle
concentration in the suspension, temperature of the substrate and solvent
composition have been found to influence the size of the formed crystals. These
factors have been discussed in terms of the thermodynamic and kinetic analysis.
The estimation of the crystal size based on the theoretical modeling may provide
guidance for future work.
3. Mechanical property improvement: The compressive strength (22-28 MPa) of the
freeze-cast 13-93 glass scaffolds was almost twice the value for human trabecular
bone (2-12 MPa). This makes the glass scaffolds promising for the repairing of
load-bearing sites such as segmental bone defects. Furthermore improvement in
the compressive strength to a level comparable to human cortical bone (120-180
MPa) at the expense of limited reduction of the porosity will make the scaffolds
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more attractive. The refinement of the directionality and control of the sintering
temperature of the glass are options to improve the mechanical strength.
4. Control of scaffold degradation: The present work investigated the fabrication,
and in vitro and in vivo evaluation of bioactive 13-93 glass scaffolds. Little work
was done on the in vitro and in vivo degradation behavior of the scaffolds. With
regards to the application of scaffolds in bone repairing and regeneration, a match
between the new bone growth and scaffold degradation rate should be achieved.
The evaluation and control of the glass scaffold degradation rate will provide
useful information for future in vivo application in bone repair.
5. Repair of segmental bone defects: The in vivo performance of the bioactive 13-93
glass was assessed by subcutaneous implantation in the dorsum of rats. This
preliminary work showed evidence that 13-93 glass scaffolds could support tissue
ingrowth and extracellular matrix formation. An investigation into the ability of
the scaffold to support new bone formation in large bone defect sites will provide
further guidance for the property and microstructure control of the scaffolds.
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A. POSSIBLE TOUGHENING MECHANISMS IN UNIDIRECTIONAL
HYDROXYAPATITE SCAFFOLDS PREPARED BY FREEZE CASTING

Qiang Fu, Mohamed N. Rahaman∗
Department of Materials Science and Engineering, Missouri University of Science and
Technology, Rolla, MO 65409, USA

ABSTRACT

In our previous work, oriented scaffolds prepared by unidirectional freezing of
suspensions showed a unique elastic-plastic mechanical response during compression
parallel to the freezing direction. The objective of the present work was to characterize
changes in the microstructure resulting from the deformation of the scaffolds in
compression to different strains. Scanning electron microscopy indicated that several
mechanisms, including microcracking, crack deflection, tortuous crack path, lamellar
sliding and ceramic bridges between the lamellas, might contribute to the elastic-plastic
mechanical response. These results may provide a guide for the design of scaffold
materials for the repair of load-bearing bones.

1. INTRODUCTION

Biological systems produce composites that are composed of both inorganic and
organic components in complex anisotropic arrangement. They create hierarchically
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organized composites that can achieve orders of magnitude increase in strength and
toughness compared to their constituent phases [1-3]. Nacre consists of sub-micrometer
(~ 500 nm) layered aragonite (CaCO3) platelets in which adjacent platelets are bonded by
a thin (20-30 nm) layer of organic protein, which are organized into a layered brick-like
structure. The fracture toughness of nacre is roughly an order of magnitude higher than
that of either the aragonite or the protein layer [1]. The toughening mechanisms of nacre
occur through its multi-dimensional architectural design and the viscoelastic energy
dissipation within the biopolymer layer. Microcrack formation, crack bridging and sliding
of the aragonite layers also act as effective toughening mechanisms [1, 2].
Bone is another hierarchical composite of a fibrous polymer (collagen) and hard
mineral nanoparticles (hydroxyapatite, HA) [1]. The enduring strength and toughness of
bone is attributed to the simultaneous operation of the toughening mechanisms at the
microscale level. Crack deflection, crack bridging, constrained microcracking, and
viscoplastic flow have been reported as the main toughening mechanisms for cortical
bone [4-7]. Wood is a cellular composite, consisting of cellulose, a high molecular weight
polysaccharide. The specific stiffness (stiffness per unit weight) and specific strength of
wood is comparable to steel [8]. Wood exhibits highly anisotropic fracture toughness, and
its highest toughness is ten times larger than that of a fibrous composite with the same
fraction of fibers and matrix. Fiber pull-out is the main toughening mechanism
responsible for the high toughness of wood [9]. Inspired by these strong and tough
biological materials, attempts are being made to fabricate synthetic materials with bonelike and nacre-like microstructures.
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In our previous work, porous bioactive 13-93 glass and ceramic (HA) scaffolds
with highly oriented microstructures were fabricated by a unidirectional freeze casting
technique. Both lamellar- and columnar-type pores oriented along the freezing direction
were observed within these scaffolds [10-12]. Upon compression in the pore orientation
direction, the scaffolds exhibited a unique “elastic-plastic” response with a high
deformation for failure (>20%) and strain rate sensitivity [11, 12]. This type of
mechanical response is similar in nature to that of biological materials such as nacre,
bone and wood [1, 13, 14], and is of importance for the potential application of these
bioactive glass and HA scaffolds in the repair of load-bearing bones.
The objectives of the present work were to investigate the microstructure changes
that occur during the compressive loading of HA scaffolds fabricated by the
unidirectional freeze casting technique, and to provide a rationalization of the unique
elastic-plastic response in terms of the observed microstrutural changes. An
understanding of the relationship between the microstructure and mechanical behavior
could provide useful information for the manipulation of the structure of these scaffolds
for different applications. HA scaffolds with a lamellar-type microstructure prepared
from aqueous suspension were investigated, since this system forms the basis for the
development of other freeze casting structures.

2. MATERIALS AND METHODS

The procedures for preparing HA scaffolds with an oriented microstructure by
unidirectional freezing of HA suspensions are described in detail elsewhere [10]. Briefly,
the suspensions contained 20 vol% HA particles (average particle size <1 µm; Alfa
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Aesar, Haverhill, MA), 0.75 wt% dispersant (Dynol 604; Air Products & Chemicals, Inc.,
Allentown, PA), and 1.5 wt% binder (DuPont Elvanol® 90-50; DuPont, Wilmington,
DE). Unidirectional freezing was initiated by pouring the suspensions into poly(vinyl
chloride), PVC, tubes (∼10 mm internal diameter × 20 mm long) placed on a cold steel
substrate at –20°C in a freeze dryer (Genesis 25 SQ Freeze Dryer, VirTis Co., Gardiner,
NY). After sublimation of the frozen solvent in the freeze dryer (Genesis 25 SQ), the
constructs were sintered in air for 3 h at 1350°C (heating and cooling rate = 3°C/min).
The mechanical response of the sintered constructs (∼8 mm in diameter × 16 mm) in
compressive loading was measured according to ASTM-C773 using an Instron testing
machine (Model 4204, Norwood, MA) at a crosshead speed of 0.5 mm/min. The samples
were tested in the directions parallel to the freezing direction. The test was stopped at
different stages of deformation, and the deformed samples were carefully removed.
Scanning electron microscopy, SEM (Hitachi S-4700, Hitachi Co., Tokyo, Japan) was
used to observe the microstructure of the deformed samples.

3. RESULTS AND DISCUSSION

Figure 1 shows the microstructure of HA scaffolds prepared from aqueous
suspensions with 20 vol% particles. The scaffolds consisted of a uniform lamellar-type
microstructure with the pores oriented in the direction of freezing. Ceramic bridges were
observed between the adjacent lamellae. It has ben suggested that these ceramic bridges
arose from the local ice crystal tip splitting and the engulfment of particle agglomerates
due to particle repulsion from the solidification front and subsequent tip healing [15].
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Figure 2 shows the mechanical response of the lamellar HA constructs prepared from
aqueous suspension (20 vol% particles) upon compression parallel to the freezing
direction. The data shown are engineering stress and deformation, based on the initial
cross-sectional area and length of the test sample, and do not represent the true stress and
deformation. The curve had a smoothly varying, asymmetric bell shape, and could be
divided into three regions: an elastic regime in which the stress–deformation response
was linear (Region I), a stress plateau region representing a region of highest sustainable
loading (Region II), and a failure region of decreasing load-beating ability (Region III).
Catastrophic failure of the samples was not observed during the compression test (up to
5% deformation). This type of stress–deformation curve, with an asymmetric bell shape,
has been observed in nacre when the compression loading is applied parallel to the
layered structure [16]. Crack deflection, delocalization of damage, plastic microbuckling,
and viscoplastic deformation of the organic layers were considered to be the main
mechanisms contributing to the mechanical properties of nacre [1, 2, 16].
In an attempt to understand the toughening mechanisms in the HA scaffolds
prepared in this work, the microstructural changes in the HA constructs which resulted
from mechanical testing in compression were observed using SEM. Figure 3 (a1-d1)
shows SEM images (a1-d1) of the fractured surface of HA constructs after they were
compressed to different strains and removed from the mechanical testing machine. The 4
images show representative microstructures of samples that were deformed to different
regions of the stress vs. deformation curve shown in Figure 2. Figure 3a1 indicated that in
the initial elastic region (Region I), microcracking in the lamellae occurred (deformation
= 1%). These microcracks initiated in the lamellae, and did not grow to become
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macrocracks. Instead they formed a process zone which decreased the stress
concentration ahead of the crack tips. The presence of the microcracks is believed to
dissipate the crack energy in flaws below the critical size for failure, thereby enhancing
the toughness [17]. This toughening mechanism has the added benefit that strength need
not be reduced substantially, and has been reported to be of importance in toughening
bone and nacre [1, 2].
With an increase in the load (Region I; deformation = 4%), major cracks in the
scaffolds were tilted and twisted out of the crack plane, leading to crack deflection
(Figure 3 b1 and b2). Crack deflection enhanced the toughness by providing the initial
barriers to crack propagation, and by changing the crack angle from the optimum 90º
condition. This mechanism is reported to contribute over 50% to the overall toughness of
bone [19].
The propagation of large cracks through the HA lamellae (Figure 3 c1 and c2)
were observed as the load increased to around the maximum value (Region II;
deformation = 6%). The SEM image showed a highly tortuous path, which provided a
large increase in the crack path. This type of tortuous fracture mode has been proposed as
an effective toughening mechanism in biological materials [1].
Figure 4 d1 shows the microstructure of the HA constructs after the testing into
Region III (deformation = 15%). In addition to the propagation of large cracks through
the lamellae, sliding of the lamellae was also observed. As bridges were observed
between the adjacent lamellae (Figure 1 b, d), the breaking of these bridges also provided
an effective toughening mechanism. This type of ceramic bridging between the mineral
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layers has been observed in nacre and was reported to play a key role in the mechanical
performance of nacre [2].

4. CONCLUSIONS

Hydroxyapatite scaffolds with an oriented microstructure of lamellar-type pores,
fabricated by a unidirectional freeze casting technique, showed an “elastic-plastic”
mechanical response with a high strain for failure (>20%) in compression parallel to the
freezing direction. Scanning electron microscopy observation of the scaffolds deformed
to different strains indicated that several mechanisms, including microcracking, crack
deflection, tortuous crack path, lamellar sliding, and ceramic bridges between the
lamellae, might contribute to the enhanced toughness of the scaffolds. The results may
provide a guide to the design of scaffold materials for applications in the repair of loadbearing bones.
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Figure 1. SEM images of the cross sections of HA scaffolds with a lamellar
microstructure prepared by unidirectional freezing of suspensions: (a, b) perpendicular,
and (c, d) parallel to the freezing direction.
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Figure 2. Stress-deformation curve in compression testing parallel to the freezing
direction for HA constructs prepared from aqueous suspension (20 vol% particles). Three
different regions are outline for the curve: I, elastic region; II, stress plateau region; III,
failure region.
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Figure 3. Microstructures (a1–d1) of lamellar-type HA scaffolds after testing in
compression (in the direction of freezing) to increasing strains (deformation) shown.
(Regions I, II, and III refer to the different regions of the strss vs. deformation curve in
Fig, 2). The diagrams on the right illustrate the dominant toughening mechanisms: (a2)
microcracking, (b2) crack deflection, (c2) tortuous crack path, and (d2) sliding.
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ABSTRACT

The silicate-based 45S5 bioactive glass, typically in particulate form, has been
widely investigated for bone repair. However, its application as a scaffold for bone tissue
engineering is limited due to the difficulty of forming porous three-dimensional
constructs with complex shapes. In this study, the use of another silicate-based bioactive
glass, referred to as 13-93, was investigated for the preparation of porous constructs.
Particles of 13-93 glass (255–325 µm) were consolidated and sintered to form cylindrical
constructs. Characterization of these constructs was performed using mercury
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porosimetry, scanning electron microscopy (SEM), and mechanical testing. Constructs
with porosities of 40–45% and pore sizes in the range 100–300 µm were found to have a
compressive strength of 22 ± 1 MPa. The bioactivity of the 13-93 glass was studied by
immersing disks in a simulated body fluid at 37°C and characterizing the reaction
products. X-ray diffraction, Fourier transform infrared (FTIR) spectroscopy, and SEM
showed the formation of a crystalline hydroxyapatite layer on the glass surface after
~7days. The ability to fabricate the complex geometrical shape of the articulating surface
of a human tibia from 13-93 glass particles was demonstrated.

Keywords: bioactive glass; biomaterials, scaffold; tissue engineering

1. INTRODUCTION

Tissue engineering, involving the implantation of cells/tissues or stimulating host
cells to grow in an implanted scaffold, has emerged as a promising approach for the
regeneration of lost or damaged tissues [1,2]. The key components of this approach are a
suitable supply of cells, environmental factors such as growth and differentiation
supplements, and three-dimensional biomaterial scaffolds that can guide the growth of
new tissue in vitro and in vivo [3-7]. Biomaterial constructs for bone tissue engineering
must have a combination of desirable characteristics, such as biocompatibility, sufficient
mechanical strength to support physiologic loads, and the ability to be fabricated into
anatomically-correct shapes.
Both ceramics and polymers have been used as scaffold materials for bone tissue
engineering [8,9]. Polymers such as polylactic acid (PLA), polyglycolic acid (PGA), and
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their copolymers (PLGA) are degradable in vivo, so the scaffold can be gradually
replaced by new bone matrix synthesized by tissue-forming cells [10-13]. The use of
degradable polymers such as PLGA in replacing load-bearing bones is limited by their
relatively low mechanical strength [8,9]. Attempts have been made to reinforce the
degradable polymers to improve their load-bearing properties, but the usefulness of this
approach is unclear [14,15].
Bioactive glasses, glass-ceramics, and ceramics have been widely investigated for
healing bone defects, because of their ability to enhance bone formation and bond to
surrounding tissue [16-19]. Cell seeded bioactive ceramics are also of interest as
potential scaffolds for bone tissue engineering. Hydroxyapatite (HA) and tricalcium
phosphate (TCP) ceramics, composed of the same ions as bone, are biocompatible and
produce no systemic toxicity or immunological reactions. However, stoichiometric HA
resorbs slowly or undergoes little conversion to a bone-like material after implantation
[20,21]. Many bone regeneration applications require gradual resorption of the implanted
biomaterials and their concurrent replacement by the host bone.
The silicate-based 45S5 bioactive glass, referred to as Bioglass® (composition: 45
wt% SiO2; 24.5 wt% Na2O; 24.5 wt% CaO; 6 wt% P2O5), has been of primary interest for
biological applications [16,18,19]. In vivo studies have shown that 45S5 glass can
stimulate bone regeneration [22-24], whereas in vitro studies have shown that the glass
itself and the soluble ionic species released by dissolution have osteoinductive properties
[25-28]. Porous 45S5 glass scaffolds with simple shapes have been developed [25,29]
and cell culture experiments indicate that porous glass can function as a template for
generating mineralization in vitro [29]. However, the formation of 45S5 glass into porous
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constructs with complex, anatomically relevant shapes is limited by the difficulty of
sintering the glass particles to form a strong interconnected network.
In the present work, the use of 13-93 bioactive glass for the preparation of porous
constructs for bone tissue engineering applications was investigated. The 13-93 glass
(composition: 53 wt% SiO2, 6 wt% Na2O, 12 wt% K2O; 5 wt% MgO, 20wt% CaO and 4
wt% P2O5) has a silicate-based composition. Previous work has shown that 13-93 glass
can be melted and pulled into fibers more easily than 45S5 glass, indicating enhanced
viscous flow [30]. The glass has also been shown to support cell growth [31]. The better
flow characteristics and the ability to support cell growth warrant further investigation of
13-93 glass as a scaffold material for bone tissue engineering. The objectives of the
present work were to investigate the processing conditions for preparing porous
constructs of 13-93 glass and to characterize the structure and mechanical properties of
the fabricated constructs.

2. MATERIALS AND METHODS
2.1 Preparation of Porous 13-93 Glass Constructs

Glass with the 13-93 composition was prepared by melting a mixture of the
appropriate quantities of analytical grade Na2CO3, K2CO3, MgCO3, CaCO3, SiO2 and
NaH2PO4.2H2O in a platinum crucible at 1300°C and quenching between cold stainless
steel plates. The glass was crushed in a hardened steel mortar and pestle and classified
using stainless steel sieves to provide particles with sizes in the range of 255–325µm.
A slip casting method was used to form the particles into three-dimensional shapes
because the process has the capability for producing complex shapes by casting in a
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shaped mold [32]. Initially, only simple shapes such as cylinders and disks were required
to determine the process variables and to characterize the fabricated material. The
suspension for slip casting was prepared by dispersing 85 wt% glass particles in an
aqueous solution containing 7.5 wt% poly(vinyl alcohol), PVA. Constructs were formed
by casting the suspension into cylindrical cavities in a gypsum mold, followed by drying
for ~24 h in air at 60°C.
The construct was heated to burn off the PVA binder, and sintered to join the
glass particles together into a three-dimensional network with adequate strength. Since
the glass can undergo undesirable crystallization if sintered under unsuitable conditions,
experiments were carried out to determine the optimum conditions to bond the particles
into a network without causing any measurable crystallization. Differential thermal
analysis, DTA (Perkin Elmer DTA7, Perkin Elmer Corp., Norwalk, CT) was used to
determine the glass transition temperature (Tg) and the crystallization temperature by
heating 40 mg of 13-93 glass particles (<45 µm) at a rate of 10°C/min from 50°C to
1200°C. From a series of experiments, it was found that heating the slip-cast samples at
3°C/min to 550°C (holding time = 30 min), followed by 5°C/min to 700°C (holding time
= 15 min), allowed the PVA binder to be burned out completely and sintering to take
place without crystallization of the glass.
The ability to use the slip casting process to form porous constructs with
anatomically-correct shapes was investigated. A plastic model of the proximal
articulating end of a human tibia was used to prepare the shaped cavity in a gypsum
mold, into which the suspension of glass particles was cast. The procedure for fabricating
the tibial construct was similar to that described above for the cylindrical samples.
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2.2 Characterization of Porous 13-93 Glass Constructs

The pore morphologies of the cylindrical constructs were observed using scanning
electron microscopy, SEM (Hitachi S-4700), of the surfaces and cross-sections of the
constructs. Cross-sections were prepared by infiltrating the construct with an epoxy resin
under vacuum, followed by grinding with silicon carbide (SiC) paper and polishing with
diamond paste. The porosity and pore size distribution of accessible (open) pores were
measured using mercury intrusion porosimetry (Poremaster; Quantachrome, FL) [32].
The compressive strength of cylindrical samples (8 mm in diameter × 16 mm) was
measured using an Instron testing machine (Model 4204) at a crosshead speed of 0.5
mm/min. Eight samples were tested, and the average strength and standard deviation
were determined.

2.3 Conversion of 13-93 Glass to Hydroxyapatite in SBF

The formation of hydroxyapatite (HA) on the surface of 13-93 glass disks when
immersed in a simulated body fluid (SBF) at 37°C was investigated using SEM (Hitachi
S-4700), X-ray diffraction, XRD (Rigaku; Model D/mas 2550 v), and Fourier transform
infrared reflectance spectroscopy, FT-IRRS (Model 1760-X, Perkin Elmer Corp.,
Norwalk, CT). Table 1 gives the composition of the SBF [33]. Glass samples with a
regular geometry, such as disks, were required to facilitate the characterization of the HA
formation, particularly for short reaction times. The disks were formed by casting the
molten glass into graphite molds (1 cm in diameter and 2 mm in thickness), followed by
annealing for 6 h at 500ºC to relieve thermal stresses. Prior to immersion in the SBF, the
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surfaces of the glass disks were prepared by wet grinding with 320-grit SiC paper,
followed by dry grinding with 600-grit SiC paper. The samples were then cleaned in
ethanol in an ultrasonic bath, and dried in air.
To study the conversion to HA, the glass disks were suspended in sealed
polyethylene bottles containing 20 cm3 of SBF, to give a sample surface area to SBF
volume ratio of 0.1 cm–1. After immersion in SBF for various times, the disks were dried
in air at room temperature for at least 24 h. Crystalline phases formed on the surface of
the glass were detected using thin-film XRD (Cu Kα radiation; λ = 0.15406 nm) at a
scanning rate of 1.8º/min in the 2θ range of 10–80°. The functional groups in the reacted
surface layer were analyzed using FT-IRRS in the range of 400 to 2000 cm-1.
Following the thin film XRD and FT-IRRS characterization, cross-sections of disks
soaked in SBF were prepared and observed in the SEM to characterize the thickness of
the HA layer. Prior to observation in the SEM, the disks were mounted in epoxy resin,
ground with SiC paper, and polished with diamond paste, using the procedure described
earlier.

3. RESULTS AND DISCUSSION

The DTA pattern of the 13-93 glass is shown in Figure 1. Whereas the peaks and
troughs are not as clearly identified as in other glasses with simpler compositions, the
onset of the glass transition can be assumed to occur at 606°C. There appeared to be two
crystallization events, with onset temperatures of 714°C and 851°C, respectively. Since
one objective of the fabrication process was to bond the glass particles by viscous flow
sintering into a porous construct without any measurable crystallization, the DTA pattern
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indicated that the sintering temperature should be chosen between 606°C and 714°C.
From preliminary experiments, it was found that sintering for 15 min at 700°C provided
adequate strength for subsequent handing without any measurable crystallization of the
glass. These sintering conditions were used in subsequent experiments.
Figure 2(a) shows an SEM micrograph of the surface of the porous glass construct
after sintering. Joining of the particles at the contact points resulted in the formation of
necks (Figure 2(b)), that produced an interconnected network with enhanced strength. A
cross-section (Figure 2(c)) shows the network of bonded glass particles and porosity.
Mercury porosimetry data (Figure3) showed that the porosity of the sintered constructs,
determined from the volume of mercury intruded divided by the total volume of the
sample, was 40 ± 2%. By taking the volume intruded for pore radius values between 50
and 150 µm and dividing by the total volume intruded, it was found that ~75% of the
interconnected pores had channel diameters between 100 and 300 µm. Similarly, it was
found that ~90% of the pores had channel diameters larger than 100 µm. Generally, it has
been found that pores larger than ~100 µm are capable of supporting cell ingrowth
[34,35]. Thus, the pores in the present constructs appear to have dimensions that are
suitable for biomedical scaffolds.
The compressive strength of porous cylindrical samples was 22 ± 1 MPa. This
value is significantly higher than the value for cancellous bone (2–12 MPa), but it is also
significantly lower than that for cortical bone (100–200 MPa). While the design criteria
for scaffolds for bone tissue engineering are unclear, it should be noted that the strength
of the present constructs can be enhanced by a greater degree of sintering, at the expense
of some reduction in the porosity and average pore size. It is possible that sintering at a
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higher temperature or for a longer time could lead to crystallization of the glass.
However, the preliminary studies in the present work indicated that sintering for 15 min
at 710°C, which is 10°C higher than the temperature used in the experiments reported
here, produced more rapid sintering without detectable crystallization. Based on data for
45S5 bioactive glass [36], a limited extent of crystallization would not affect the ability to
bond to bone, although the rate of formation of HA would be reduced.
Thin-film XRD patterns for the as-prepared glass and for the glass after soaking
in SBF for 1, 7, and 14 days are shown in Figure 4. The as-prepared glass showed the
commonly observed band centered ~30° 2θ, which is typical of an amorphous glass.
After 1 day in the SBF, the pattern became almost flat. A possible reason for the
disappearance of the broad band, previously observed for the as-prepared glass, is the
formation of an amorphous product on the surface of the glass. The thin-film technique
analyzed the amorphous reaction layer, and not the underlying glass. After 7 days, peaks
corresponding to those in a standard hydroxyapatite (HA) were observed. These peaks
increased in intensity after 14 days of immersion, but the peak intensities were still well
below those for a standard crystalline HA, indicating that the as-formed HA was
incompletely crystallized or only weakly crystalline.
The FT-IRRS spectra (Fig. 5) demonstrated that the major resonances associated
with crystalline HA, at wavenumbers of 560 and 605 cm–1 [37,38], were observed for the
glass soaked in SBF for 7 days but not for the as-prepared glass, providing further
indication for the formation of an HA layer on the surface of the glass soaked in SBF.
The spectrum for the as-prepared glass showed resonances at 1050 and 940 cm-1
attributed to the stretching vibration modes of Si bonded to nonbridging O in the glass
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network, as well as a resonance at 440 cm-1 corresponding to the bending vibration of the
Si-O-Si bond. The spectrum for the glass soaked in SBF for 7 days also showed
resonances at 1030 and 1243 cm-1 corresponding to the phosphate group. There was a
resonance at 866 cm–1 as well, corresponding to the stretching vibration of CO32- function
group, which indicated that the as-formed HA had carbonate groups substituted into the
structure [39]. The FT-IRRS spectra therefore indicated that the surface of the glass
soaked in SBF was coated with a carbonate-substituted hydroxyapatite layer.
Figure 6(a, b) shows SEM micrographs of the cross-sections of the 13-93 glass
prior to immersion in SBF and after immersion for 14 days. Micrographs were also
obtained for immersion times of 1 day and 7 days but they are omitted for the sake of
brevity. The as-formed HA layer in Figure 6(b) suffered from a greater degree of
degradation during the sample preparation step (grinding and polishing of the crosssection), which accounted for the rough nature of the layer seen in the micrograph. The
thickness of the HA formed after each immersion in SBF was determined from at least 5
SEM micrographs of the cross-section. Figure 7 shows data for the HA thickness versus
the immersion time in SBF. Within the limits of experimental error, the growth of the HA
layer was linear, increasing at a rate of ~0.4 µm per day. Since the HA product was
porous, it might be expected that the diffusion of ions through the liquid in the pores of
the HA would be fast, so the reaction at the planar interface between the HA and the glass
would be rate-controlling. For an interface reaction-controlled mechanism, a linear
increase in the reaction layer thickness would be expected, as indeed observed in Figure
7.
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The mechanism of formation of silicate-based bioactive glasses, such as 45S5
glass, in a dilute phosphate solution, such as an SBF, has been discussed by Hench [1719]. It is expected that a similar mechanism would operate for the silicate-based 13-93
glass used in the present work because it is based on the 45S5 composition. The present
work provided information on the structure and characteristics of the HA formed on the
13-93 glass surface, as well as the rate at which the HA layer formed. Recent data for the
conversion of particles of 45S5 glass and 13-93 glass at 37°C in 0.02 M K2HPO4
solution with a pH of 7.0 indicated that the formation of HA was slower for the 13-93
glass than for the 45S5 glass [40,41].
Figure 8 shows SEM micrographs of the surface of the glass prior to, and after
immersion in the SBF. Except for scratches and grooves resulting from the grinding
process, the surface of the glass was flat and featureless (Fig. 8(a)). After 1 day (Fig.
8(b)), the surface of the glass was covered with a reaction layer, shown earlier by thinfilm XRD to be amorphous. The reaction layer (but not the underlying glass) contained
cracks, typical of capillary-induced drying cracks. After 7 days (Figure 8(c)), the glass
surface was covered with a reaction layer on which another layer of precipitates were
forming. The reaction layer, shown earlier to consist of a carbonate-substituted HA, also
contained typical drying cracks. High-resolution SEM (Figure 8(d)) showed that the
precipitates consisted of a porous network of nanoscale crystals, not unlike the rod-like
HA crystals in human bone.
The ability to fabricate 13-93 glass particles into a complex shape was
demonstrated by using the articulating surface of a proximal human tibia as a model.
Figure 9 shows a [1/4] scale model of the tibial surface, measuring ~1.5 in × 1 in, with a
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thickness of 0.5 inch. Since the tibial construct was prepared using the same conditions
described previously, the structure, mechanical properties, and chemical properties
should be almost identical to those described earlier for the cylindrical samples.
The present work demonstrated that 13-93 glass particles can be formed into constructs
with the porous structure and complex shape suitable for applications in bone tissue
engineering. Future work will examine the in vitro interaction with cells and the in vivo
behavior of the glass constructs.

4. SUMMARY AND CONCLUSIONS

Porous cylindrical constructs of a silicate-based 13-93 glass were prepared using a
process involving slip-casting and sintering of particles (255-325 µm). The cylinders had
a porosity of 40–45%, with the majority of the pores having sizes in the range of 100–300
µm. The compressive strength of the porous cylinders was 22 ± 1 MPa. Upon immersion
in a simulated body fluid at 37°C, a carbonate-substituted hydroxyapatite was detected on
the glass surface in less than 7 days, indicating the bioactivity of the glass and the
potential for bonding to bone. The rate of formation of the hydroxyapatite layer on the
glass was ~0.5 µm per day. The ability to form a porous construct with the shape of a
human tibia was demonstrated. The bioactivity of 13-93 glass, coupled with the ability to
make porous constructs with anatomically correct dimensions, indicates the suitability of
this material for applications in bone tissue engineering.
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Table 1. Ion concentration (mM) in SBF and in human blood plasma [31]
Ion

Na+

K+

Mg2+

Ca2+

Cl-

HCO3-

HPO42-

SO42-

SBF

142.0

5.0

1.5

2.5

147.8

4.2

1.0

0.5

Human plasma

142.0

5.0

1.5

2.5

103.0

27.0

1.0

0.5

-0.10

o

Normalized ∆T endo down ( C/mg)
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Figure 1. Differential thermal analysis of 13-93 glass, showing the glass transition and
crystallization regions.
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Figure 2. SEM of (a) the surface of a porous glass construct prepared by sintering, (b) the
neck region between two particles, showing bonding between the particles, and (c) a
cross-section of the construct showing the bonded particles and pores.
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Figure 3. Mercury porosimetry of the fabricated constructs, showing the pore volume and
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Figure 6. SEM micrographs of the cross-sections of the 13-93 glass (a) prior to
immersion, and (b)after immersion for 14 d in a simulated body fluid at 37°C, showing
the hydroxyapatite layer.
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Figure 8. SEM of (a) the surface of 13-93 glass, and the surface after immersing the glass
in a simulated body fluid for 1 day (b), and 7 days (c). A high magnification micrograph
of the surface (7 days immersion) is shown in (d).
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Figure 9. Optical micrograph of a porous construct with the shape of the articulating
surface of a human proximal tibia prepared by slip casting and sintering 13-93 glass
particles.
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ABSTRACT

A polymer foam replication technique was used to prepare porous constructs of
bioactive 13-93 glass with a microstructure similar to that of human trabecular bone. The
constructs, with a porosity of 85 ± 2% and pore size of 100–500 µm, had a compressive
strength of 11 ± 1 MPa, approximately equal to the highest value reported for human
trabecular bone. The strength was also considerably higher than the values reported for
polymeric, bioactive glass-ceramic, and hydroxyapatite constructs prepared by the same
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technique and with the equivalent level of porosity. The in vitro bioactivity of the
fabricated constructs was observed by the conversion of the glass surface to a
nanostructured hydroxyapatite layer within 7 days in a simulated body fluid at 37°C.
Scanning electron microscopy indicated a continuous increase in cell density on the
scaffolds during 6 days of culture. Protein and MTT assays of in vitro cell cultures
showed excellent ability of the scaffolds to support the attachment and proliferation of
MC3T3-E1 pre-osteoblastic cells, both on the surface and in the interior of the porous
constructs. Scanning electron microscopy showed cells with a closely adhering, well
spread morphology and a continuous increase in cell density on the scaffolds during 6
days of culture. The results indicate that the 13–93 bioactive glass scaffolds could be
applied to bone repair and regeneration.

Keywords: scaffold; bioactive glass; cell culture

1. INTRODUCTION

The development of synthetic scaffolds and their processing into structures that
have properties tailored for applications in bone repair and regeneration are becoming
increasingly important, because of several shortcomings of autografts (limited supply and
donor site morbidity) and allografts (immune rejection and possible transmission of
pathogens). In addition to being biocompatible, scaffold materials for bone repair and
regeneration should have adequate mechanical properties to support physiological loads.
Tissue infiltration and facile integration of the scaffold with surrounding tissue are
required for ultimate clinical application.
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Some synthetic and natural polymers, such as poly(lactic acid) (PLA),
poly(glycolic acid) (PGA), copolymers of PLA and PGA, and collagen are
biodegradable, so the scaffold can be gradually replaced by new bone matrix synthesized
by tissue-forming cells [1–4]. However, the use of degradable polymers for replacing
load-bearing bones is often challenging, because of their low mechanical strength [1].
Reinforcement with particles or short fibers of hydroxyapatite (HA) or bioactive glass
improves the load-bearing properties of these polymers, and provides scaffolds that are
biodegradable as well as bioactive [5–7]. Bioactive glasses, glass–ceramics and ceramics
are attractive scaffold materials for bone repair, because of their abilities to enhance bone
formation and to bond to surrounding tissue [8,9]. Upon implantation, bioactive glasses
gradually convert to HA, the main mineral constituent of bone [9–12], and are
osteoconductive as well as osteoinductive [9]. Although brittle, bioactive glass scaffolds
can provide higher mechanical strength than the aforementioned polymers [13]. The
silicate-based bioactive glass designated 45S5, approved for in vivo use in the USA and
elsewhere, has been widely investigated for biomedical applications [9]. The 45S5 glass
cannot be easily pulled into fibers because of its tendency to devitrify (crystallize).
Thermal bonding (sintering) of 45S5 particles into anatomically relevant shapes requires
temperatures of ~ 1000 ºC and higher, which leads to devitrification to form a
predominantly combeite crystalline phase (Na2O ⋅ 2CaO ⋅ 3SiO2). While devitrification
does not inhibit the ability to form an HA surface layer, the rate of conversion to HA (the
bioactive potential) is reduced [14,15].
Another silicate-based bioactive glass, designated 13–93, with a modified 45S5
composition [16,17], has more facile viscous flow behavior and less tendency to
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crystallize than 45S5. The 13–93 glass is approved for in vivo use in Europe. The glass
can be pulled into fibers, and particles or short fibers have been sintered, without
devitrification, to form porous scaffolds with anatomically relevant shapes, such as the
human proximal tibia [13]. Porous scaffolds consisting of 13–93 fiber rafts supported the
in vitro growth and differentiation of MC3T3-E1 preosteoblastic cells [18].
Quantitative measurement of DNA showed no significant difference in cell proliferation
between dense disks of 45S5 and 13–93 glass [18]. Several techniques have been
employed to produce porous three-dimensional scaffolds of polymers and bioactive
ceramics. These methods include thermally induced phase separation (TIPS) [19,20],
solid freeform fabrication [21,22], solvent casting and particle leaching [23,24],
freezecasting [25–28] and polymer foam replication [15,29–32]. Interconnected pores
with a mean diameter (or width) of 100 µm or greater and open porosity of >50% are
generally considered to be the minimum requirements to permit tissue ingrowth and
function in porous scaffolds [33,34].
Using a foam with the appropriate architecture, scaffolds with a microstructure
approximating trabecular bone can be prepared by the polymer foam infiltration
technique [35]. In this technique, a polymer foam is infiltrated with a stable suspension of
colloidal particles. After drying, the system is heated to decompose the polymer foam,
and sintered at a higher temperature to densify the network of particles. The method has
been used to prepare porous scaffolds of 45S5 glass–ceramic [15], HA [29,30], biphasic
calcium phosphate [31] and akermanite [32]. The strength of the construct is critically
dependent on the ability to achieve a solid network with high density. This is dependent
on the particle packing of the infiltrated foam, which, in turn, is dependent on the colloid
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stability of the suspension used to infiltrate the foam. Generally, a stable suspension leads
to a more homogeneous and higher particle packing density in the infiltrated foam, which
leads to more facile densification of the particulate network.
Based on the aforementioned forming characteristics and bioactivity of 13–93
glass, coupled with the ability of the polymer foam infiltration technique to produce a
bone-like microstructure, an investigation of the mechanical and in vitro performance of
13–93 glass scaffolds prepared by this technique was undertaken. The microstructure and
compressive mechanical properties of the fabricated scaffolds were characterized, and the
ability of the constructs to support the attachment and growth of osteoblastic cells was
evaluated. The mouse MC3T3-E1 cell line chosen for these experiments has been used
extensively in previous in vitro investigations of biomaterials for bone repair and tissue
engineering [36,37].

2. MATERIALS AND METHODS
2.1 Preparation of 13-93 Glass Scaffolds

Glass with the 13–93 composition (wt.%) (53SiO2, 6Na2O, 12K2O, 5MgO, CaO,
4P2O5) was prepared by melting a mixture of analytical grade Na2CO3, K2CO3, MgCO3,
CaCO3, SiO2 and NaH2PO4 ⋅ 2H2O (Fisher Scientific, St. Louis, MO) in a platinum
crucible at 1300 ºC and quenching between stainless steel plates. The glass was crushed
in a hardened steel mortar and pestle and classified using stainless steel sieves to provide
particles of size <150 µm. These particles were further ground for 2 h in an attrition mill
(Model 01-HD, Union Process, Akron, OH), using high-purity Y2O3-stabilized ZrO2
milling media and ethanol as the solvent, to provide particles in the colloidal size range
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(<5–10 µm). The average size and size distribution of the particles were measured using a
laser diffraction particle size analyzer (Model LS 13 320; Beckman Coulter Inc.,
Fullerton, CA).
The colloidal properties of the 13–93 glass particles and the ability of different
dispersants to stabilize the particles in water were investigated in order to prepare stable
suspensions for use in the polymer foam replication technique. Preliminary experiments
were performed to test the sedimentation behavior of suspensions (5 vol.% particles)
stabilized with 0.25–2 wt.% of five different dispersants (based on the dry mass of the
particles). The dispersants were ammonium polymethacrylate (Darvan C; mol. wt. =
10,000–16,000; R.T. Vanderbilt Co., Norwalk, CT), sodium polyacrylate (Darvan 811,
mol. wt. = 5000; R.T. Vanderbilt Co.), poly(methylvinyl ether) (EasySperse; ISP, Wayne,
NJ), Dynol 604 (Air Products & Chemicals Inc., Allentown, PA) and Targon 1128 (BK
Ladenburg GmbH, Ladenburg, Germany). The suspensions were poured to a height of ~
5 cm into test tubes (~ 3 cm in diameter × 6.5 cm) and, after vigorous shaking, allowed to
settle for 24 h. The suspensions stabilized with Dynol 604 or Targon 1128 settled almost
completely to give loose flocculated sediments, indicating that these two dispersants were
ineffective for stabilizing the particles. On the other hand, the suspensions stabilized with
EasySperse showed the least sedimentation, whereas Darvan C or Darvan 811 produced
sedimentation results that were intermediate between those for EasySperse and Dynol
604 (or Targon 1128). Because of their ineffectiveness, Dynol 604 and Targon 1128 were
not used in subsequent experiments.
The zeta-potential of the particles in an aqueous medium, with or without the
presence of Darvan C, Darvan 811 or EasySperse, was measured as a function of the pH
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of the aqueous medium using electrophoresis (Zeta-meter 3.0, Zeta-Meter Inc., NY). At
each pH value, the zeta-potential was measured at least 10 times, and the results were
determined as a mean ± standard deviation. To determine the concentration of dispersant
for optimum stability, the viscosity of the suspension (35 vol.% particles) was measured
as a function of the dispersant concentration using a rotating cylinder viscometer (VT500;
Haake Inc., Paramus, NJ).
Aqueous suspensions containing 20–50 vol.% glass particles, 0.5 wt.%
Easysperse as dispersant and 1 wt.% poly (vinyl alcohol) (PVA; DuPont Elvanol® 90–
50) as binder were prepared by ball milling for 24 h in polypropylene bottles using Al2O3
as the milling media. (The concentrations of the dispersant and binder were based on the
dry mass of glass powder used.) The viscosity of the suspensions vs. particle
concentration was measured using a rotating cylinder viscometer (Haake VT500).
Based on the zeta-potential and viscosity data, an aqueous slurry containing 35
vol% glass particles, 0.5 wt% Easysperse as dispersant, and 1 wt% poly(vinyl alcohol),
PVA, (DuPont Elvanol® 90-50) as binder, was prepared and used in subsequent
experiments for preparation of the constructs. (The concentrations of the dispersant and
binder were based on the dry mass of glass powder used.) The suspension, in
polypropylene bottles and with Al2O3 as the milling media, was milled for 24 h in a ball
mill to provide a homogeneous slurry.
Four commercial polymer foams were examined in a scanning electron
microscope (Hitachi S-4700) and the structure of each foam was compared with that of
human trabecular (or cancellous) bone. On the basis of these observations, a polyurethane
foam with a structure close to that of trabecular bone was selected for the present
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experiments. Scaffold was prepared by infiltrating the particulate slurry (35 vol.%
particles) into a polyurethane foam (9mm in diameter × 20mm thick), so that the walls of
the foam were coated with the slurry. Excess slurry was squeezed out of the foam. In the
infiltration step, the immersed foam was compressed and released several times to let the
slurry adhere to the walls of the polymer network. The as-coated foam was dried at room
temperature for 24 h, and then subjected to a controlled heating schedule to first
decompose the polymer phase, and then densify the network of glass particles. The
sample was heated at 1°C/min to 500°C in flowing O2 gas to decompose the foam, then at
5°C/min to 700°C, and kept at this temperature for 1 h to densify the glass network and
form a porous, cylindrical glass construct without crystallizing the glass. A diamondcoated wafering blade was used to section the porous glass cylinder to disk-shaped
scaffolds (6mm in diameter ×2mm thick) for use in the cell culture experiments.

2.2 Characterization of 13-93 Glass Scaffolds

To assess the crystallinity of the 13–93 glass after sintering, scaffolds were
ground into a powder (particle size <45 µm) and analyzed using X-ray diffraction (XRD;
Rigaku, Model D/mas 2550 v) in a step-scan mode (0.05º 2θ and 2 s per step; Cu Kα
radiation; λ = 0.15406 nm). For comparison, the powder of a sample of dry human
trabecular bone was also analyzed using XRD. Samples of the 13–93 glass constructs and
a section of dry human bone were sputter-coated with Au/Pd and examined in a scanning
electron microscope (SEM; Hitachi S-4700) to compare the pore morphology of the
scaffolds with that of human trabecular bone. The open porosity of the samples was
measured using the Archimedes method. Pore size distribution of the accessible (open)
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pores was measured using mercury intrusion porosimetry (Poremaster; Quantachrome,
FL) [38]. The compressive strength of cylindrical samples (6 mm in diameter × 12 mm
long) was measured using an Instron testing machine (Model 4881; Instron Co.,
Norwood, MA) at a crosshead speed of 0.5 mm min-1. Eight samples were tested, and the
mean strength and standard deviation were determined.

2.3 Assessment of Scaffold Bioactivity

Porous scaffolds and dense disks of 13–93 glass were immersed in simulated
body fluid (SBF) at 37ºC and then analyzed for the formation of a calcium phosphate
layer on the glass surfaces as one indication of bioactivity. The composition of the SBF
was identical to that described by Kokubo et al. [39]. Cylindrical scaffolds (6 mm in
diameter × 2 mm thick) and disks (10 mm in diameter × 2 mm thick) were cleaned with
ethanol in an ultrasonic bath, dried in air and placed in sealed polyethylene bottles
containing 50 ml of SBF at 37 ± 2 ºC. The SBF was replaced every 24 h. After a given
immersion time, the scaffolds and disks were dried for at least 24 h in air at room
temperature and observed in the SEM. Crystalline phases formed on the surface of the
glass disks were detected using thin-film XRD at a scanning rate of 1.8º/min in the 2h
range 10–80º.

2.4 Cell Culture

The established MC3T3-E1 line of mouse pre-osteoblastic cells was obtained
from ATCC and cultured in ascorbic acid-free α-MEM medium supplemented with 10%
fetal bovine serum plus 100 U/ml penicillin and 100 µg/ml streptomycin sulfate. Prior to
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seeding with cells, dry-heat sterilized scaffolds (6 mm in diameter × 2 mm thick) were
soaked for 1 h in a 0.01% solution of polylysine (mol. wt. >150,000) to enhance cell
adhesion. The pre-treated constructs were blotted dry, rinsed twice with phosphate
buffered saline (PBS), placed on a 6 cm diameter Teflon disk, and seeded with 50,000
MC3T3-E1 cells suspended in 35 µl of complete medium. After incubation for 4 h to
permit cell attachment, the cell-seeded constructs were transferred to a 24-well plate
containing 2 ml of complete medium per well. The control group consisted of the same
amount of cell suspension cultured in the wells with 2 ml of complete medium. All cell
cultures were performed at 37 ºC in a humidified atmosphere of 5% CO2, with the
medium changed every 2 days.

2.5 MTT Detection of Viable Cells

Some of the cell-seeded scaffolds were laced in 400 µl serum-free medium
containing 100 µg of the tetrazoliumTetrazolium salt MTT for the last 4 h to permit
visualization of metabolically active cells on and within the porous 13-93 glass
constructs. After the incubation, the constructs were briefly rinsed in PBS and blotted
dry. Images of the constructs were obtained using a stereomicroscope fitted with a digital
camera to qualitatively assess the distribution of purple formazan, a product of
mitochondrial reduction of MTT by viable cells. The MTT-labeled scaffolds were frozen
at -70 ºC and fractured with a cooled microtome blade, and the fracture cross section
visually examined to assess the presence of purple formazan within the interior of the
scaffold.
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2.6 Cell Morphology

At selected culture intervals glass scaffolds with attached cells were removed,
washed twice with warm PBS, and placed in 2.5% glutaraldehyde in PBS. After an
overnight soak in glutaraldehyde, fixed samples were washed extensively with PBS,
dehydrated with a graded ethyl alcohol series, and then soaked for 10 min in
hexamethyldisilazane (HMDS). After a second wash in HMDS, the samples were were
allowed to fully evaporate before being sputter-coated with Au/Pd. The samples were
observed in an SEM at 5 kV accelerating voltage.

2.7 Quantitative Protein Assay

Total protein in lysates recovered from the cell-seeded scaffolds was measured
with a micro-BCA Protein Assay Kit (Piece Biotechnology, Rockford, IL) to assess cell
proliferation on the scaffolds. Cells were detached from the glass constructs and the
control wells by lysis in 400 µl of 1% Triton solution for 1 h. Aliquots of the released
lysate were mixed with 100 µl of micro-BCA working reagent and the resultant mixture
incubated at 50ºC for 20 min. Sample absorbance values were measured at 550 nm in a
BMG FLUORstar Optima plate reader with bovine serum albumin used as a standard for
comparison.

2.8 Statistic Analysis

All biological experiments (4 samples in each group) were run either in duplicate
or triplicate. The data are presented as the mean ± standard deviation. Statistical analysis
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was performed using Student’s t-test. Values were considered to be significantly different
when p<0.05.

3. RESULTS
3.1 Particle and Suspension Properties

The median particle size (d50) was 2.0 µm, with a standard deviation of the mean
= 1.0 µm. Fig. 1 shows data for the zeta-potential of the 13-93 glass particles as a
function of the pH of the aqueous suspension, for suspensions containing no dispersant,
and for suspensions containing Darvan 811, Darvan C, or EasySperse (1.0 wt% based on
the dry mass of the glass particles). The isoelectric point (the pH at which the zetapotential is zero) was found to be pH ≈ 3.0. When a bioactive glass is immersed in an
aqueous solution, ions (such as Na+) dissolve from the glass into the solution at different
pH values [9,10], which might be expected to influence the zeta-potential of the glass
particles. For silicate 45S5 bioactive glass, Hench [9] showed that the early stages of the
dissolution process resulted in the formation of a silica-rich surface layer. Since the 13–
93 composition is based on that of 45S5, a similar dissolution mechanism might be
expected. Furthermore, the time frame for each zeta-potential measurement was <30 min,
so the surface layer might correspond to that of a silicate glass. If additional changes
occur, such as the formation of a calcium phosphate material on the surface of the glass
particles, then changes in the zeta-potential might be expected at later times.
Both Darvan 811 and Darvan C caused no change in the zeta-potential of the
particles, which may be an indication that these two anionic dispersants were not
adsorbed (or only weakly adsorbed) on to the particle surfaces. These two anionic
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dispersants are highly charged at pH values >4–5, due to a high degree of dissociation
[38]. Significant adsorption should result in a marked change in the zeta-potential of the
particles, which was not observed. On the other hand, a considerable increase in the
magnitude of the zeta-potential occurred with the dispersant EasySperse, indicating that
this anionic dispersant was adsorbed onto the particle surfaces. Since the higher zetapotential was expected to provide enhanced colloidal stability of the suspension by the
mechanism of electrosteric stabilization, the data indicated that EasySperse was more
effective for dispersing 13–93 glass particles than Darvan C or Darvan 811.
The optimum concentration of EasySperse required to stabilize the glass particles
was determined from the data for the viscosity of an aqueous suspension (35 vol%
particles) as a function of the dispersant concentration at a constant shear rate (100 s–1).
Fig. 2 indicated that 0.5 wt% EasySperse gave the lowest viscosity of the suspension
(~220 mPa.s). Henceforth, the aqueous suspensions used in the experiments were
stabilized with 0.5 wt% EasySperse.
Fig. 3 shows the relative viscosity (shear rate =100 s–1) of the suspension as a
function of glass particle concentration. The data can be fitted by a modified KriegerDougherty equation [40, 41]:

⎛
φ ⎞
⎟⎟
η r = ⎜⎜1 −
φ
m ⎠
⎝

−n

(1)

where ηr, the relative viscosity, is defined as the viscosity of the suspension, η, divided
by the viscosity of the solvent (water) ηL, φ is the volume fraction of the particles, φm is
the volume fraction of particles at which the viscosity becomes practically infinite, and n
is a fitting parameter. The maximum solids loading predicted by this model was φm = 55
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vol%, with n = 3.4. The colloid stability and viscosity of the suspension are important
parameters for the preparation of scaffolds by the polymer foam replication method.
Highly concentrated suspensions (>40 vol.% particles) were difficult to infiltrate
homogeneously into the foam, whereas suspensions containing less than ~20 vol.%)
resulted in scaffolds that were too weak for handling. A suspension containing 35 vol.%
particles was selected to provide a compromise between ease of infiltration and scaffold
strength.

3.2 Microstructure of Fabricated 13-93 Glass Scaffolds

Fig. 4a shows that the microstructure of the polyurethane foam used in these
experiments was generally similar to that of a sample of dry human trabecular bone (Fig.
4b). The microstructure of a fractured cross-section of the 13–93 glass scaffold (Fig. 4c
and d) consisted of a dense network of glass and interconnected cellular pores. In general,
the microstructural and morphological features of the scaffold were similar to those of
human trabecular bone (Fig. 4b). The solid network (50–100 µm in diameter) of the
scaffold appeared to be fully dense, with a smooth surface, and the diameter of the pores
was in the range 100–500 lm. At the sintering temperature used, no visible deformation
of the overall shape of the scaffold occurred. The porosity of the scaffolds was 85 ± 2%.
Mercury intrusion porosimetry (Fig. 5) confirmed the SEM observations that the
fabricated glass constructs contained interconnected pores of size ~100–500 µm.

3.3 Mechanical Properties of Fabricated 13-93 Glass Scaffolds
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The stress–strain behavior of a fabricated 13-93 glass scaffold in compression is
shown in Figure 6. The stresses and strains are the engineering values calculated from the
initial cross-sectional area and length. The peaks and valleys in the curve may be related
to progressive breaking of the solid particulate network. The response showed linear
elastic behavior during the initial compression, followed by a decrease in stress, possibly
because of the fracture of some struts in the solid network. As the strain increased, the
additional struts were fractured. Finally, the macro-cracks propagated in the scaffold,
leading to a decrease in stress to almost zero. The determination of the elastic modulus
from compression tests is subject to several sources of error, which can lead to
considerable variation. In the present experiments, the modulus determined from the
initial linear region of the stress–stain curve was 3.0 ± 0.5 GPa. Taking the compressive
strength as the highest stress on the stress–strain curve, the average compressive strength
was 11 ± 1 MPa for eight samples tested (porosity = 85 ± 2%)..

3.4 In vitro Bioactivity

Fig. 7 shows SEM images of the surface of a 13–93 glass scaffold after
immersion in an SBF for 7 days. Compared to the smooth glass surface of the asfabricated construct (Fig. 4a and b), the treatment in the SBF produced a fine particulate
surface layer. High-resolution SEM images (Fig. 7c) showed that the surface consisted of
a porous network of nanometer-sized, needle-like crystals.
XRD analysis showed that the as-formed porous glass scaffolds were amorphous
(Fig. 8b). The band centered at ~30º 2θ was indicative of an amorphous material. After
immersion for 7 days in the SBF, the thin-film XRD pattern of the dense disks (Fig. 7c)
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contained peaks corresponding to those of a reference HA(JCPDS 72-1243), indicating
the formation of HA on the glass surface. The width of the major peaks may be caused by
X-ray line broadening due to nanometer-sized crystals, confirming the presence of the
fine, needle-like crystals observed by SEM. The major peaks in thepattern also occurred
at approximately the same 2θ values as those for human trabecular bone (Fig. 8d).

3.5 Cell Culture

SEM images in Figure 9 show the morphology of MC3T3-E1 cell growth on the
surface of the 13–93 glass scaffolds for 2, 4 and 6 days. The pre-osteoblastic cells visible
in these micrographs were elongated and appeared to align along the long axis of the
dense struts of the scaffold. The cells were well-spread at all three culture intervals with
numerous cytoplastic projections, and they appeared to be well attached to the surface of
the constructs (Figure 9(a). The number of cells on the scaffold increased as a function of
culture time (Figure 9(b)). A highmagnification image (Figure 9(c)) showed cell growth
into pores of size <100 µm, as well as the formation of numerous cell projections,
features that indicated firm cell attachment to the surface. After culturing for 6 days,
almost the whole surface of the scaffold was covered with cells (Figures 9(d) and 9(e)),
and cell spreading on the struts was visible. The cells began to aggregate, and
neighboring cells appeared to maintain physical contact with each other by multiple
extensions (Figure 9(e)).
Results of the quantitative assay of total protein in cell lysates recovered from the
13–93 glass scaffolds and the control wells after incubations of 2, 4, and 6 days are
shown in Figure 10. The amounts of protein recovered from the scaffolds showed a
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nearly linear increase in cell proliferation during the 6-day incubation, a finding that
complements the progressive increase in cell density seen in the SEM images.
Furthermore, the results indicated that the cell proliferation kinetics on the scaffolds were
the same as those in the control wells. These data indicated that the MC3T3-E1 cells were
able to grow on the 13–93 glass scaffolds at essentially the same rate as they did on the
surface of plastic culture vessels.
Photographic images of cell-seeded scaffolds treated with MTT during the last 4 h
of incubation are shown in Figure 11. The purple pigment visible on the scaffold was an
indication of viable cells, and was the result of mitochondrial reduction of MTT to an
insoluble formazan product. The increase in intensity of the purple color with culture
time indicated the proliferation of viable, metabolically active cells on the scaffold
(Figure 11(a)). The purple formazan visible on the freeze-fracture face of a scaffold
cultured for 6 days (Figure 11(b)) indicated the presence of metabolically active cells
within the interior of the construct. Furthermore, the uniformly distributed purple
formazan on the surface and within the interior of the constructs indicated that the pore
network had good interconnectivity.

4. DISCUSSION

The colloid stability of the suspension is critical for achieving homogeneous
particle packing in the construct formed by the polymer foam infiltration technique, and
therefore for achieving a fully dense solid network during sintering. By optimizing the
suspension characteristics and heating schedule, 13–93 glass scaffolds with a porosity of
85 ± 2% and pores of size 100–500 µm were produced. The use of a selected polymer
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foam resulted in the production of constructs with a microstructure approximating that of
trabecular bone (Figure 4). The compressive strength of the fabricated 13-93 glass
constructs (11 ± 1 MPa) was approximately equal to the highest compressive strength
reported for trabecular bone (2–12 MPa) [42,43]. The mechanical behavior of cellular
solids with open cells has been described by the Gibson and Ashby model [35].
According to the model, the compressive strength scr of brittle cellular foams (ceramic or
glass) is given by:

σ cr
ρ
1 + (ti / t ) 2
1 + (ti / t ) 2
= C1 ( )3 / 2
= C1 (1 − P )3 / 2
σ fs
ρ0
1 − (ti / t ) 2
1 − (ti / t ) 2

(2)

where σcr is the compressive crushing strength of the brittle foam, σfs is the modulus of
rupture of the struts, C1 is the constant of proportionality, ρ and ρo are the density of the
porous cellular material and the fully dense solid, respectively, P is the porosity of the
cellular material, ti/t is the ratio of the box-like central voids and the struts size. The
modulus of rupture in bending is the maximum stress at failure. For 13–93 glass fibers
with a diameter of 50–100 µm, the tensile strength has been reported as 650 ± 390 MPa
[44]. The diameter of the struts in the sintered 13-93 glass scaffolds was in the range 50–
100 µm, so the modulus of rupture of the struts was estimated as the tensile strength of
the 13–93 glass fibers. For brittle cellular foams, C1 = 0.2 [35]. The struts in the present
work were almost fully dense, so ti/t = 0. Based on these values, the compressive strength
of the 13–93 glass scaffolds (P = 0.83–0.87) was predicted to be 2–15 MPa, which is the
same order of magnitude as the measured compressive strength (11 ± 1 MPa).
The measured compressive strength of the 13-93 glass constructs was at least one order
of magnitude higher than the values reported for biodegradable polymer scaffolds or
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polymer– ceramic composites prepared by the TIPS method or by the gas foaming
method [5,20,45,46]. The strength was also considerably higher than the values reported
for bioactive glass-ceramic and HA constructs with similar porosity, which were
produced by a polymer foam replication technique. Glass-ceramic constructs formed
from bioactive 45S5 glass had a compressive strength of 0.3–0.4 MPa (porosity = 89–
92%) [15], and constructs formed from a calcium phosphate glass had a compressive
strength of 0.8–1.4 MPa [47]. HA constructs had compressive strengths of 0.01–0.2 MPa
(porosity = 86%) [29], 0.2 MPa (porosity = 86%) [48], and 0.6–5.0 MPa (porosity =70–
77%) [30], while HA constructs coated with apatite–wollastonite (A/W) glass ceramic
had a compressive strength of .1 MPa (porosity = 93%) [49]. A higher compressive
strength of 17 MPa (porosity = 73%) was obtained for HA constructs prepared by a gas
foaming technique [50], whereas a much higher strength (30 ± 8 MPa) was obtained for
HA constructs formed by a solid freeform fabrication (or rapid prototyping) technique but
the porosity of the constructs was only 35% [51].
When compared to constructs prepared by the polymer foam replication
technique, the higher strength achieved in the present work was attributed to two reasons:
(1) the homogeneous particle packing in the as-formed constructs, which facilitated the
densification of the particulate network during sintering, and (2) the ease of densifying
the particulate network during sintering, due to the favorable viscous flow characteristics
of 13–93 glass. In comparison, 45S5 glass suffers from limited viscous flow, and the
glass crystallizes prior to densification, so full densification of the particulate network of
the construct is difficult. In the polymer foam replication technique, decomposition of the
polymer results in the formation of triangular voids in the particulate network [52]. In
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glass-ceramics and crystalline ceramics such as HA, these triangular voids, much larger
than the particle size of the material, are difficult to remove during the sintering stage
because of the limited viscous flow or diffusion in these materials. This residual porosity
in the solid network of the cellular structure leads to a reduction in strength. The
triangular voids in the constructs fabricated in this work were filled by facile viscous flow
of the 13–93 glass during sintering, giving a dense solid network with higher strength.
The elastic modulus of the fabricated 13–93 glass scaffolds was 3.0 ± 0.5 GPa,
approximately equal to the upper limit of values reported for human trabecular bone (0.1–
5 GPa) [36]. The elastic modulus of cellular low-density solids is given by [35]:
n

⎛ ρ ⎞
E
n
= C2 ⎜⎜ ⎟⎟ = C2 (1 − P )
Eo
⎝ ρo ⎠

(3)

where E and Eo, are the elastic modulus of the porous cellular material and the fully
dense solid, respectively, C2 and n are constants that depend on the microstructure, where
C2 includes all geometric constants of proportionality. For cellular structures with a dense
solid network, C2 = 1, whereas in the case of a hollow ceramic network with a central
void, C2 = 0.3. The constant n has a value in the range 1 < n <4, with n = 2 for open-cell
structures. Microstructural observations (Figure 4) indicated that the fabricated 13-93
constructs can be approximated as an open-cell structure in which the solid network was
fully dense. In this case, C2 = 1, and n = 2. The elastic modulus of dense silicate glass is
60–80 GPa [53]. Using these values, and the measured porosity of the fabricated glass
constructs (P = 0.83–0.87), the elastic modulus E of the porous glass scaffold is predicted
to be 1.0–2.3 GPa, which is within a factor of 2 of the measured value (3.0 ± 0.5 GPa).
The formation of a biologically active HA layer, which is equivalent chemically and
structurally to the main mineral constituent of bone, is a key requirement for developing a
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strong interfacial bond between bioactive ceramics and tissues in vivo [9]. The formation
of an HA surface layer in vitro is indicative of a material’s bioactive potential in vivo [3].
In the present work, the formation of an HA surface layer was observed within 7 days for
the 13-93 glass immersed in an SBF (Figure 7). The HA crystals were similar to those of
human trabecular bone in terms of size, morphology, and chemical composition. In
comparison, the formation of an amorphous calcium phosphate layer on the surface of
porous 45S5 glass-ceramic constructs was observed after 28 days in an SBF [15]. More
rapid formation of an HA layer is favorable for obtaining early biological fixation of a
bioactive implant in bone repair and regeneration.
The MC3T3-E1 cells are a well-characterized mouse pre-ostoblastic cell line, and
they have been used widely for in vitro cytotoxicity testing of biomaterials [36,37]. The
M3T3-E1 cell morphology on the porous 13–93 glass scaffolds in this work was similar
to that observed on 45S5 glass discs reported elsewhere [54]. The cells colonized the
surfaces of the porous 13-93 glass scaffolds, and aggregated with each other. The cell
morphology, coupled with the in vitro cell culture data, indicated the ability of the 13–93
glass scaffolds to support the attachment and proliferation of MC3T3-E1 osteoblastic
cells, both on the surface and within the interior of the porous constructs (Figures 9 to
11). This, coupled with the favorable pore characteristics, microstructure, in vitro
bioactivity, and compressive mechanical properties, indicates the potential of the
fabricated 13-93 glass constructs for eventual application in bone repair and regeneration.
Additional work is presently underway to assess the ability of the 13–93 glass scaffolds
to support the production of extracellular matrix and bone mineralization in vitro.
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5. CONCLUSIONS

Scaffolds of 13–93 bioactive glass, with a porosity of 85 ± 2% and pores of size
100–500 µm, were fabricated with a microstructure similar to that of trabecular bone
using a polymer foam replication technique. The constructs had a compressive strength of
11 ± 1 MPa and an elastic modulus of 3.0 ± 0.5 GPa, equal to the highest values reported
for human trabecular bone. Upon immersion in a simulated body fluid, a nanostructured
hydroxyapatite layer formed on the surface of the porous scaffolds within 7 days,
indicating the in vitro bioactivity of the scaffolds. In vitro cell culture and SEM
observations showed that the scaffolds had an excellent ability to support the attachment
and subsequent proliferation of MC3T3-E1 pre-osteoblastic cells, both on the surface and
in the interior of the constructs. The results suggest that the fabricated 13-93 glass
scaffolds could be applied as biological scaffolds for osseous repair and regeneration.
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Figure 1. Zeta-potential of 13-93 glass particles versus pH, for suspensions without
dispersant, and for suspensions containing 1 wt.% Darvan 811, Darvan C, or EasySperse.

284

320

Viscosity (mPa•S)

300

280

260

240

220
0.0

0.5

1.0

1.5

2.0

Dispersant concentration (%)

Figure 2. Viscosity of aqueous suspensions containing 35 vol% 13-93 glass particles
versus dispersant concentration (shear rate = 100 s–1).
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Figure 3. Relative viscosity versus volume fraction of glass particles in aqueous
suspensions stabilized with 0.5 wt% EasySperse (shear rate = 100 s-1).
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Figure 4. Microstructures of: (a) polyurethane foam used in the experiments; (b) dry
human trabecular bone; and (c, d) 13–93 glass scaffolds fabricated by a polymer foam
replication technique.
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Figure 5. Mercury porosimetry data for the pore volume and pore size distribution versus
pore radius, for the fabricated 13-93 glass scaffolds.
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Figure 6. Stress-strain response of porous 13-93 glass constructs in compression.
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Figure 7. SEM images of the surface of 13-93 glass construct after immersion for 7 days
in SBF: (a) lower magnification image; (b, c) higher magnification image showing fine
needle-like hydroxyapatite crystals.
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Figure 8. X-ray diffraction patterns of: (a) reference hydroxyapatite (JCPDS 72-1243);
(b) porous 13–93 glass scaffold in the as-sintered condition; (c) sintered 13–93 glass
scaffold after immersion in a simulated body fluid for 7 days; and (d) human trabecular
bone.
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Figure 9. SEM images of 13-93 glass constructs seeded with MC3T3-E1 cells and
cultured for (a) 2 days; (b,c) 4 days; (d,e) 6 days.
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Figure 10. Quantitative measurement of total protein content per scaffold or well in
MC3T3-E1 cell cultures incubated for 2, 4, and 6 d on porous 13-93 constructs prepared
by the polymer foam replication method, and in control wells. Mean ± sd; n = 4.
*Significantly increase in total amount of protein on the porous 13-93 glass constructs
with increasing culture duration (p<0.05).
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Figure 11. Cell-seeded 13–93 glass scaffolds treated with MTT: (a) surface of scaffolds
after culture intervals of 2, 4 and 6 days (left to right, respectively); and (b) freezefracture section of scaffold cultured for 6 days, showing clusters of MTT-labeled cells
within the interior.
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